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ABSTRACT 
During haematopoiesis multipotent stem cells generate all cellular components of the 
blood including lymphocytes. Despite great progress in the isolation of lineage 
restricted progenitors, the exact precursor-product relationship of these subsets remains 
poorly understood. In particular the exact branch point of T- and B-cell development in 
the bone marrow has not been unequivocally mapped. The aim of my project was to 
investigate the developmental relationship of various progenitor subsets in normal mice 
and during an acute inflammation. 
In order to permanently identify all cells which emanated from early lymphoid 
compartments we generated a mouse model in which a Cre recombinase was inserted 
into the Rag1 locus and functional Cre activity would result in activation of an eYFP 
reporter. Expression of the reporter was found in all T- and B-cells and in a significant 
subset of NK-cells and dendritic cells. Furthermore this model allowed the prospective 
isolation of an ‘ELP analogue’ and two subsets of CLPs on the basis of their reporter 
expression. Functional analysis of these subsets in vivo demonstrated comparable 
developmental properties with slightly different kinetics. Furthermore, in vitro analysis 
of isolated progenitors established that reporter-positive CLPs were significantly more 
advanced in their commitment to the B-cell lineage. 
We extended our studies by investigating the impact of an acute systemic inflammation 
on the size and composition of early haemato-lymphoid subsets. Administration of LPS 
or heat-inactivated E. coli to mice in vivo resulted in a complete halt of bone marrow 
lymphopoiesis. In addition, a marked decrease in the number of myeloid progenitors 
accompanied by upregulation of Sca-1 on haematopoietic progenitors was observed. 
These inflammation-induced changes were found to be mainly caused by IFNγ and to a 
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lesser extend by TNFα, thus identifying these cytokines as key mediators for the 
infection-induced regulation of haematopoiesis. 
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1.1 The discovery of haematopoietic stem cells 
The last fifty years of science have been critical to our understanding of embryonic and 
somatic development, owing to the discovery of pluripotent embryonic and multipotent 
adult stem cells. Defining characteristics of any stem cell are their ability to self-renew 
for several cell divisions (Verfaillie, 2002), the ability to generate at the single cell level 
differentiated progeny cells (Prockop, 1997) and the ability to functionally reconstitute 
a given tissue in vivo. Embryonic stem cells (ESCs), first obtained from mouse (Martin 
et al., 1981) and adult stem cells from various tissues have been shown to fulfill those 
criteria. It was found that ESCs from the inner cell mass of the blastocyst gave rise to 
cells from the three somatic germ layers; the ectoderm, the mesoderm and the endoderm 
(Martin, 1981; Thomson et al, 1998). The typical adult stem cell is considered 
multipotent as it can only give rise to differentiated cell types from the tissue of origin. 
For example, neural stem cells give rise to neurons, astrocytes and oligodendrocytes 
(Gage, 2000) whilst mesenchymal stem cells differentiate into fibroblasts, adipocytes, 
osteoblasts, chondrocytes and skeletal muscle cells (Prockop, 1997).  However, the 
most well characterised adult stem cells are those which give rise to all components of 
the blood, namely haematopoietic stem cells (HSCs).  
In 1961, Till and McCulloch demonstrated the existence of clonogenic bone marrow 
(BM) precursors that gave rise to multilineage haematopoietic colonies in the spleen. 
Such colonies, termed colony-forming unit spleen (CFU-S), were found to contain 
differentiated progeny of multiple blood lineages and a cellular subset of these colonies 
could re-establish CFU-S when transplanted into secondary hosts (Siminovitch et al., 
1963). Based mainly on these results, further research to elucidate the identity of BM 
progenitor cells was undertaken and in later years monoclonal antibodies were produced 
which were able to bind to specific cell surface markers on haematopoietic cells, and 
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which has since allowed the identification of stem and progenitor cells. In addition, 
isolation and transplantation of BM progenitor populations has indicated the functional 
roles of these cell types. One of the most important findings from these studies has been 
that HSCs are able to differentiate at the single cell level into all mature blood elements 
and can functionally repopulate the haematopoietic system of a lethally irradiated 
mouse in a process named haematopoiesis (Williams et al., 1984). 
 
1.2 The classical model of haematopoiesis  
Haematopoiesis is the developmental process generating all mature blood cells which, 
under normal conditions, is compartmentalised in the BM of an adult organism. This 
process originates from a pluripotent cell population, the long-term haematopoietic stem 
cell (LT-HSC), which constitutes in mice ~ 0.005% of BM mononuclear cells. The 
phenotypic and functional characterisation of this cell population was carried out by 
isolation of lineage negative (LIN–) Thy-1.1lo Sca-1hi cells, which were injected into 
lethally irradiated hosts and long term reconstitution was observed in all the lineages of 
the blood (Spangrude et al., 1988). This isolated population contained all functional 
LT-HSC activity and has subsequently allowed the prospective isolation of 
lineage-restricted progenitors downstream of HSCs (see Table 1), which can be grouped 
into various hierarchical developmental models. One of the most common models used 
in the literature to describe the developmental progression from a LT-HSC into a mature 
cell of the blood is the ‘classical’ hierarchical model (see Figure 1.1).  
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In the ‘classical’ model of haematopoiesis, LT-HSCs first differentiate into short term 
haematopoietic stem cells (ST-HSCs). All HSCs lack expression of lineage markers 
expressed by mature cell types, express the receptor tyrosine kinase c-kit and the GPI 
anchored protein Sca-1 and thus reside within the LIN– c-kithi Sca-1+ (LSK) fraction of 
the BM. ST-HSCs differ from LT-HSCs by possessing only limited self-renewing 
capacity and are phenotypically different by expression of the CD34 cell surface 
marker. Recently, all LT-HSCs have been identified by LSK CD150+ CD48– which is 
known as the ‘SLAM’ (Signaling Lymphocyte Activation Molecule) definition (Kiel et 
al., 2005). Kiel and colleagues reported that single LT-HSCs, identified by the SLAM 
definition, competitively reconstituted into irradiated mice gave rise to long-term 
reconstitution, whereas LT-HSCs isolated as LSK Thy1lo did not. Therefore, the SLAM 
definition provides a more simple and enhanced method to isolate a highly enriched 
population of LT-HSCs. This method would also be useful for the isolation and 
transplantation of pure LT-HSCs in order to fully repopulate cells of the blood in 
patients with immunological deficiencies. The next developmental step from ST-HSCs 
is the irreversible loss of self-renewal, producing a population named ‘multipotent 
progenitors’ (MPPs). Although this cell population also resides within the LSK 
compartment, these cells can be distinguished from ST-HSCs by low level expression of 
the tyrosine kinase receptor Flk-2 (foetal liver kinase 2; Adolffson et al., 2001). 
Expression of Flk-2 on haematopoietic progenitor cells has been shown to signify the 
stage in which cells lose long-term reconstitution potential (Zeigler et al., 1994) and 
develop down the lymphoid and myelo-erythroid lineages (Borge et al., 1999). 
According to the model by Akashi and colleagues (Akashi et al., 2000), MPPs then 
further differentiate along one of two pathways, the lymphoid or the myeloid-erythroid. 
It is thought that MPPs become irreversibly committed to one of these lineages, 
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eliminating the other lineage choice. In order to differentiate along these pathways, an 
MPP must first develop into one of two lineage restricted progenitors: a ‘common 
lymphoid progenitor’ (CLP)’ or a ‘common myeloid progenitor’ (CMP).  The lymphoid 
pathway gives rise to B-, T- and NK-cells whilst the myeloid pathway produces 
monocytes, granulocytes, platelets and red blood cells (RBCs).  
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Figure 1.1 
The ‘classical’ hierarchical model of haematopoiesis. 
 
Adapted from Akashi et al., 2000. 
In this hierarchical model of haematopoiesis, the generation of all blood lineages 
originates from self-renewing HSCs. LT-HSCs first give rise to ST-HSCs, losing some 
self-renewal activity. The next step in development is upregulation of Flk-2 on the cell 
surface, a population now known as MPPs. At this stage there is a strict bifurcation of 
the lymphoid and myelo-erythroid pathways. The CLP is thought to be the main 
progenitor giving rise to all mature lymphoid cells, whilst the CMP is the main myeloid 
progenitor which develops into a granulocyte-macrophage progenitor (GMP) or a 
megakaryocyte-erythroid progenitor (MEP), further differentiating into myelo-erythroid 
cells. 
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1.3 Lineage-restricted progenitors of the lymphoid and 
myelo-erythroid pathways 
According to the ‘classical’ hierarchical model of haematopoiesis (Figure 1.1), the first 
step in lineage restriction is thought to occur when a MPP commits to the lymphoid or 
myelo-erythroid lineage and in doing so, differentiates into a CLP or a CMP. Cellular 
requirements which distinguish a CLP from other BM progenitors include phenotypic 
isolation based specifically on IL-7Rα expression in the LIN– compartment of the BM. 
In addition, the CLP is thought to possess restricted lymphoid potential by producing 
T-, B- and NK-cells, with no evidence of myeloid potential. This cell population was 
identified phenotypically by Kondo et al., (1997) and comprised ~0.02% of BM cells. In 
this study, LIN– IL-7Rα+ c-kitint Sca-1int cells were transferred into Ly5.1+ mice and 
reconstitution of T and B donor-derived cells was evident in the blood. This lymphoid 
restricted developmental potential fulfilled the requirements of a CLP.  
Another BM progenitor which was identified by phenotypic isolation was the CMP 
(Akashi et al., 2000). This cell population was defined as LIN– Sca-1– c-kithi CD34+ 
FcγRII/IIIlo, and was reported to give rise to all myeloid lineages in vitro. This 
myelo-erythroid restricted progenitor developed into either a MEP, characterised as 
LIN– Sca-1– c-kithi CD34– FcγRII/IIIlo or a GMP, characterised as LIN– Sca-1– c-kithi 
CD34+ FcγRII/III+.  
Based mainly on these findings, it was hypothesised that CLPs and CMPs were the sole 
progenitors orchestrating development down the lymphoid and myeloid lineages. 
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1.4 Early progenitors of lymphopoiesis 
In the past ten years, the existence of intermediate progenitors between the ST-HSC and 
the CLP has created a more comprehensive view of lymphoid development. Adolfsson 
and co-workers (Adolfsson et al., 2005) reported heterogeneity of Flk-2 within the MPP 
compartment. Flk-2lo MPPs exhibited megakaryocyte-erythrocyte (MegE), 
granulocyte-macrophage (GM) and lymphoid potentials, whereas Flk-2hi MPPs lacked 
MegE potential. It was proposed that during the first lymphoid restriction step, MPPs 
lost their MegE potential, becoming ‘lymphoid primed multipotent progenitors’ 
(LMPPs) and gradually committing to the lymphoid lineage. However, this report was 
challenged by Forsberg and colleagues (Forsberg et al., 2006) who found that Flk-2+ 
LMPPs retained MegE potential in vivo. This group isolated Flk-2+ LMPPs from 
β-actinGFP mice, transplanted the cells into wildtype mice and found the presence of 
GFP+ platelets in the blood. They therefore proposed that segregation of lymphoid and 
myelo-erythroid lineages occurred in the MPP population and that restriction to the 
lymphoid or myelo-erythroid pathways only occurred after development into either CLP 
or CMP progenitors. However, although GFP+ platelets were detected, the frequency of 
donor-derived cells which had developed into platelets was less than that of LT-HSC, 
ST-HSC and MPP populations, suggesting that as cells developed into LMPPs, they 
were losing MegE potential. In addition, this group also analysed LMPPs for putative 
erythroid potential by using CFU-S assays. They reported detectable CFU-S from 
LMPPs by day ten, although with a lower frequency than LT-HSCs, ST-HSCs or MPPs, 
consistent with the gradual loss of MegE potential in this population. Therefore, 
although minor MegE potential was detected in the LMPP population, the majority of 
LMPP cells appeared to be losing MegE potential.  
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Yoshida et al., (Yoshida et al., 2006) however reported supporting evidence for the loss 
of MegE potential in LMPPs by analysing a transgenic reporter mouse strain expressing 
GFP under control of the Ikaros promoter. They observed high expression of reporter 
activity in the LMPP, which was additionally found to possess GM and T-cell potential, 
but no MegE potential. Furthermore, it was reported that the Flk-2hi MPP population 
lacked Gata1 or EpoR (Erythropoietin receptor) expression at the transcriptional level, 
genes indicative for MegE development (Månsson et al., 2007). In addition, Arinobu 
and colleagues (Arinobu et al., 2007) reported that in Gata1GFP mice, reporter 
expression could only be detected in LSK cells which were Flk-2–, and was absent in 
LMPP cells. Therefore, due to these recent reports, it is generally accepted that MegE 
potential is lost in the LMPP population. 
Another intermediate progenitor identified was the early lymphocyte progenitor (ELP). 
Igarashi and colleagues (Igarashi et al., 2002) utilised GFP expression to isolate ELPs in 
the LSK Flk-2+ CD27+ GFP+ subset upon transcription and translation of the 
recombinase activating gene 1 (Rag1) locus. It was reported that after intravenous 
injection, ELPs could give rise to NK-, B- and T-cells.  This cell population could also 
exhibit myeloid potential in vitro.  
The discovery of these additional lymphoid progenitors introduced refined models of 
haematopoiesis (Figure 1.2), however the relationship between the LMPP, the ELP and 
the CLP populations remains unclear. In addition, although all populations have been 
shown to contain robust T-cell potential, the identity of the sole progenitor population 
which exits the BM, enters the circulation and seeds the thymus, giving rise to thymic 
seeding cells (TSCs) and subsequently early thymic progenitors (ETPs) is not known.  
CHAPTER 1 
 30 
Table 1 
Definitions of haematopoietic progenitor populations. 
 
Table showing all haematopoietic progenitor populations, their abbreviations and the 
cell surface phenotype by which these cell populations can be identified. 
All stem cells and lymphoid progenitors, except the CLP, reside in the LSK 
compartment of the BM. In the LSK fraction, LT-HSCs differ in their phenotype to 
ST-HSCs by lacking the expression of CD34. Both HSC subsets are negative for Flk-2 
expression. As cells progress into the lymphoid compartment, Flk-2 expression appears 
on the surface of these cells (LMPPs) and Rag1 upregulation can be observed during 
further lymphoid development (ELPs). The CLP expresses intermediate levels of both 
c-kit and Sca-1 and is defined strictly according to IL-7Rα expression.  
Myelo-erythroid progenitors are defined according to FcγRII/III and CD34 expression 
and reside within the LIN– c-kithi Sca-1– fraction of the BM.  
Also included in this table is the common plasmacytoid and conventional dendritic cell 
progenitor (CDCP) which is believed to be the main progenitor giving rise to 
conventional (cDC) and plasmacytoid dendritic cells (pDC).  
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Cell population Abbreviation Phenotype 
Long term haematopoietic stem cell LT-HSC LIN– c-kithi Sca-1+ Flk-2–  CD34–  
Short term haematopoietic stem cell ST-HSC LIN– c-kithi Sca-1+ Flk-2–  CD34+  
Lymphoid primed multipotent progenitor LMPP LIN– c-kithi Sca-1+ Flk-2+ CD34+ 
Early lymphocyte progenitor ELP LIN– c-kithi Sca-1+ Flk-2+ Rag1GFP+ 
Common lymphoid progenitor CLP LIN– IL-7Rα+ Flk-2+ c-kitint Sca-1int 
Common myeloid progenitor CMP LIN– c-kithi Sca-1– CD34+ FcγRII/IIIlo 
Megakaryocyte-Erythroid progenitor MEP LIN– c-kithi Sca-1– CD34– FcγRII/IIIlo 
Granulocyte-Macrophage progenitor GMP LIN– c-kithi Sca-1– CD34+ FcγRII/III+ 
Common dendritic cell precursor CDCP LIN– c-kitint Flk-2+ MCSF-R+ IL-7Rα–  
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Figure 1.2 
Early lymphocyte development and thymic colonisation. 
 
Adapted from Ye and Graf, 2007. 
This model illustrates possible routes of T-cell development in relation to BM 
progenitors. Haematopoiesis begins in the LSK compartment of the BM with HSCs, 
which have the potential to develop into all cell types of the blood. In a first step, these 
cells become lymphoid-primed, losing MegE potential but retaining GM potential. 
These LMPPs are positive for Flk-2. It is believed that the LMPP population further 
develops into the ELP population, activating the Rag1 locus, and that this population 
further differentiates into the CLP. However, the relationship between these three 
lymphoid progenitor pools remains unclear, as highlighted by the red circles and the red 
arrows between populations. As cells develop down the lymphoid pathway, GM 
potential is gradually lost. It is thought the main cell type giving rise to B-cells is the 
CLP, however it is not known which cell type is responsible for ETP generation. This 
model favours the ELP as the main thymic colonising population which first develops 
into a TSC before becoming an ETP. However, the model does not rule out the 
possibility that the LMPP or CLP populations contribute to the constant replenishment 
of the intrathymic progenitor pool. 
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1.5 Cellular pathways of T-cell fate specification 
The entry of BM-derived progenitors into the thymus is not a simple process. Foss et 
al., (Foss et al., 2001) reported that the murine thymus is not continually receptive to the 
import of haematopoietic progenitors and that there are specific refractory periods 
whereby progenitors are able to enter the thymus more efficiently. The first step in this 
process of thymic settling is the efficient migration and homing of BM progenitors to 
become part of the ETP pool.  
Intrathymic T-cell development is initiated by the production of ETPs, which are 
defined by the phenotype LIN– CD44+ CD25– c-kithi (Godfrey et al., 1992). 
Development into a mature T-cell first entails the ETP progressing through double 
negative (DN) stages, characterised by the absence of CD4 and CD8 cell surface 
expression.  These DN stages can be further subdivided by the expression of CD44 and 
CD25 antigens: DN1 is identified as LIN– CD44+ CD25– (encompassing the ETP), DN2 
is LIN– CD44+ CD25+, DN3 is LIN– CD44– CD25+ and DN4 is LIN– CD44– CD25–. 
Maturation proceeds into the double positive (DP) stage and finally results in 
differentiation into a committed CD4 single positive (SP) or CD8 SP T-cell (Figure 
1.3). 
CHAPTER 1 
 35 
Figure 1.3 
Stages of T-cell development. 
 
T-cell development begins once a BM-derived lymphoid progenitor has settled in the 
thymus and has become a TSC. These TSCs first develop into ETPs, which are part of 
the DN1 compartment and express high levels of c-kit on their cell surface. ETPs then 
progress through DN stages 1-4, finally becoming DP for both CD4 and CD8 antigens. 
In a final maturation step, a cell will finish its thymic development as either as CD4 SP 
or a CD8 SP cell.  
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The definitive identity of the progenitors that leave the BM, enter the circulation and 
home to the thymus giving rise to the ETP population however still remains 
controversial. It is thought that only progenitors downstream of HSCs have the capacity 
to migrate to the thymus, as there is little evidence for self-renewing HSCs in this organ 
(Goldschneider et al., 1986). In addition, it was reported by Lai and Kondo (Lai and 
Kondo, 2006) that HSCs do not express the chemokine receptor CCR9 which is thought 
to be important for thymic homing.   
Kondo and colleagues (Kondo et al., 1997) hypothesised that the CLP was the main cell 
type producing T-cells and more importantly the ETP. Moreover, Martin et al., (Martin 
et al., 2003) reported the identification of a CLP-2 population which was defined as 
c-kit– IL-7Rα+ B220+ CD19– and had the ability to produce T-cells.  However, there has 
been sufficient evidence in the literature to suggest that CLPs may not be the main BM 
progenitors giving rise to ETPs in the thymus.  
One report which clearly addressed this question was by Allman and colleagues 
(Allman et al., 2003). In order to investigate the relationship between CLPs and ETPs, 
this group compared CLPs to ETPs in respect to phenotypes, the kinetics from which 
they generated T-cells and the effect of a null mutation in Ikaros. They failed to detect 
IL-7Rα surface expression on ETPs, suggesting ETPs differed from IL-7Rα+ CLPs. 
Additionally, they found that the cell surface expression of c-kit and Sca-1 on ETPs 
resembled the LSK fraction of the BM, supporting a model whereby cell populations 
such as LMPPs and ELPs are responsible for thymic homing. To assess the kinetics of 
development, CLPs and ETPs were injected intrathymically into allotype-matched 
recipients. In these experiments, the number of DP thymocytes in CLP inoculated mice 
declined between two and three weeks post transfer, whereas they peaked at three weeks 
in mice reconstituted with ETPs. Therefore, the authors suggested these cell populations 
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had different developmental properties. Moreover, in Ikaros-deficient mice, no CLPs or 
B-cells could be detected in the BM. In contrast, normal frequencies of ETPs were 
observed in the thymus of these animals, suggesting that B-cells may derive 
predominantly from CLPs, but the majority of ETPs developed via a CLP-independent 
pathway. Additional work from this group also showed that ETPs lack IL-7Rα mRNA 
expression at the population level. Therefore, the absence of IL-7Rα expression on 
ETPs may indicate colonisation by IL-7Rα– precursors such as LMPPs or ELPs.  
The hypothesis that CLPs should constitute the main source for thymic T-cell 
development clearly predicts the absence of myeloid potential in ETPs. However, there 
are some publications which have disagreed with this hypothesis. Wada et al., (Wada et 
al., 2008) showed that thymocytes at stages DN1-2 of thymopoiesis could develop into 
CD11b+ cells, showing macrophage-like appearance in histology. Similarly, Bell and 
Bhandoola, (2008) found that ETPs placed in short term cultures with Flk-2 ligand and 
interleukin-7 (IL-7) underwent expansion and expressed the myeloid lineage markers, 
CD11b, F4/80, Gr1 and MCSF-R. Furthermore, injected ETPs could give rise to 
myeloid cells. Taken together, these reports clearly demonstrate a robust myeloid 
potential in early intrathymic progenitors thereby further questioning the physiological 
role for the CLP as the main precursor entity of intrathymic T-cells. Additional 
evidence which promotes this assumption is the finding that CCR9 surface expression, 
which is thought to be important for thymic homing, was conveyed to be first acquired 
at the ELP stage (Heinzel et al., 2007). It seems conceivable that the ELP and earlier 
progenitors, such as the LMPP, may play a major role in providing TSCs.  
Taking into account that there is considerable evidence for either LMPP or ELP 
populations being the main source of TSCs, a recent report has suggested that ETPs are 
derived from IL-7Rα expressing precursors (Schlenner et al., 2010). Despite the fact 
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that ETPs have been found to lack IL-7Rα mRNA expression (Allman et al., 2003), 
Schlenner and colleagues showed, by using Il7rαCre-driven fate mapping experiments, 
that approximately 85% of ETPs had a previous history of IL-7Rα expression. 
Therefore, this data suggests that ETPs are derived predominantly from IL-7Rα+ 
progenitors such as CLPs, and to a lesser extent LMPP and ELP populations, which 
express Il7rα transcripts. Therefore, it may be possible that all LMPP, ELP and CLP 
populations give rise to ETPs. 
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1.6 Cellular pathways of B-cell fate specification 
In addition to identifying TSCs, the exact identity of BM-derived progenitors which 
give rise to B-cells is also not clear. The earliest progenitor cell type which is thought to 
be responsible for B-cell development is the CLP. B-cell development in the mouse BM 
can be characterised at all stages, from early progenitors to mature B-cells. Immediately 
after the CLP stage, B-lineage commitment can be first recognised by expression of 
B220 and AA4.1 antigens, labelling a population of pre-pro B-cells (Li et al., 1996). 
B-lineage cells cannot be recognised solely as B220+, as NK-cell progenitors can also 
be found in this compartment (Rolink et al., 1996). However, clonal analysis of B220+ 
AA4.1+ pre-pro B-cells for B/macrophage potential has shown that only B-cells are 
produced (Allman et al., 1999). These pre-pro B-cells also express intermediate levels 
of c-kit and are positive for IL-7Rα expression. As B-cell development continues, cells 
begin to upregulate Cd19, the target gene of the transcription factor paired box protein 5 
(Pax5), and the cells are then known as pro B-cells. During this stage of development, 
both alleles of the immunoglobulin heavy chain locus are DHJH rearranged. Completion 
of a functional VH-DHJH rearrangement results in the expression of the pre B-cell 
receptor and the cells at this stage are then fully committed to the B-cell lineage, as 
transplantation of these cells into Rag-deficient hosts leads to long term reconstitution 
of mature B-cell populations (Rolink et al., 2000). In the final steps of B-cell 
development, cells express CD25 and IgM whilst downregulating c-kit and are defined 
as pre B and then immature B-cells. Upon entering the periphery, B-cells which survive 
undergo further differentiation to become fully mature B-cells that express IgD. Given 
the presented evidence, the developmental checkpoints of early B-cell development 
seem to be quite well established. 
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1.7 Transcription factors important for lymphoid specification 
Another way to elucidate which cell pools contribute to T and B-cell development is the 
analysis of genes indicative or indispensable for lineage commitment. Differential 
expression of transcription factors is considered operational in directing cells towards a 
particular developmental fate. Of crucial importance for T-cell development in 
particular are Notch1, Tcf1 and Gata3. 
Notch comprises a family of highly conserved receptors, whose activation is induced by 
Delta and Jagged ligands, via cell-cell interactions (Artavanis-Tsakonas et al., 1999). 
Once activated, the Notch intracellular domain (NICD) is cleaved by γ-secretase, which 
leads to translocation of the NICD into the nucleus. Subsequently, the NICD associates 
with the transcription factor RBP-J, which initiates transcription of target genes such as 
the hairy/enhancer of split (Hes) and Deltex. Recent data suggests that Notch signalling 
and Hes-1 may play a critical role in promoting progression of T-cell development, 
including the choice of committing to the T-, rather than the B-cell lineage (Radtke et 
al., 1999). Radtke and colleagues utilised a mouse model whereby a loxP-flanked 
Notch1 gene was inactivated by inducing Cre-recombinase under the control of the mx1 
promoter, thus allowing the inactivation of Notch1 via type 1 interferon (Radtke et al., 
1999). After Notch1 inactivation, instead of T-cell generation, evidence for intrathymic 
B-cell generation was presented. This evidence suggests that Notch-1 is important in 
specifying progenitors in the thymus and may be further involved in the inhibition of 
B-cell development. In addition, it has been shown that Notch1 mRNA is expressed in 
LMPPs, ELPs and CLPs, which is consistent with the presence of T-lineage potential in 
these populations (Rumfelt et al., 2006). 
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T-cell Factor-1 (TCF-1) is a T-cell specific nuclear binding protein. It is expressed in all 
thymocyte subpopulations, including the earliest DN1 stage, and has been regarded as 
the first definitive T-lineage marker (Verbeek et al., 1995). Mutation of TCF-1 results in 
the severe impairment of T-cell development during late DN cell stages, immediately 
following pre-TCR expression and ahead of TCRα gene expression (Verbeek et al., 
1995). 
One family of transcription factors which are clearly implicated in haematopoietic 
differentiation are members of the GATA family. The GATA-3 transcription factor is 
thought to be expressed at various levels in nearly every stage of lymphoid 
development, starting with HSCs, and is believed to drive cells specifically towards a 
T-cell fate. Evidence of this role was discovered by Ting and colleagues (Ting et al., 
1996) who carried out experiments supporting a role for Gata3 in early thymocyte 
development. A Rag2-null complementation system was utilised in conjunction with 
Gata3-null ESCs, to evaluate the role of Gata3 in T-cell development. These cells 
contained normal B-cell numbers but there appeared to be no evidence of T-cell 
progenitors in the thymus.  
Other members of this family are the GATA-1 and GATA-2 transcription factors. The 
GATA-1 transcription factor has a specific promoter which directs its expression in the 
erythroid, megakaryocytic, mast cell and eosinophil lineages (Burch, 2005). GATA-2 is 
expressed abundantly in HSCs and progenitor cells, but in the erythroid lineage, 
expression is thought to decrease with an opposing increase in GATA-1 expression 
(Ohneda et al., 2002). Determining the expression of GATA-1 and GATA-2 in 
haematopoietic tissues is likely to illustrate the myelo-erythroid potential and the lack of 
lymphoid potential in certain cell populations. Similarly, the expression of GATA-3 
appears to indicate a commitment to the lymphoid lineage. 
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In contrast to T-cell specification, a completely different set of transcription factors are 
thought to be required for B-lineage specification. The most crucial of these have been 
reported to be Pax5, early B-cell factor (EBF) and the basic helix-loop-helix 
transcription factors. 
The transcription factor Pax5 is exclusively expressed in the B-lymphoid lineage of the 
haematopoietic system and is crucial to the development of B-cells. It has been reported 
that in Pax5-deficient mice, VH to DHJH rearrangements are severely reduced at the pro 
B-cell stage (Nutt et al., 1997) and further differentiation along the B-lineage pathway is 
blocked (Nutt et al., 1999). However, this defect could be overcome by retroviral 
induction of Pax5 (Nutt et al., 1999). Moreover Pax5-deficient progenitors from the BM 
efficiently develop into c-kit+ B220+ pre-pro B-cells in culture with stromal ST2 cells in 
the presence of IL-7 (Nutt et al., 1997). However, unexpectedly, if the IL-7 cytokine is 
substituted with alternate lineage cytokines such as GM-CSF, M-CSF or IL-2, these 
cells are able to differentiate into functional macrophages, granulocytes, DCs and NK-
cells (Nutt et al., 1999). Hence, Pax5-deficient pre-pro B-cells appear to be 
uncommitted lymphoid progenitors harbouring a small amount of myeloid potential 
(Cobaleda et al., 2007). Together, these data identify Pax5 as the critical factor which 
directs developing cells down the B-lineage pathway.   
The initiation of B-cell development also depends critically on the EBF transcription 
factor and the basic helix-loop-helix proteins encoded by the E box binding protein 2A 
(E2A) gene. In the absence of either transcription factors, B-cell development is 
attenuated at the pre-pro B-cell stage.  
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1.8 The effect of aging and gender on haematopoiesis 
Aside from factors which can directly govern the fate of progenitor cells, other factors 
which can influence the kinetics of lymphoid development and the function of lymphoid 
progenitors are age and gender. The concept of aging during haematopoiesis has been 
widely investigated primarily in mature cells of the immune system. The aim of this 
research by many groups has been to understand why we age and the causes of it. The 
general consensus has been that as we age, the functions of the immune system decline. 
One example of this is that elderly people are more susceptible to infections such as 
influenza than younger individuals. Furthermore, investigations have been carried out 
which show that vaccinations are also less effective in the aged (McElhaney and Effros, 
2009). Studies focusing on the innate immune system have been contradictory in the 
sense that some reports have shown an age-related decline in the number and function 
of neutrophils (Butcher et al, 2001), macrophages (Fietta et al., 1993) and NK-cells 
(Albright and Albright, 1983), whereas other studies have not observed these changes 
(Gomez et al., 2008). Therefore, the effect of aging within these compartments and on 
their respective progenitors still remains unclear. In contrast, studies on the adaptive 
immune system and aging have been rather fruitful. It has been very well established 
that thymic involution occurs with age and that the frequency and function of pre 
B-cells are markedly diminished in senescent mice (Stephan et al., 1996; Stephan et al., 
1998). Examples of these defects include reduced antibody production by B-cells and 
reduced proliferation in response to antigen. However, studies on B-cell progenitors 
have not been as well characterised. One paper which partly addressed this was a study 
by Min et al., (2006) who reported age related defects in CLPs and pro B-cells. This 
group investigated the effects of aging using young (4-6 weeks) and old (18-20 months) 
mice by comparing the number of CLPs and pro B-cells. They found a significant 
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reduction in the number of cells as well as in the proliferative potential of these cells 
during aging and they attributed one of the reasons being loss of responsiveness to IL-7. 
Interestingly they found that the development of myeloid progenitors in old mice 
remained unchanged compared to young mice, indicating that lymphoid progenitors 
may be particularly susceptible to aging factors. However, to date studies into 
age-related changes in the functional competence of the LMPPs or ELPs have not been 
published.  
There have however been numerous reports which suggest that HSCs are affected by 
aging. This has been very well demonstrated by isolating young and old HSCs from the 
same mouse strain and transplanting them into the same recipient (Harrison et al., 
1983). Young mice exhibited a significantly higher repopulating efficiency than the 
older counterparts suggesting that there must have been an intrinsic factor such as aging 
which was negatively regulating the function of HSCs, as cells from both young and old 
mice were competing in the same environment. Taking into account the effect of aging 
in all haematopoietic populations, investigating lymphoid and myeloid progenitor 
numbers in relation to young and aged mice would further elucidate the effect of aging 
on haematopoietic progenitor composition. 
Another factor which could influence haematopoietic progenitor composition and 
function is gender. There has been a variety of evidence suggesting that lymphopoiesis 
in the BM is limited by sex steroids and therefore gender may have profound effects on 
haematopoietic development. One observation which illustrates this concept is that in 
pregnant or oestrogen-treated mice there is a noticeable suppression of B-lymphopoiesis 
(Medina et al., 1993). During this study, B-cell subsets were compared between 
pregnant and non-pregnant mice and the number of pre B-cells was reduced by an 
average of five fold in pregnant mice. Furthermore, IL-7 responsive precursors declined 
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in number after injection of 1 mg 17-β estradiol indicating that B-cells and lymphoid 
progenitors are susceptible to regulation by oestrogen. This group also studied the 
number of myeloid progenitors and CD11b+ cells by colony formation but found no 
significant differences. Furthermore, Kouro et al., (2001) isolated LIN– c-kithi cells and 
placed them in stromal cell-free cultures containing only stem cell factor (SCF), Flk-2 
ligand and IL-7. They found that with the inclusion of β-estradiol in the medium, the 
production of CD19+ lymphocytes was almost completely prevented. These data 
indicate that early B-cell development is partially blocked by oestrogen treatment; 
whereas the myeloid compartment appears to be unresponsive to the effect of oestrogen, 
or is simply not affected by the hormone.  
There have only been a limited number of studies which have addressed the effect of 
oestrogen on early lymphoid precursors. One study by Medina et al., (Medina et al., 
2001) presented evidence that the LIN– IL-7Rα+ c-kitint population, which would 
otherwise be representative of the CLP, was depleted in oestrogen treated animals. In 
addition, they utilised a competitive repopulation foetal thymic organ culture system to 
assess the potential of LIN– c-kithi precursors for T-cell differentiation. Using cells 
isolated from oestrogen treated Ly5.1+ mice and control Ly5.2+ mice, they observed that 
upon mixtures of these cells, almost all of the progeny came from Ly5.2+ mice. 
Therefore this study indicated that T- and B-cell progenitors may be affected by sex 
hormones. In order to further elucidate whether gender profoundly affects the number of 
BM and ETPs, a detailed comparative analysis would need to be carried out between 
male and female mice. In addition, there is a virtual absence of reports which have 
investigated the effects of aging in conjunction with gender in haematopoietic 
progenitor compartments.  
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1.9 Infection-induced changes of haematopoiesis 
Another extrinsic factor which has been shown to influence the phenotype and function 
of haematopoietic progenitor populations is infection. There has been a significant 
amount of evidence suggesting that in conditions of stress, haematopoietic progenitor 
compartments are phenotypically and functionally altered. During steady state 
conditions, haematopoietic progenitor cells can be defined by particular cell surface 
markers which allows the isolation and functional assessment of these cells. However, 
surface expression of some of these antigens has been demonstrated to be significantly 
altered during acute infection or inflammation. One of the most notable changes appears 
in the LSK fraction of the BM which contains HSC and LMPP populations. Work in 
our lab using malaria as a model for an acute infection (Belyaev et al., 2010) has 
illustrated an expansion of the LSK compartment and a retraction in the frequency and 
number of LIN– Sca-1– c-kithi myeloid progenitors three days after infection. This was 
mainly due to the upregulation of Sca-1 on myeloid progenitors. Importantly, analysis 
of LT-HSCs during infection presented no change in the number of these cells, 
indicating that the upregulation of Sca-1 was not as a consequence of LT-HSC 
mobilisation and the need to generate differentiated progeny. Instead, the infected LSK 
fraction also appeared to express FcγRII/III, a marker of GM development and 
functional analysis of these cells produced myeloid progeny. Hence, a major proportion 
of LSK cells during infection or inflammation were lineage-restricted myeloid cells. 
The cytokine inducing the expression of Sca-1 on myeloid progenitors in malaria was 
IFNγ, as infection induced in Ifngr1-null mice showed no change in the expression of 
Sca-1 on myeloid progenitors compared to those observed during physiological 
conditions. These findings illustrate the plasticity of haematopoietic progenitors to alter 
their phenotype and function. Another study by Baldridge et al., (Baldridge et al., 2010) 
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reported alternate differences in haematopoietic progenitors during induction of a 
chronic Mycobacterium avium infection. This group reported a small mobilisation of 
LT-HSCs, accompanied by a decrease in the number of BM GMPs, CMPs and MEPs 
and an increase in the number of CLPs. These changes are more representative of a 
T-cell mediated response, rather than one of the innate immune system. However, both 
these reports clearly show that during a systemic infection, there are major phenotypic 
and functional differences in haematopoietic progenitor compartments.  
One model of an acute bacterial septicaemia in which the haematopoietic response has 
not been fully examined is that of Escherichia coli (E. coli). So far, only one group have 
published data on the effect of E. coli on the LSK compartment of the BM. Zhang et al., 
(2008) injected E. coli intravenously (i.v.) into C57BL/6 mice and observed that 12 
hours post infection, the number of LSK cells was increased seven fold. This 
compartment was further expanded to approximately ten fold after 24 hours. However, 
the infected LSK cells were not analysed for any other markers of the myeloid lineage 
and so the cause of LSK expansion could not be attributed directly to Sca-1 
upregulation on myeloid cells. However, they did report a decrease in the number of 
LIN– c-kithi Sca-1– cells during infection. In addition, they also measured the elevation 
in cytokines during E. coli infection and found GM-CSF, IL-6 and TNFα to have the 
highest increase compared to wildtype controls. TNFα, LPS and IFNγ were also 
sufficient to induce upregulation of Sca-1 on LIN– c-kithi Sca-1– cells in vitro, however 
GM-CSF and IL-6 had minimal effect. Although these results provide an idea as to the 
mechanisms behind the alteration in haematopoietic progenitors, much further analysis 
is required in order to determine the exact nature of these observations, the effects in the 
periphery and the cytokines directly responsible for these changes. 
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Similar to E. coli, there have been few reports which have investigated the effects of 
lipopolysaccharide (LPS) on haematopoietic progenitor populations. One report which 
did provide some idea on how haematopoietic progenitors respond to LPS was by Nagai 
and colleagues (Nagai et al., 2006) who showed by flow cytometric analysis that TLR 
complexes could be found on haematopoietic progenitor cells. They reported that HSCs 
and CLPs expressed TLR4-MD complexes on their surface, the receptor by which LPS 
is recognised (Hoshino et al., 1999). In addition, LSK, LIN– c-kithi Sca-1– and CLP cells 
also expressed TLR2 on their surface. Furthermore, when CLPs were isolated and 
placed in culture with added LPS, only CD11b+ cells were produced, indicative of 
myeloid or DC populations. Therefore, in response to LPS, CLP cells appeared to give 
rise to cells of the myeloid lineage instead of the lymphoid lineage, indicating that there 
may be a high degree of plasticity within haematopoietic progenitor compartments in 
response to LPS. This effect was dependent on the TLR4 pathway, as CLPs did produce 
B-cells when isolated from Myd88-deficient mice. Therefore, although there is some 
evidence to suggest that haematopoietic progenitor cells can respond to LPS and gram 
negative bacteria, this has not been studied in depth. An in vivo model using LPS and/or 
E. coli could be further exploited to address the relative role for direct TLR-mediated 
signals as well as the action of pro-inflammatory cytokines on haematopoiesis.  
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1.10 Aims of study 
One issue which many groups are still trying to understand is which BM-derived 
progenitors give rise to T- and B-cells. At this moment in time, there have been many 
publications which have questioned the role of the CLP as the main source of thymic 
progenitors. With the discovery of alternate lymphoid progenitor populations such as 
the LMPP and the ELP, research into the phenotype and developmental potential of 
these pools has indicated a more suitable role for these cells as thymic precursors.  
However, more elegant methods to monitor the development of these cells, for example 
utilising lineage tracing models, needs to be performed in order to fully establish the 
relationship between the LMPP, the ELP and the CLP populations and to determine 
which of these populations give rise to T- as well as B-cells. We aimed to assess the 
relationship between lymphoid progenitors; analyse their functional potential in vivo 
and in vitro; determine the expression of genes in these populations and ultimately 
dissect lymphoid developmental pathways utilising a novel lineage tracing reporter 
model, whereby the ELP population and all subsequent progeny were marked by 
enhanced yellow fluorescent protein (eYFP).   
In addition, we also aimed to examine extrinsic factors which could influence the 
phenotype and composition of lymphoid progenitor compartments. It is clear from the 
literature that aging has a significant affect on the function of mature lymphoid cells; 
however this has not been fully investigated in early lymphoid progenitors. Similarly, 
there is little evidence of investigations into gender and haematopoiesis. Therefore, we 
aimed to combine the effects of both aging and gender and analyse the frequency and 
number of haematopoietic progenitor populations.  
Another important factor which can exert profound effects on haematopoietic 
development is inflammation. There have been numerous publications which suggest an 
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alteration of phenotype and function in haematopoietic progenitor compartments upon 
infection. However, the effect of gram negative bacteria such as E. coli on the 
phenotype and composition of haematopoietic progenitors has been poorly investigated, 
as has the identification of key cytokines which are involved in phenotypic and 
functional changes. Therefore, by administering either LPS or E. coli into C57BL/6 and 
reporter mice, we aimed to further evaluate the effect of inflammation on 
haematopoiesis and identify the potential mechanism involved.  
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CHAPTER 2 
 
MATERIALS AND METHODS 
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2.1 Mouse strains 
C57BL/6 wildtype mice were bred and housed at the MRC National Institute for 
Medical Research (NIMR). The B6.R26ReYFP strain was made by Srinivas et al., (2001) 
who inserted eYFP cDNA, preceded by a loxP-flanked stop sequence, into the 
constitutively active Rosa26 locus. B6.Rosa26eYFP mice, with ubiquitous expression of 
eYFP from the Rosa26 locus, were generated by Belyaev and co-workers (Belyaev et 
al., 2010) by breeding B6.R26ReYFP reporter mice with PC3Cre mice. The B6.R26ReYFP 
strain was also crossed to the B6.vav1::iCre strain (Georgiades et al, 2002), which was 
first active in the HSC compartment, the B6.Rag1Cre strain (Esplin et al., 2009) which 
was expressed in early lymphoid development and the B6.hCD2::iCre strain (de Boer et 
al., 2003).  
Recombinase activating gene 2-deficient (Rag2-null) mice on C57BL/6 background 
were generated by Shinkai et al., (1992). Mice deficient in both Rag2 and the common 
cytokine receptor γ chain (Rag2/Il2rg-null) were created by Goldman and colleagues 
(Goldman et al., 1998). Mice lacking the interferon gamma receptor 1 (IFNγR1) were 
produced by Huang et al., (1993) and crossed to C57BL/6 mice to generate the 
B6-Ifngr1-null strain. Mice which were homozygous for a disrupted tumour necrosis 
factor receptor 1 (TNFR1) allele were created by Rothe et al., (1993). These mice were 
crossed to C57BL/6 mice for six generations to produce the Tnfr1-null (p55;N6) strain. 
All strains were bred and housed under specific pathogen free conditions at the MRC 
NIMR. 
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2.2 Isolation of progenitor subpopulations 
2.2.1 Cell preparation 
All organs were placed directly into Iscove’s Modified Dulbecco’s Medium (IMDM) 
buffer and mechanically processed to achieve single cell suspensions. BM was isolated 
by flushing the femur bones with IMDM and then passing through a 70 µm nylon mesh 
(BD Falcon). Spleens which were digested with 0.4 mg/ml collagenase (Liberase CI, 
Roche) were first perfused and then left to incubate at 37oC for 20 minutes. Cell 
numbers were determined utilising 0.4% Trypan Blue solution (Sigma) and counted on 
a Neubauer chamber. Blood was isolated by cardiac puncture of lethally anesthetised 
mice (50 mg/kg Pentobarbitone, Animalcare Ltd.) with a heparin syringe (Heparin, 
Sigma-Aldrich).   
 
2.2.2 Magnetic mediated depletion of cells 
Enrichment of LIN– cells was carried out firstly by incubation of single cell suspensions 
with Fc-receptor II/III antibody and then by using biotinylated antibodies against 
lineage antigens (see Table 2) which were incubated at 4oC for 15 minutes in the dark. 
After washing with FACS (Fluorescence Activated Cell Sorting) buffer (PBS, 0.5% 
BSA, 2.5 mM EDTA), cells were labelled with streptavidin microbeads (Miltenyi 
Biotec) and passed though a cell separation column (Miltenyi Biotec), according to the 
manufacturer’s instructions. The resulting eluant was referred to as LIN– cells.   
 
2.2.3 Analytical and preparative flow cytometry 
All antibodies throughout this study were used at optimised dilutions and as given in 
Table 2. 
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For dead/live discrimination, 7-aminoactinomycin D (7AAD, 1:2000, Sigma) was 
added prior to analysis. Samples were analysed on a FACS Canto II flow cytometer 
(Becton Dickinson) or LSR II (Becton Dickinson). All flow cytometry data were 
analysed with Flowjo (Tree Star, Inc). 
The sorting of cells for RNA preparation and transplantation was performed on a FACS 
Aria II (Becton Dickinson, UK). Cells were collected into either RNAse-free 1.5 ml 
tubes containing 600 µl Trisol (Helena Biosciences), supplemented with 6 µl polyacryl 
carrier (Helena Biosciences, UK), or FACS tubes filled with 5 ml sterile 
heat-inactivated FCS (Biosera, South America).  
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Table 2 
Antibodies used throughout the study. 
 
Table illustrating the antibodies used for defining lineage positive cells and antibodies 
used throughout the study to identify specific antigens. Columns illustrate the antigens 
recognised by the antibody, the fluorochrome with which the antibody is labelled and 
detected by flow cytometry, the isotype of the antibody, the manufacturer and the 
working dilution.  
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Antigen Label Isotype Manufacturer Dilution 
Lineage         
CD11c Biotin Armenian Hamster IgG eBioscience 1:200 
Ter119 Biotin Rat IgG2b eBioscience 1:200 
CD11b Biotin Rat IgG2b eBioscience 1:200 
CD3ε  Biotin Armenian Hamster IgG eBioscience 1:200 
NK1.1 Biotin Rat IgG2a eBioscience 1:200 
CD8α Biotin Rat IgG2a eBioscience 1:200 
B220 Biotin Rat IgG2a eBioscience 1:200 
CD19 Biotin Rat IgG2a eBioscience 1:200 
Gr1 Biotin Rat IgG2b eBioscience  1:200 
Other antibodies      
7/4 PE Rat IgG2a AbD Serotec 1:200 
B220 Pacific Blue Rat IgG2a eBioscience 1:200 
B220 PE Rat IgG2a eBioscience 1:400 
CD4  Pacific Blue Rat IgG2a eBioscience 1:200 
CD8 PE-Cy7 Rat IgG2a eBioscience 1:200 
CD11b Pacific Blue Rat IgG2b eBioscience 1:200 
CD11c APC-Cy7 Armenian Hamster IgG eBioscience 1:200 
CD19 APC Rat IgG2a Caltag 1:200 
CD19 PE-Cy7 Rat IgG2a eBioscience 1:200 
CD34 APC Rat IgG2a eBioscience 1:50 
CD48 APC Armenian Hamster IgG eBioscience 1:200 
CD49b PE Rat IgM eBioscience 1:400 
CD71 PE Mouse IgG1 eBioscience 1:800 
CD150 PE-Cy7 Rat IgG2a eBioscience 1:200 
c-kit APC-Cy7 Rat IgG2b eBioscience 1:200 
Flk-2 PE Rat IgG2a eBioscience 1:50 
FcγRII/III PE Rat IgG2a eBioscience 1:200 
FcγRII/III PE-Cy7 Rat IgG2a eBioscience 1:200 
Gr1 APC Rat IgG2b eBioscience 1:400 
Gr1 APC-Cy7 Rat IgG2b eBioscience 1:400 
IgD Biotin Rat IgG2a eBioscience 1:200 
IgM PE Rat IgG2a eBioscience 1:200 
IL-7Rα APC Rat IgG2a eBioscience 1:200 
IL-7Rα PE-Cy7 Rat IgG2a eBioscience 1:200 
Ly6C APC Rat IgG2a eBioscience 1:500 
M-CSF R APC Rat IgG2a eBioscience 1:200 
M-CSF R PE Rat IgG2a eBioscience 1:200 
MHC Class II Biotin Rat IgG2b eBioscience 1:200 
NK1.1 PE-Cy7 Mouse IgG2a eBioscience 1:200 
PDCA-1 APC Rat IgG2b eBioscience 1:200 
Sca-1 Pacific Blue Rat IgG2a eBioscience 1:200 
Streptavidin Alexa Fluor 610 N/A Invitrogen 1:2000 
Streptavidin Pacific Blue N/A Molecular Probes 1:200 
Streptavidin PE N/A Molecular Probes 1:2000 
Streptavidin PercP N/A Molecular Probes 1:200 
TCRαβ APC Armenian Hamster IgG eBioscience 1:400 
TCRγδ PE Armenian Hamster IgG eBioscience 1:200 
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2.3 RNA Extraction and Complementary DNA Synthesis 
Cells were sorted into Trisol and homogenised for ten minutes by gentle inversion. In 
order to induce phase separation, 6 µl 1-bromo-3-chloropropane (BCP; Molecular 
Research Center, Inc.) was added to cells followed by centrifugation.  The clear aqueous 
RNA layer was transferred into an RNAse free 1.5 ml eppendorf tube and precipitated 
with isopropanol (Fisher Scientific). RNA was washed repeatedly with 70% ethanol 
(Fisher Scientific). Finally, RNA was air dried and solubilised in Molecular Biology 
Grade water (Eppendorf) at a concentration of 500 cells/µl.  
For one cDNA reaction (10,000 cells), 2 µl 500 µg/ml oligo dT (New England Biolabs) 
and 4 µl 10 mM dNTP (GE Healthcare) were added to the RNA. This mixture was 
heated to 65oC for five minutes, followed by addition of 4 µl reaction buffer 
(Invitrogen), 2 µl 0.1 M DTT (Invitrogen) and 1 µl 40 U/µl ribonuclease inhibitor 
(Promega). 1 µl Superscript reverse transcriptase (Invitrogen) was added to the RNA 
and the reaction was left at 42oC for 50 minutes. The reaction was inactivated by 
incubation at 70oC for 15 minutes. The quality of the cDNA was tested by polymerase 
chain reaction (PCR) using HPRT primers.   
 
2.4 Semi-quantitative Polymerase Chain Reaction and Agarose Gel 
Electrophoresis 
PCRs were carried out in a final volume of 20 µl which was composed of 0.5 µM 5’ 
HPRT Primer (See Table 3 for primer sequences), 0.5 µM 3’ HPRT Primer, 0.4 µl 10 
mM dNTPs, 2 µl 10X reaction buffer (Roche), 0.2 units Taq DNA polymerase (Roche), 
50 ng cDNA and water. All PCR reactions were carried out using the PTC-200 Peltier 
Thermal Cycler (MJ Research) for 35 cycles. PCR products were analysed by agarose 
gel electrophoresis using a 1.5% gel, 6 x Orange G loading buffer and a current of 
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100V. Gels were visualised by emersion in ethidium bromide and observation on a UVP 
GelDoc-It TS Imaging System.  
 
2.5 Quantitative Reverse Transcription Polymerase Chain Reaction 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to 
analyse gene expression in specific cell populations. Reactions were carried out in a 
total volume of 20 µl containing 1 µl Quantitect Custom Assay Primer mix (Qiagen), 1 
µl Quantitect Custom Assay Probe (Qiagen), 10 µl Quantitect probe PCR mastermix 
(Qiagen) and 8 µl cDNA at a concentration of 125 cells/µl (see Table 3 for primer 
sequences). All reactions were carried out in triplicates for 45 cycles and covered with 
an adhesive film to prevent evaporation.  QRT-PCR was carried out using a 7900HT 
fast Real-Time PCR System (Applied Biosystems) according to manufacturer’s 
instructions. Data was analysed using the standard curve method (Applied Biosystems) 
and normalised according to levels of the housekeeping gene acidic ribosomal 
phosphoprotein (Arbp) as a standard.  
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Table 3 
Primers used in semi-quantitative and qRT-PCR. 
 
A) Primers used in semi-quantitative PCR. Primers were tested with total BM 
cDNA to determine their specificity.  
 
B) Primer and Probe sequences used in qRT-PCR. Primer/probe sequences were 
designed manually by our lab using the Quantitect Assay software. Primers were 
tested with titrated total BM cDNA by generating a regression curve of 
threshold cycle (CT) versus log10 template dilution. Correlation co-efficients 
over 0.98 meant a good primer probe combination.   
CHAPTER 2 
 61 
A 
 
 
 
 
 
 
 
B 
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2.6 In vitro culture of lymphoid progenitors 
BM ELP, CLP eYFP– and CLP eYFP+ populations were sorted into 5 ml sterile 
heat-inactivated FCS, then centrifuged and resuspended in IMDM. 103 ELP cells or 2 x 
103 CLP eYFP– or CLP eYFP+ cells were placed onto confluent GFP+ OP9 stromal cells 
in six well plates, which had been irradiated with 3 Gray, and incubated at 37oC with 
7.5% CO2. Cells were cultured with IMDM supplemented with 10% heat-inactivated 
FCS, L-glutamine, 10-4 M β-mercaptoethanol (Sigma) and IL-7 cytokine (1 ng/ml), 
Flk-2 ligand (5 ng/ml) and SCF (100 ng/ml), all purchased from Peprotech UK. 
Cultures were analysed at time points indicated by analytical flow cytometry. 
 
2.7 In vivo transplantation assays 
2 x 103 sorted CLP progenitor cells from 30 x B6/J CD45.1 mice were injected i.v. into 
Rag2/Il2rg-null mice which had been irradiated with 3 Gray, four to six hours prior to 
injection. Mice were analysed for CD45.1+ donor-derived cells in BM, spleen and 
thymus at time points of two, three and four weeks post injection by flow cytometry. 
For analysis of other cell populations, 103 ELP progenitor cells or 2 x 103 CLP eYFP– or 
CLP eYFP+ progenitor cells were injected into Rag2/Il2rg-null mice which had been 
irradiated with 3 Gray four to six hours prior to injection. Mice were analysed for 
eYFP+ donor-derived cells in BM, spleen and thymus at indicated time points by flow 
cytometry.  
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2.8 Infection models 
2.8.1 LPS-induced infection 
LPS (Enzo Life Sciences), derived from Salmonella minnesota R595, induced 
inflammation was carried out on C57BL/6 mice, Rag1wt/Cre x R26Rwt/eYFP mice, 
Ifngr1-null and Tnfr1-null (p55;N6) male and female mice aged six to ten weeks old. In 
order to measure the LPS-induced effect on body temperature and to identify each 
individual mouse, programmed temperature transponders (PLEXX) were inserted into 
the shoulder of each mouse according to the manufacturer’s recommendations. Mice 
were then monitored for skin infection for at least 48 hours prior to LPS injection. To 
induce a sub-lethal inflammatory effect, 40 µg LPS or 40 µl double distilled endotoxin 
free water (Enzo Life Sciences) was injected intraperitoneally (i.p.) into each mouse at 
8am on the day of the experiment. Temperature was measured at indicated time points 
using a DAS-7007S transponder reader (PLEXX). To measure the number of 
circulating granulocytes, lymphocytes, monocytes and RBCs, 5 µl blood from the tail of 
mice was collected at 3.5, 7, 12, 24 and 72 hour time points and added to 45 µl heparin 
and Krebs buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 4.2 
mM NaHCO3, 2 mM CaCl2, 10 mM glucose, 200 mM sulphinpyrazone and 10 mM 
Hepes). Blood was analysed on a Vetscan HM2 Haematology System (Abaxis). In order 
to investigate the cytokine levels of LPS injected and non-injected mice, blood was 
taken by cardiac puncture of lethally anesthetised mice with a heparin covered syringe 
at 3.5, 7, 12, 24 and 72 hour time points. Blood was left at 4oC overnight and then 
serum was isolated for analysis. To measure the levels of TNFα and IFNγ cytokines in 
the serum during LPS challenge, ELISA was carried out by Ana-Isabel Garcia-Diaz. For 
analysis of haematopoietic populations, BM and spleen were taken at 12, 24 and 72 
hour time points. 
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In order to block TNFα, 675 µg anti-TNFα cytokine antibody (BioXcell) was injected 
i.p. into Ifngr1-null mice 24 hours prior to and immediately before LPS injection.  
 
2.8.2 E. coli-induced infection  
E. coli (strain DH10 B) containing a plasmid incorporating an ampicillin resistant gene 
was grown in L-Broth with 50 µg/µl ampicillin. The use of ampicillin selected for        
E. coli which had transformed the plasmid and also killed any additional bacteria which 
may have been growing in the media. The growth of E. coli was halted once the cells 
had reached the exponential phase, which was measured using a spectrophotometer at a 
wavelength of 600 nm. The total amount of E. coli was counted and calculated to be 
4.48 x 1010 cells in 1 L. This was then transferred to a shaking water bath, which was set 
to a temperature of 56-58oC, to induce pasteurisation. Cells were washed in distilled 
water and centrifuged, producing a pellet which weighed 2.64 g. The pellet was 
resuspended in 5 ml distilled water and left to lyophilise. Once the E. coli had dried, it 
was weighed again and resuspended in distilled water to give a concentration of 4.8 x 
109 cells/ml. Before injection into mice the E. coli solution was sonified.  
The amount of E. coli which was equivalent to 40 µg LPS was calculated to be 1.5 x 109 
cells (Freudenberg et al., 1991). The equivalent volume was injected i.p. into C57BL/6 
mice aged six to eight weeks old. To investigate the effect of a lower dose of E. coli, 3 x 
108 cells were also injected. These mice were also checked for temperature and changes 
in blood parameters. In addition, BM and splenic populations were analysed at the same 
time points as previous LPS experiments (see LPS-induced infection). To measure the 
levels of TNFα and IFNγ cytokines in the serum during E. coli infection, ELISA was 
carried out by Ana-Isabel Garcia-Diaz. 
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2.9 Statistical tests 
Statistical significance was calculated using the Student’s T-test with p < 0.05 (*) or p < 
0.01 (**), indicating significance. Identical developmental populations from different 
individuals were subjected to a one-tailed test, with p < 0.05 considered to be 
significant. 
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CHAPTER 3 
 
INVESTIGATION OF LYMPHOID PROGENITOR 
DEVELOPMENT UTILISING A NOVEL LINEAGE TRACING 
REPORTER 
 
CHAPTER 3 
 67 
3.1 Introduction 
The precise pathway by which lymphoid progenitors develop from multipotent stem 
cells into fully functional mature lymphocytes is still unknown. Whilst some groups 
argue that the CLP is the main lymphoid progenitor giving rise to T- as well as B-cells 
(Kondo et al., 1997, Karsunky et al., 2008), other reports favour a model whereby ETPs 
are derived from earlier progenitors such as LMPPs or ELPs (Benz and Bleul, 2005, Lai 
and Kondo, 2007). We aimed to investigate the source of thymic progenitors and further 
clarify the routes of lymphoid developmental pathways.  
One experimental model which further dissected lymphoid development was the 
Rag1GFP reporter mouse (Igarishi et al., 2002). This model allows isolation and 
functional analysis of an ELP population, however lineage mapping of ELP progeny in 
situ was limited due to non-continuous expression of GFP and rapid degradation of the 
fluorescence reporter with time. To overcome this limitation, we created a reporter 
model by inserting Cre recombinase into the Rag1 locus (Rag1Cre), thereby enabling 
eYFP expression from the Rosa26 locus of R26ReYFP reporter mice (Srinivas et al., 
2001). We predicted that eYFP would permanently label cells which had passed via the 
ELP or any stage characterised by Rag1 gene expression.  
In addition to monitoring the onset and lineage specificity during lymphoid 
development by analysing eYFP expression in our reporter model, we also wanted to 
assess the effect of gender and age on lymphoid development. Lymphopoiesis has been 
shown to be depressed in pregnant (Medina et al., 1993) or oestrogen-treated mice 
(Medina et al., 2001) and abnormally elevated in ovariectomized female (Smithson et 
al., 1994) and castrated male mice (Wilson et al., 1995), indicating that steroid 
hormones play an important role in lymphoid development. Therefore, we wanted to 
compare the frequency and number of haematopoietic progenitor populations in male 
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and female mice. It has previously been reported that aging can also have a significant 
effect on lymphoid development. Involution of the thymus is one of the most prominent 
features of age-related changes and explains the diminished output of T-cells. In 
addition, B-cell generation is substantially reduced (reviewed by Linton and Dorshkind, 
2004). It is generally thought that these changes are related to decreased output of 
lymphoid progenitor populations from the BM, and this was confirmed by Rossi and 
colleagues (Rossi et al., 2005) who reported a significant decrease in the frequency of 
LMPP and CLP populations in aged mice. This group also reported an increase in the 
frequency of LT-HSC and GMP populations, whilst ST-HSC, CMP and MEP 
populations remained unchanged. Taking into account the reports that age and gender 
can have inhibitory effects on haematopoiesis, we aimed to assess the effect of both age 
and gender simultaneously on the frequency and number of haematopoietic progenitor 
populations by analysing male and female mice of young and old age.   
Other factors which are critical in lymphoid cell fate specification are the stepwise 
induction of genes (reviewed by Rothenberg and Taghon, 2005). Genes which are 
required for lymphoid development include pTα, Gata3, Pax5, Il7rα and Ikzf3 (Aiolos). 
The expression of transcription factors in haematopoietic progenitor cells is thought to 
be crucial in promoting lymphoid development or by inhibiting the expression of other 
transcription factors required for the myelo-erythroid lineage. The transcription factor 
GATA-3 in particular is thought to be important for the specification of lymphoid 
progenitors into ETPs and is the only GATA family member expressed in T-cells 
(reviewed in Hosoya et al., 2010). A previous report by Hattori et al (1996) showed that 
in foetal thymic organ culture, the use of anti-sense oligonucleotides against Gata3 in 
LIN– c-kit+ foetal thymocytes resulted in diminished T-cell development. In addition 
studies by Hendriks and colleagues (Hendriks et al., 1999) revealed that blastocysts 
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generated from Gata3-null embryonic stem cells could not contribute significantly 
towards intrathymic T-cell development. Both of these experiments suggest an 
important role for GATA-3 in T-cell fate specification.  
Furthermore, genes which are thought to promote HSC development into the 
myelo-erythroid lineage include Mpo (myeloperoxidase), Csf3r (granulocyte-colony 
stimulating factor receptor; GCSF-R), Csfr1 (macrophage-colony stimulating factor 
receptor; MCSF-R), Cebpα, Gata1, Gata2 and Epor (erythropoietin receptor) as studied 
by Miyamoto and colleagues (2002). GATA-1 and GATA-2 are transcription factors 
involved predominantly in megakaryocyte and erythroid development (Zon et al., 1993; 
Harigae et al., 1998; Pevny et al., 1991) as well as in mast cell formation and 
differentiation (Tsai et al., 1997; Migliaccio et al., 2003) and inhibit the expression of 
PU.1, a transcription factor indistinguishable for GM or lymphoid development (Zhang 
et al., 1999; Nerlov et al., 2000, Dekoter et al., 2000). Therefore, the expression of 
Gata1 and Gata2 in haematopoietic cell populations can be used as readout for 
myelo-erythroid specification. Since members of the GATA family are expressed in 
both lymphoid (Gata3) and myelo-erythroid lineages (Gata1/2) and at specific stages of 
development, it was anticipated that analysing haematopoietic progenitor cells for their 
expression of Gata1, 2 and 3 would provide an indication as to which subsets would 
give rise to myeloid or lymphoid progeny, and most importantly ETPs. 
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3.2 Defining haematopoietic progenitors in the adult BM 
One way to identify specific haematopoietic progenitor populations in the mouse BM is 
by utilising antibodies against selected surface markers of these cells. All 
haematopoietic progenitor populations are negative for the expression of mature lineage 
cell markers (LIN–). The LT-HSC, ST-HSC and LMPP populations all reside within the 
LSK compartment and can be identified based on the expression of the receptor tyrosine 
kinase Flk-2 (CD135). All LT-HSCs and ST-HSCs can be defined as LSK Flk-2– 
(Christensen and Weissman, 2001), whilst LMPPs can be defined as LSK Flk-2+ 
(Adolfsson et al., 2001; Figure 3.1A). Taken together, the LT-HSC and ST-HSC 
populations consist of approximately 0.01% of the total BM, whereas LMPPs are 
approximately 0.05% of the total BM. For a more enriched population of LT-HSCs, the 
SLAM definition (Kiel et al., 2005) of LSK CD48– CD150+ could be used (Figure 3.1B) 
which constitutes approximately 0.005% of mouse BM. LT-HSCs are also negative for 
the expression of CD34 on their cell surface, whereas ST-HSCs and LMPPs are positive 
and therefore ST-HSCs are defined as LSK CD34+ Flk-2– and LMPPs as LSK CD34+ 
Flk-2+ (Figure 3.1C). Throughout this study, LT-HSCs will be detected utilising the 
SLAM definition (Figure 3.1B), whilst ST-HSC and LMPP populations will be 
identified as LSK CD34+ Flk-2– and LSK CD34+ Flk-2+ (Figure 3.1C) 
Similarly to stem cells and multipotent progenitors, myelo-erythroid progenitors also 
reside in the LIN– compartment of the BM. However, these cells are found in LIN– 
c-kit+ Sca-1– compartment (Figure 3.1D) and can be separated into three distinct subsets 
based on CD34 and FcγRII/III (CD16/32) expression (Akashi et al., 2000). The first 
progenitor population to arise in the myeloid compartment is the CMP which can be 
identified as CD34+ FcγRII/III– and which constitutes 0.2% of total BM cells. This cell 
population is then thought to further develop into GMP and MEP populations. The 
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GMP subset is defined as CD34+ FcγRII/III+ and constitutes 0.4% of total BM cells, and 
the MEP subset is defined as CD34– FcγRII/IIIlo and constitutes 0.1% of total BM cells 
(Figure 3.1D). 
Another progenitor population which was recently described (Onai et al., 2007) is the 
CDCP. This cell population was isolated as LIN– c-kitint Flk-2+ MCSF-R+ (Figure 3.2). 
The CDCP has been reported to derive from macrophage/DC progenitors in the BM 
(reviewed by Geissman et al., 2010) and is able to differentiate into cDCs and pDCs in 
vitro and in vivo. The CDCP population is the believed to represent the main DC 
progenitor and we will use this definition throughout the study. 
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Figure 3.1 
Phenotypic definition of stem and progenitor subsets in lineage depleted adult BM cells.  
 
A Representative FACS plot illustrating the definitions of HSC and LMPP 
populations in lineage depleted BM. Populations were isolated as LSK and 
further characterised as Flk-2– (all stem cell activity) or Flk-2+ (LMPPs). 
Relative frequencies of each gated population are given in the respective figure.  
 
B Representative FACS plot illustrating the HSC ‘SLAM’ definition for 
specifically identifying LT-HSCs in lineage depleted BM. The HSC SLAM 
definition allows the identification of LT-HSCs cells as LSK CD48– CD150+. 
 
C Representative FACS plot illustrating a more specific definition for the 
identification of ST-HSC and LMPP populations in lineage depleted BM. 
ST-HSC cells can be distinguished as LSK CD34+ Flk-2–. The LMPP population 
however is LSK CD34+ Flk-2+.  
 
D Representative FACS plot illustrating the identification of myelo-erythroid 
progenitors. CMP, GMP and MEP cells are separated into three populations by 
cell surface expression of CD34 and FcγRII/III. Gates were positioned according 
to positive and negative control populations. 
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Figure 3.2 
Definition of the CDCP progenitor subset in the lineage negative compartment of the 
adult mouse BM. 
 
Representative FACS plot showing how CDCP cells are identified in BM cells. Cells 
were first subject to a sub-optimal lineage depletion. Isolation of these cells was carried 
out according to Flk-2+ and c-kitint expression and was further defined by the presence 
of MCSF-R and the absence of IL-7Rα expression.  
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Based on the ‘classical’ hierarchical scheme of haematopoiesis which segregates 
lymphoid and myeloid development (Akashi et al., 2000), the counterpart to the CMP 
population in the lymphoid lineage is the CLP. This progenitor population was 
originally defined by Kondo and co-workers as LIN– IL-7Rα+ c-kitint Sca-1int and 
constituted 0.02% of total BM cells (Kondo et al., 1997). When we applied this 
definition to BM cells, we found that whilst c-kit and Sca-1 levels were predominantly 
intermediate, a small frequency of LIN– IL-7Rα+ cells expressed high levels of c-kit and 
Sca-1 and also there was a noticeable contamination of Sca-1hi c-kit– cells in this pool 
(Figure 3.3B). After gating on only the intermediate levels of c-kit and Sca-1, a high 
frequency of cells were positive for Flk-2 expression (Figure 3.3B). Based on this 
observation, we used a refined definition to isolate a CLPFlk-2+ population defined as 
LIN– IL-7Rα+ Flk-2+ which expressed mainly intermediate levels of c-kit and Sca-1 and 
lacked the contaminating Sca-1hi c-kit– expressing cells (Figure 3.3C). This definition 
has since been used by other groups to identify the CLP population (Karsunky et al., 
2008). An overlay of the expression of c-kit and Sca-1 from both the original CLP and 
the CLPFlk-2 populations is shown in Figure 3.3D. This reflects how the CLPFlk-2 
definition is a true subset of the original CLP. Therefore, we used the CLPFlk-2 definition 
in all experiments throughout the study.  
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Figure 3.3 
Defining the CLP population in the adult BM. 
 
A Flow cytometry staining of the LSK fraction of the BM. This gate is used as a 
reference in 3.3B and C in order to compare LSK cells in different populations.  
 
B Representative FACS plot illustrating the original definition of the CLP as LIN–
IL-7Rα+. This gating strategy identifies various c-kit and Sca-1 levels as 
opposed to specific intermediate levels of c-kit and Sca-1, which define the true 
CLP population. Nearly all LIN– IL-7Rα+ c-kitint Sca-1int are positive for Flk-2 
expression.  
 
C Representative FACS plot of the CLPFlk-2 population whereby cells are isolated 
according to IL-7Rα and Flk-2 co-expression in the LIN– compartment of the 
BM. This definition identifies cells which express predominantly intermediate 
levels of c-kit and Sca-1 expression. 
   
D Flow cytometry staining overlay of the c-kit and Sca-1 levels of the originally 
defined CLP population (red) and the CLPflk-2+ population (blue) illustrating that 
the CLPFlk-2 subset specifically identifies cells which express intermediate levels 
of c-kit and Sca-1. 
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Another subset of cells in the lymphoid lineage which phenotypically resemble LMPPs 
is the ELP population. As previously explained, this population was originally isolated 
by insertion of GFP into the Rag1 locus (Igarishi et al., 2002) and was defined as LSK 
Flk-2+ CD27+ Rag1GFP+. These cells share the same phenotype as LMPPs except that 
ELPs are positive for reporter expression in the Rag1GFP model. We aimed to create and 
identify an ‘ELP analogue’ and explore its developmental potential. Instead of inserting 
GFP into the Rag1 locus, Rag1wt/Cre x Rosa26wt/eYFP mice were produced in our 
laboratory. In this reporter model, a Cre recombinase was inserted into the Rag1 locus 
which was expressed upon activation of Rag1. This protein subsequently excised a 
transcriptional stop sequence upstream of an eYFP reporter on the constitutively active 
Rosa26 locus, thereby driving eYFP expression in these cells (Figure 3.4B). In order to 
obtain this genotype, mice which were homozygous for Cre on the Rag1 locus were 
bred with mice that were homozygous for eYFP on the Rosa26 locus (Figure 3.4A). 
One advantage of this model over the Rag1GFP model is that all cells which express 
Rag1-driven Cre remain permanently marked by eYFP. We aimed to ensure we had 
correctly identified an ‘ELP analogue’ by examining the phenotype, frequency, number 
and function of this population. Based on the fact that all mature B- and T-cells 
critically depend on Rag1 and hence would be positive for expression of eYFP, we first 
analysed these populations in the spleen. 
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Figure 3.4 
The Rag1wt/Cre x Rosa26wt/eYFP reporter model. 
 
A Generation of Rag1wt/Cre x Rosa26wt/eYFP reporter mice. Mice which were 
homozygous for Cre insertion in the Rag1 locus were crossed to a homozygous 
R26ReYFP strain. This generated a mouse which was heterozygous for Cre 
recombinase on the Rag1 locus and heterozygous for the fluorescent reporter on 
the Rosa26 locus.  
 
B Diagram of Cre-mediated reporter expression. Cre-recombinase expressed under 
the Rag1 promoter excises the loxP flanked stop sequence inserted into the 
Rosa26 locus, driving expression of eYFP permanently in all cells.  
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3.3 Analysis of mature haematopoietic splenic subsets in Rag1 
reporter mice 
In order to characterise the Rag1wt/Cre x Rosa26wt/eYFP reporter model with respect to 
expression in the periphery, splenic lymphoid subsets were analysed for eYFP 
expression. All splenic B- and T-cells were virtually 100% positive for eYFP expression 
(Figure 3.5A). Early developmental stages of splenic B-cells were identified as CD19+ 
IgM+ IgD–, of which 97.78 ± 0.34% were eYFP+. Transitional B-cells, defined as 
CD19+ IgM+ IgD+, were 98.47 ± 0.16% eYFP+ and CD19+ IgMlo IgD+ B-cells 
containing both fully differentiated mature B-cells and re-circulating B-cells were 98.90 
± 0.19% eYFP+. Both CD4 and CD8 αβ T-cells were labelled eYFP+ (CD4+ T-cells: 
99.64 ± 0.068%; CD8+ T-cells: 99.58 ± 0.07%). The γδ T-cell population was 96.72 ± 
0.26% positive for eYFP expression (see Figure 3.5A). NK T-cells as defined by cell 
surface expression of TCRαβ, NK1.1 and CD49b were 96.05 ± 0.70% positive for 
eYFP, a value comparable to that of CD4, CD8 and γδ T-cells. In contrast, NK-cells, 
which were identified as NK1.1+, CD49b+ (See Figure 3.7A) showed only 29.27 ± 
1.56% eYFP expression (Figure 3.5A). 
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Figure 3.5 
EYFP expression in splenic cell populations of Rag1wt/Cre x Rosa26wt/eYFP mice. 
 
A Bar chart representing the relative frequency of eYFP expressing cells in splenic 
lymphocytes. B-cell (CD19+), T-cell, NK- and NK T-cell populations were 
analysed from at least eight individual mice in at least three independent 
experiments on animals aged six to eight weeks of age. Values represent mean ± 
S.E.M. 
 
B Bar chart representing the relative frequency of eYFP expressing cells in 
myelo-erythroid subsets of the spleen. At least eight individual mice were 
analysed in at least three independent experiments on mice aged six to eight 
weeks of age. Values represent mean ± S.E.M. 
 
C Bar chart representing the relative frequency of eYFP expressing cells in cDCs 
and pDCs of the spleen, without (w/o) or with (w) collagenase digestion. The 
decrease in the frequency of CD8– DCs which were eYFP+ after collagenase 
treatment was significant. Six individual mice were analysed. Values are mean ± 
S.E.M. 
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We next extended our studies to erythroid and myeloid subsets of the spleen in 
Rag1wt/Cre x Rosa26wt/eYFP mice. Splenic erythroid precursors were identified as Ter119+ 
CD71+ (normoblasts) and Ter119+ CD71– (reticulocytes). In both of these populations it 
was clear that eYFP expression was virtually absent (see Figure 3.5B and 3.6A). 
Similarly to erythroid cells, myeloid cells also expressed minimal eYFP expression. 
Splenic macrophage/monocytes and neutrophils were identified by Gr1+ CD11b+ and 
only 0.70 ± 0.13% of cells were positive for eYFP expression, which was reduced to               
0.10 ± 0.02% when the macrophage marker F4/80 was included in the staining (Figure 
3.5B). However, in Gr1+ CD11b+ myeloid cells expressing high levels of MHC class II, 
the frequency of eYFP expression was 6.22 ± 1.29% (Figure 3.5B and 3.6B), which 
may represent activated macrophages capable of phagocytosing eYFP+ cells. 
Intermediate and low levels of eYFP were also observed in this subset of cells (Figure 
3.6B) and this could represent degradation of eYFP fluorescence in the lysosomal 
compartment of the macrophage. 
PDCs and cDCs were assessed for eYFP expression with and without collagenase 
treatment (Figure 3.5C). PDCs were identified as PDCA-1+, B220+, CD11c+ and MHC 
class IIint, whilst DCs were classified as ‘myeloid-derived’ (CD11c+, MHC class II+, 
CD8α–) or ‘lymphoid-derived’ (CD11c+, MHC class II+, CD8α+). As shown by Figure 
3.5C, prior to collagenase digestion 19.9 ± 1.11% of pDCs expressed eYFP, whilst 
lymphoid-derived DCs were 18.7 ± 2.04% positive for eYFP expression, with a slightly 
lower expression in myeloid-derived DCs (13.47 ± 1.00%). 
After collagenase digestion, the relative frequency of eYFP+ pDCs remained similar. 
However, there was an increase in the relative frequency of eYFP+ cells in the CD11c+ 
MHC class II+ subset of DCs from 0.88% to 1.97% after exposure to collagenase 
treatment (Figure 3.7B and C). In contrast, the relative frequency of eYFP expression in 
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lymphoid-derived DCs decreased from 18.70 ± 2.04% to 12.67 ± 1.87%, whilst the 
relative frequency of eYFP expression in myeloid-derived DCs decreased from 13.47 ± 
1.0% to 9.03 ± 0.64% (Figure 3.5C). This suggested that collagenase treatment was 
needed to remove all DCs from the spleen, and that DCs which were removed were 
largely negative for eYFP. 
The results of lineage mapping in the spleen showed that all mature T- and B-cells were 
marked by eYFP, which was expected as these cells expressed Rag1 at least twice 
throughout their development. There was no evidence for significant expression of 
eYFP in any mature myelo-erythroid populations, suggesting in the first instance that 
the Rag1wt/Cre x Rosa26wt/eYFP reporter model could be used to monitor lymphoid 
development. NK, pDC and DC populations were only partially marked by eYFP, 
suggesting that development of these mature populations could have derived from 
alternate lineages as well as the lymphoid lineage. In order to investigate these 
observations further, we next looked at eYFP expression in the BM.   
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Figure 3.6 
Frequency of splenic erythroid and myeloid populations expressing eYFP in Rag1wt/Cre x 
Rosa26wt/eYFP mice. 
 
A Representative FACS plot illustrating the virtual absence of cells expressing 
eYFP in splenic erythroid populations. The erythroid compartment was 
sub-divided into normoblasts (Ter119+ CD71+) and reticulocytes (Ter119+ 
CD71–) in mice aged six to eight weeks of age.  
 
B Representative FACS plot illustrating the lack of eYFP expressing cells in MHC 
class II– myeloid cells, but a significant frequency of cells expressing eYFP in 
the MHC class II+ subset. Cells were first identified by Gr1 and CD11b and 
further characterised by MHC class II expression in mice aged six to eight 
weeks of age.  
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Figure 3.7 
Frequency of splenic NK and DC populations expressing eYFP in Rag1wt/Cre x 
Rosa26wt/eYFP mice. 
 
A Representative FACS plot illustrating the relative frequency of splenic NK-cells 
expressing eYFP. NK-cells were defined by NK1.1 and CD49b and then 
analysed for eYFP expression. Both eYFP+ and eYFP– cells were evident.  
 
B Representative FACS plot illustrating the relative frequency of lymphoid and 
myeloid-derived DCs without collagenase treatment. DCs were identified by 
CD11c and MHC class II and then divided into either lymphoid-derived 
(CD8α+) or myeloid-derived (CD8α–) cells and analysed for eYFP expression. 
The lymphoid-derived DCs had a higher frequency of eYFP expressing cells 
than the myeloid-derived DC subset.  
 
C  Representative FACS plot illustrating the relative frequency of collagenase 
treated lymphoid (CD8α+) and myeloid (CD8α–) derived DC subsets. There is a 
clear increase in the expression of MHC class II on the DCs. The relative 
frequency of eYFP+ cells in both subsets decreased after digestion with 
collagenase.  
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3.4 Expression of eYFP in mature and progenitor cell populations of 
the BM 
We first investigated myelo-erythroid populations of the BM. In the erythroid 
compartment of the BM, erythrocyte progenitors were defined as erythroblasts 
(Ter119int CD71+), normoblasts (Ter119+ CD71+) and reticulocytes (Ter119+ CD71–).  
All three subsets showed less than 1% eYFP expression (Figure 3.8A), corresponding to 
the results obtained in the splenic compartment. Similar to erythrocytes, the Gr1+ 
CD11b+ myeloid population exhibited only 0.62 ± 0.09% eYFP+ cells (Figure 3.8A) and 
additional characterisation of this population, utilising the macrophage marker F4/80, 
presented virtual absence of eYFP expression (0.01 ± 0.002%). This frequency was 
almost identical to that in splenic myeloid populations.  
Next we explored eYFP expression in the lymphoid compartment of the BM. Immature 
and mature B-cells were identified according to the previous cell surface markers 
applied in the spleen and were almost 100% positive for eYFP (Figure 3.8B). As shown 
in Figure 3.9, B-cell progenitors were subdivided into pre-pro B-cells (IgM–, B220+, 
CD19–, c-kitint, CD25–), pro B-cells (IgM–, B220+, CD19+, c-kitint, CD25–) and pre 
B-cells (IgM–, B220+, CD19+, CD25+). Pre-pro B-cells exhibited 87.87 ± 1.76% eYFP 
expression (Figure 3.8B) which was increased after development into pro B-cells and 
expression of CD19 (98.8 ± 0.68%). In the pre B-cell compartment, 99.5 ± 0.7% of cells 
were positive for eYFP. Further observations of the pre-pro B-cell compartment 
revealed that the acquisition of eYFP preceded that of CD19 in the majority of cells. 
During maturation from pre-pro B-cells to pro B-cells, there was only a small 
percentage of cells which were CD19+ and eYFP– (Figure 3.9A). This relationship was 
also clear in the pre B compartment where almost all of the cells were CD19+ eYFP+ 
(Figure 3.9B).  
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Figure 3.8 
Expression of eYFP in mature and progenitor cell populations of the BM in Rag1wt/Cre x 
Rosa26wt/eYFP mice. 
 
A Bar chart illustrating the virtual absence of eYFP expressing cells in the 
myelo-erythroid compartment of the BM. Six individual mice were analysed per 
myelo-erythroid subset in two independent experiments on mice aged six to 
eight weeks old. Values represent mean ± S.E.M. 
 
B Bar chart illustrating the average frequency of eYFP expressing cells in all 
B-cell subsets. Six individual mice were analysed per B-cell subset in two 
independent experiments on mice aged six to eight weeks old. Values represent 
mean ± S.E.M. 
 
C Bar chart illustrating the frequency of eYFP+ cells in haematopoietic progenitor 
compartments. Expression of eYFP was evident in the LMPP and CLP 
populations with minimal expression in all other progenitor subsets. At least ten 
individual mice were analysed per progenitor subset in at least five independent 
experiments on mice aged six to eight weeks of age.  
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Figure 3.9 
EYFP expression in BM B-cell subsets of Rag1wt/Cre x Rosa26wt/eYFP mice. 
 
A Representative FACS plot illustrating eYFP expression in the pre-pro and pro 
B-cell compartments of the BM. Pre-pro B-cells develop into pro B-cells by 
acquiring CD19 expression. This plot clearly shows that eYFP precedes the 
acquisition of CD19 in the majority of cells. 
 
B Representative FACS plot illustrating eYFP expression in the pre B-cell subset 
of the BM. Pre B-cells have already acquired CD19 and are virtually all positive 
for eYFP expression. There is a minimal frequency of cells which are positive 
for CD19 expression but negative for eYFP expression.  
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We next explored eYFP expression in stem cells and haematopoietic progenitors. 
LT-HSCs and ST-HSCs exhibited a virtual absence of eYFP expressing cells (0.11 ± 
0.06% and 0.21 ± 0.16%, Figure 3.8C, Figure 3.10A and B). This proved that there was 
no aberrant expression of Cre recombinase in any stem cell subsets. The LMPP 
subpopulation however comprised 5.94 ± 0.84% eYFP+ cells on average (Figure 3.8C), 
of which the range was between 3.5% and 9% (Figure 3.10B). These eYFP+ cells 
represented the ‘ELP analogue’ population. 
The ‘ELP analogue’ could be defined as LSK Flk-2+ IL-7Rα– eYFP+. CD27 was not 
utilised in the staining as all LMPP and CLP cells are uniformly positive for this 
marker. Hence this population is a true subset of the LMPP pool with the additional 
hallmark of eYFP expression (Figure 3.11A). There was a significant increase in eYFP 
expression from the LMPP pool to the CLP pool indicating, at least in part, 
development via the ELP population. 
Upon observation of the CLP population, remarkably only 48.89 ± 4.07% of CLP cells 
were eYFP+ (Figure 3.8C). The eYFP histogram resolved an eYFP– cell population, an 
eYFPint population and an eYFP+ population (Figure 3.11B). The relative frequency of 
eYFP– cells was almost equivalent to the relative frequency of eYFP+ cells, with a small 
percentage (~10%) of cells residing in the eYFPint pool. These cells appeared to be 
acquiring eYFP expression, which is indicative for a developmental relationship from 
the eYFP– population to the eYFP+ population. In addition, the segregation of eYFP 
expression also correlated with a minor decrease of c-kit expression in these subsets 
(Figure 3.11B). 
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Figure 3.10 
EYFP expression in HSC and multipotent progenitor populations of the BM in 
Rag1wt/Cre x Rosa26wt/eYFP mice. 
 
A Representative FACS plot illustrating the virtual absence of eYFP expression in 
the LT-HSC compartment of the BM, as defined by the SLAM definition. Due 
to the absence of Rag1 expression in LT-HSCs, it is expected that these cells 
would be negative for eYFP expression.  
 
B Representative FACS plot illustrating eYFP expression in the ST-HSC and 
LMPP populations of the BM. There was a virtual absence of eYFP expressing 
cells in the ST-HSC compartment, but a significant percentage of cells 
expressing eYFP in the LMPP pool. This figure shows that eYFP is first 
significantly expressed in the LMPP population, which represents the ELP 
subset.   
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Figure 3.11 
EYFP expression in early lymphoid compartments of the BM in Rag1wt/Cre x 
Rosa26wt/eYFP mice. 
 
A Representative FACS plots illustrating the isolation of an ‘ELP analogue’. This 
cell population was defined as LSK, Flk-2+, IL-7Rα– and further isolated by 
expression of eYFP. 
 
B   Representative FACS plot illustrating expression of eYFP in the CLP subset. 
Cells were first identified as LIN– IL-7Rα+ Flk-2+. Further characterisation of 
this population revealed a divide in eYFP expression.  
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Next we investigated eYFP expression in lineage committed subsets of early 
haematopoietic progenitors. The LIN– c-kithi Sca-1– compartment of the BM was 
subdivided into CMP, GMP and MEP populations (Figure 3.12A). In concordance with 
the absence of reporter expression in mature myeloid and erythroid cells in the 
periphery, all subpopulations were virtually negative for eYFP expression. Similarly, 
the CDCP population expressed only a minimal amount of eYFP (1.9 ± 0.24%, Figure 
3.8C and 3.12B). Due to the fact that approximately 20% of pDC and DC splenic 
populations were eYFP+, this might suggest that the CDCP may not be the only 
progenitor population giving rise to mature DCs. An eYFP+ progenitor such as the ELP 
or the CLP may have given rise to a substantial frequency of DCs. Alternatively, a small 
frequency of CDCPs could expand preferentially at a later stage or activation of Rag1 
and subsequent expression of eYFP could have occurred after the CDCP stage in some 
cells.  
 
CHAPTER 3 
 102 
Figure 3.12 
EYFP expression in myeloid and dendritic progenitor populations of the BM in 
Rag1wt/Cre x Rosa26wt/eYFP mice.  
 
A Representative FACS plot illustrating the virtual absence of eYFP expression in 
myeloid progenitors. Three subpopulations of LIN– c-kithi Sca-1– cells could be 
isolated based on the expression of CD34 and FcγRII/III expression. The CMP 
pool was identified as CD34+ FcγRII/III–, the GMP was characterised as CD34+ 
FcγRII/III+ and the MEP was defined as CD34– FcγRII/IIIlo. 
 
B  Representative FACS plot illustrating the percentage of cells expressing eYFP in 
the CDCP population of the BM. The CDCP population was identified as LIN– 
Flk-2+ c-kitint MCSF-R+ IL-7Rα– and showed that only a minute frequency of 
cells were positive for eYFP expression. 
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3.5 Investigation of the frequency of eYFP+ cells in the thymic 
compartment of the haematopoietic system 
We next investigated eYFP expression in thymic populations of Rag1wt/Cre x 
Rosa26wt/eYFP mice. It is thought that the earliest thymocyte progenitors in the adult 
mouse are dependent on a continuing input of blood borne progenitors (Scollay et al., 
1986), which are of BM origin. However, the identity of these progenitors is still 
unknown. Early T-precursor populations can form B-cells (Wu et al., 1991), NK-cells 
(Carlyle et al., 1998), myeloid cells (Lee et al., 2001, Balciunaite et al., 2005; Wada et 
al., 2008; Bell and Bhandoola, 2008) and DCs (Ardavin et al., 1993) as well as T-cells, 
suggesting the thymus is seeded by some form of multipotent progenitor cell. We 
hypothesised that mapping the expression of eYFP in the thymus and correlating this 
with eYFP expression observed in BM progenitor pools would indicate which 
populations are “thymic seeding cells”. Within the thymic compartment, all subsets 
from ETPs to mature CD4 and CD8 populations were analysed for the expression of 
eYFP.  
Focusing firstly on mature cells, in concordance with splenic T-cells subsets, CD4 SP 
and CD8 SP T-cells were almost 100% positive for eYFP expression (99.77 ± 0.02% 
and 99.72 ± 0.03%, Figure 3.13A). This observation could also be extended to the 
double positive population (99.58 ± 0.32%). However, this was not the case in early 
thymic populations. The ETP population was identified as LIN– c-kithi CD44+ CD25– 
(Godfrey et al., 1992), the DN2 population as LIN– CD44+ CD25+, the DN3 population 
as LIN– CD44– CD25+ and the DN4 population as LIN– CD44– CD25–.  As shown in 
Figure 3.13A, the frequency of cells in the ETP compartment expressing eYFP was 
75.80 ± 3.50%, increasing to 84.70 ± 1.70% in DN2. Virtually all of the cells were 
eYFP+ from the DN3 stage onwards. The increase in the frequency of eYFP+ cells is 
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depicted in Figure 3.13B. Unlike the cells in the CLP pool which expressed 
intermediate levels of eYFP illustrating a developmental progression, there was little 
evidence for intermediate populations in early thymic compartments (Figure 3.13B). 
This suggests that ETP cells may be derived from two progenitor cell types, one which 
is eYFP– and one which is eYFP+ as there was no evidence of eYFP– cells converting 
into eYFP+ cells.  
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Figure 3.13 
Expression of eYFP in thymocyte subsets in Rag1wt/Cre x Rosa26wt/eYFP mice. 
 
A Bar chart illustrating the average frequency of cells expressing eYFP in all 
mature and thymocyte populations of the thymus. At least seven individual mice 
were analysed per subset in at least four independent experiments. Mice were 
analysed at four to six weeks of age. Values are mean ± S.E.M.  
 
B Representative FACS plots illustrating the expression of eYFP in early thymic 
subsets. DN1-4 populations were characterised on LIN– cells by CD44 and 
CD25 expression and then analysed for expression of eYFP. The ETP 
population was defined as LIN– CD44+ CD25– c-kithi. 
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3.6 Comparison of cellularity of haematopoietic populations in 
Rag1wt/Cre x Rosa26wt/eYFP mice with C57BL/6 mice 
We further enumerated the absolute numbers of all haematopoietic subsets in Rag1wt/Cre 
x Rosa26wt/eYFP reporter mice to exclude any potential aberration of haematopoietic 
development and homeostasis. 
In the spleen, (Figure 3.14) the number of all myeloid, B, pDC, CD8+ DC, NK, NK 
T-cell and αβ T-cell subsets between Rag1wt/Cre x Rosa26wt/eYFP and C57BL/6 mice were 
not significantly different. However, the reticulocyte population in C57BL/6 mice 
amounted to 2.10 x 106 ± 0.71 x 106 whereas in Rag1wt/Cre x Rosa26wt/eYFP mice this cell 
number was increased to 5.21 x 106 ± 0.43 x 106 (Figure 3.14A). In addition, there was a 
significant difference in the number of the splenic CD8α– DC population between the 
mouse strains. This difference in numbers was 1.3 fold (Figure 3.14B) with a value of 
0.54 x 106 ± 0.06 x 106 in C57BL/6 mice, compared to 0.75 x 106 ± 0.09 x 106 in 
Rag1wt/Cre x Rosa26wt/eYFP reporter mice; however this difference only occurred upon 
inclusion of collagenase to the processing of the organs. The number of CD4 TCRγδ 
T-cells was also different between strains. In C57BL/6 mice, the amount of cells only 
equated to 0.39 x 104 ± 0.06 x 104 whilst in Rag1wt/Cre x Rosa26wt/eYFP mice, 1.45 x 104 ± 
0.3 x 104 cells were present (Figure 3.14C).  
Analysis of the BM (Figure 3.15) revealed that the erythroid populations had 
significantly different numbers between mutant and wildtype mice. The Ter119+ CD71+ 
subset amounted to 4.8 x 106 ± 0.53 x 106 in C57BL/6 mice and 10.70 x 106 ± 0.23 x 
106 in Rag1wt/Cre x Rosa26wt/eYFP mice (Figure 3.15A), whilst the Ter119+ CD71– subset 
was 0.42 x 106 ± 0.07 x 106 in C57BL/6 and 2.52 x 106 ± 0.29 x 106 in Rag1wt/Cre x 
Rosa26wt/eYFP mice (Figure 3.15A). Seeing as though the number of reticulocytes in the 
spleen was also lower in the C57BL/6 strain than the Rag1wt/Cre x Rosa26wt/eYFP mice 
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strain, this suggests that cells may be proliferating at a higher rate in the Rag1wt/Cre x 
Rosa26wt/eYFP mice as they develop down the erythroid lineage. Unlike the erythroid 
compartments, the number of immature B-cells was lower in the reporter mice than in 
wildtype mice (Figure 3.15B). The absolute number of CD19+ IgM+ IgD+ B-cells was 
4.87 x 105 ± 0.57 x 105 in C57BL/6 mice and 50% less in Rag1wt/Cre x Rosa26wt/eYFP 
mice (2.42 x 105 ± 0.33 x 105). The BM myeloid and NK populations showed no 
significant changes in numbers. Additionally, in the thymus, all the cell numbers were 
comparable (Figure 3.15C). Due to the fact that there were alterations in the numbers of 
haematopoietic populations which were both positive and negative for Rag1-driven 
expression of Cre, we deduced that these differences were not caused by toxic levels of 
the Cre protein. These minor discrepancies may have been due to minor variations in 
the background of these mice strains. 
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Figure 3.14 
Absolute cell numbers of all splenic populations in C57BL/6 and Rag1wt/Cre x 
Rosa26wt/eYFP mice. 
 
A Bar chart illustrating the absolute number of cells in all myelo-erythroid, B- and 
T-cell subsets of the spleen of wildtype and Rag1wt/Cre x Rosa26wt/eYFP mice, 
aged six to eight weeks old. The number of Ter119+, CD71– erythroid cells was 
significantly higher in the Rag1wt/Cre x Rosa26wt/eYFP strain. Analysis was carried 
out on at least six individual mice per subset in at least two independent 
experiments. Values represent mean ± S.E.M. 
 
B Bar chart illustrating the absolute number of cells in pDC, DC, NK and NK 
T-cell subsets of the spleen of wildtype and Rag1wt/Cre x Rosa26wt/eYFP mice, 
aged six to eight weeks old. PDC and DC subset numbers were calculated with 
or without treatment with collagenase. There was a significant difference in the 
number of CD8– DC between the two strains after collagenase treatment. 
Analysis was carried out on at least six individual mice per subset in at least two 
independent experiments. Values represent mean ± S.E.M. 
 
C Bar chart illustrating the absolute number of cells in CD4+ and CD8+ γδ T-cells 
of the spleen of wildtype and Rag1wt/Cre x Rosa26wt/eYFP mice, aged six to eight 
weeks old. There was a significantly higher number of CD4 γδ T-cells in the 
Rag1wt/Cre x Rosa26wt/eYFP mice compared to C57BL/6 mice. Analysis was 
carried out on at least eight individual mice per subset in at least two 
independent experiments. Values represent mean ± S.E.M. 
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Figure 3.15 
Absolute cell numbers of BM and thymic populations in C57BL/6 and Rag1wt/Cre x 
Rosa26wt/eYFP mice. 
 
A Bar chart illustrating the absolute number of myeloid and erythroid cells per 
femur pair in the BM of wildtype and Rag1wt/Cre x Rosa26wt/eYFP mice, aged six 
to eight weeks old. Both erythroid subset numbers were significantly different 
between the two strains. Analysis was carried out on at least six individual mice 
per subset in at least two independent experiments. Values represent mean ± 
S.E.M. 
 
B Bar chart illustrating the absolute number of B-cell subsets and NK-cells per 
femur pair in the BM of wildtype and Rag1wt/Cre x Rosa26wt/eYFP mice, aged six 
to eight weeks old. All B-cell populations are positive for CD19 expression. 
There was a significantly higher number of transitional B-cells in wildtype mice 
compared to Rag1wt/Cre x Rosa26wt/eYFP mice. Analysis was carried out on at least 
six individual mice per subset in at least two independent experiments. Values 
represent mean ± S.E.M. 
 
C Bar chart illustrating the absolute numbers of thymic populations of wildtype 
and Rag1wt/Cre x Rosa26wt/eYFP mice, aged six to eight weeks old. All cell 
populations were similar in both strains. Analysis was carried out on at least six 
individual mice per subset in at least two independent experiments. Values 
represent mean ± S.E.M. 
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3.7 Expression of eYFP in haematopoietic populations compared in 
different Cre reporter mouse strains 
We next examined eYFP expression in all haematopoietic progenitor populations using 
different mouse strains (Figure 3.16). We compared eYFP expression in a constitutively 
active strain (Rosa26eYFP), and reporter mouse strains utilising either a lymphoid 
specific knock-in Cre (Rag1wt/Cre x Rosa26wt/eYFP), a lymphoid-specific transgenic Cre 
(hCD2::iCre x R26Rwt/eYFP) and a pan-haematopoietic transgenic Cre (vav1::iCre x 
R26Rwt/eYFP). A basic assumption for lineage tracing experiments is that there is constant 
accessibility of the reporter locus, so that chromatin modification within the locus 
during lymphoid development can be disregarded. We aimed to answer this by 
analysing the Rosa26eYFP and vav1::iCre x R26Rwt/eYFP strains. Using C57BL/6 mice as a 
negative control, the Rosa26eYFP strain had virtually identical mean fluorescence 
intensity of eYFP in all populations, indicating that there was no change in the 
transcriptional and translational activity throughout differentiation. The vav1::iCre x 
R26Rwt/eYFP reporter marked 93.4% of LT-HSCs (Figure 3.16), reflecting the fact that 
the vav1 gene is turned on at the very beginning of haematopoietic development. This 
expression increased in ST-HSCs to 96.3% and then further to 100% by the LMPP and 
later stages. This was an important observation, as LMPP and CLP populations were 
partially negative for eYFP expression in the Rag1wt/Cre x Rosa26wt/eYFP model, but this 
proved that all cells downstream of HSCs had an accessible Rosa26 locus which could 
undergo recombination.  
We also analysed the Rag1wt/Cre x Rosa26wt/eYFP and hCD2::iCre x R26Rwt/eYFP reporters 
to compare the onset of reporter activity during lymphoid development in the BM. 
Upon observation of haematopoietic progenitor populations in Rag1wt/Cre x Rosa26wt/eYFP 
mice, it was clear that this model provided several important advantages for the 
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dissection of lymphoid development. This was due to eYFP first being expressed in the 
ELP compartment (Figure 3.16), allowing us to visualise development from the earliest 
specified lymphoid pool. Lineage mapping using this reporter model revealed a 
segregation of eYFP in the CLP population; however the hCD2::iCre x R26Rwt/eYFP 
reporter labelled a significantly lower frequency of CLP cells. 
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Figure 3.16 
Expression of eYFP in all haematopoietic progenitor populations compared between 
different mouse strains in lineage depleted BM. 
 
Representative histograms of all LIN– haematopoietic progenitor populations and their 
frequency of eYFP expression in different mouse strains. Haematopoietic populations 
were identified as previously defined. C57BL/6 mice were used as a negative control 
and Rosa26eYFP mice were used as a positive control for eYFP expression. Analysis of 
the vav1::iCre x R26Rwt/eYFP strain illustrated that the Rosa26 locus opened efficiently in 
all haematopoietic populations, as all subsets downstream of LT-HSCs were positive for 
eYFP. The Rag1wt/Cre x Rosa26wt/eYFP strain provided the best tool for investigating 
lymphoid development, as eYFP expression was first evident in the LMPP population. 
The hCD2::iCre x R26Rwt/eYFP strain, which has been commonly used to observe 
thymocyte development, labelled only approximately 25% of CLP cells with eYFP. 
Analysis was carried out on at least six individual mice per subset per strain, aged six to 
eight weeks old, in at least three independent experiments. 
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3.8 The effect of gender and aging on haematopoiesis 
After investigating intrinsic factors which could affect the expression of eYFP in BM 
progenitor populations, we next focused on extrinsic factors. Oestrogen is thought to 
exert an inhibitory effect on lymphopoiesis and it has been described that in pregnant 
mice, where levels of the hormone are high, early B-lineage development is suppressed 
(Medina et al., 1993). In terms of lymphoid progenitor cells, depletion of the LSK 
fraction of the BM has already been reported after oestrogen treatment (Kouro et al., 
2001) which also includes the ELP population (Medina et al., 2001). Because levels of 
oestrogen are higher in female mice than male mice, we hypothesised that female mice 
would have a lower frequency and number of lymphoid progenitors than male mice. 
Therefore, we opted to compare the differences in pool sizes between genders. In 
addition, it is well established that lymphopoiesis is less efficient with age. Thymic 
involution and the frequency and function of pre B-cells are markedly diminished in 
senescent mice (Stephan et al., 1996; Stephan et al., 1998). However, very few studies 
on T- and B-cell progenitors combine the effect of gender and age. To address this, we 
analysed male and female C57BL/6 mice aged six weeks and one year old (Figure 
3.17A). The frequency of cells in the LSK compartment was significantly higher in 
male mice (3.24 ± 0.58% of LIN– cells) than females (1.86 ± 0.29% of LIN– cells). 
However, this was not evident in the ST-HSC compartment, which exhibited a lower 
frequency of cells in male mice (9.81 ± 1.36% of LSK cells) than female mice (12.5 ± 
0.2% of LSK cells), although this was not statistically significant. There was a 
noticeable difference in the frequency of cells in the LMPP population, which 
comprised 43.2 ± 3.05% of LSK cells in males compared to 34.1 ± 4.16% in females. In 
addition, the CLP population was of a statistically higher frequency of LIN– cells in 
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male mice (1.95 ± 0.16%) as compared to female mice (1.43 ± 0.14%), which was also 
reflected in the absolute numbers (Figure 3.18B).  
To combine the effect of gender with aging, progenitor populations in mice aged over 
one year of age were analysed. As Figure 3.17B illustrates, there was a decrease in the 
frequency of most compartments compared to mice aged six weeks, however there 
remained an overall higher frequency in cell populations of males than females. Other 
noticeable differences in aging alone were the size of the LSK Flk-2– CD34– pool and 
the IL-7Rα+ Flk-2– pool. In both male and female mice, the frequency of these pools 
appeared to increase with age (Figure 3.17A and B). The LSK Flk-2– CD34– pool 
represents LT-HSCs, although the exact function of the IL-7Rα+ Flk-2– compartment is 
unknown.  
We also calculated the absolute numbers of all lymphoid progenitors per BM femur pair 
in male and female mice aged six weeks and one year of age. The analysis demonstrated 
that the absolute number of cells in males was significantly higher than females in the 
LMPP and CLP populations at six weeks old (Figure 3.18A and B). In contrast there 
was no significant difference in the number of myeloid progenitors or thymic 
progenitors between genders (Figure 3.18C and D). In aged mice, the number of cells in 
male mice was significantly higher not only in LMPP and CLP populations, but also in 
the LT-HSC, ST-HSC, CMP, GMP, ETP, DN2 and DN3 compartments than in females 
(Figure 3.19A-D). The number of LT-HSCs increased dramatically in male mice with 
age from 0.08 x 104 ± 0.02 x 104 at six weeks in comparison to 0.193 x 104 ± 0.03 x 104 
at one year of age; however there was only a slight increase in the number of LT-HSCs 
in female mice (0.03 x 104 ± 0.008 x 104 at 6 weeks and 0.04 x 104 ± 0.02 x 104 at one 
year of age). In comparison, the number of ST-HSC cells in male and female mice did 
not change noticeably with age. However, the number of CMP and GMP populations 
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did increase with age. This could be the reason for the observed increase in LT-HSCs, 
as more of these cells may have been required to differentiate into ST-HSCs and then 
give rise to myeloid progenitors. Alternatively, the rise in LT-HSCs could be due to an 
increase in self-renewing cells. The number of CMP cells increased in male mice from 
4.13 x 104 ± 0.73 x 104 (Figure 3.18C) to 10.36 x 104 ± 0.83 x 104 in aged mice (Figure 
3.19C), and from 1.84 x 104 ± 0.23 x 104 to 2.65 x 104 ± 0.36 x 104 in the GMP 
compartment. This increase in myeloid progenitor numbers was also reflected in aged 
female mice although the numbers were still significantly lower than that in aged male 
mice (Figure 3.19C). There was also a minor increase in the number of MEP cells in 
male and female mice with age. These results indicated an expansion of myeloid 
progenitors and conversely a contraction of lymphoid progenitors, but with no impact 
on the ST-HSC number. 
In the thymus, interestingly there was a minor increase in the number of ETPs in aged 
male mice, but a decrease in aged female mice. The number of male ETPs increased 
from 0.4 x 104 ± 0.13 x 104 in mice aged six weeks (Figure 3.18B) to 0.62 x 104 ± 0.17 
x 104 in mice aged one year of age (Figure 3.19B). In female mice however, the number 
decreased from 0.58 x 104 ± 0.2 x 104 to 0.21 x 104 ± 0.08 x 104. Given that the number 
of lymphoid progenitors in the BM decreased in both genders with age, it would be 
expected that the number of ETPs would also decrease with age. However, this was not 
the case in male mice. Throughout thymic development, the DN2 and DN3 populations 
also increased in size in male mice with age, but decreased in female mice with age. 
However in the DN4 population there were a higher number of cells in aged female 
mice (119.29 x 104 ± 56.98 x 104; Figure 3.19D) than in male mice (72.15 x 104 ± 25.39 
x 104; Figure 3.19D), an inversion of what was observed at six weeks of age. This 
suggests that in aged male mice the proliferation from the DN3 to the DN4 population 
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was lower than the proliferation observed in aged female mice. In addition, this also 
suggests that the DN4 population is not suppressed by female hormones, whereas the 
ETP to DN3 populations may well be.  
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Figure 3.17 
The effect of gender and aging on stem cell and lymphoid progenitor populations of 
lineage depleted BM. 
 
A Representative FACS plots of ST-HSC, LMPP and CLP populations, compared 
between male and female C57BL/6 mice, aged six weeks old. All 
subpopulations illustrated a higher frequency of LIN– cells in male mice than in 
female mice. Analysis was carried out on eight independent male experiments 
and three independent female experiments.  
 
B Representative FACS plots of ST-HSC, LMPP and CLP populations, compared 
between male and female C57BL/6 mice, aged one year old. All populations had 
a lower relative frequency than in mice aged six weeks of age, however the 
frequencies were still higher in male mice than in female mice at one year of 
age. Analysis was carried out on six individual mice per gender from two 
independent experiments.  
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Figure 3.18 
Absolute cell numbers of haematopoietic progenitor populations compared between 
male and female mice, aged six weeks of age.  
 
A Histogram illustrating the absolute number of LT-HSC, ST-HSC and LMPP 
populations in the total BM of male and female C57BL/6 mice aged six weeks 
of age. There were a significantly higher number of LMPP cells in male mice 
than in female mice. Values represent mean ± S.E.M. 
 
B Histogram illustrating the absolute number of LMPP, CLP and ETP populations 
in the BM and thymus of male and female C57BL/6 mice aged six weeks of age. 
There were a significantly higher number of LMPP and CLP cells in male mice 
compared to female mice. Values represent mean ± S.E.M. 
 
C  Histogram illustrating the absolute number of myeloid progenitor populations in 
the BM of male and female C57BL/6 mice aged six weeks of age. There was no 
significant difference in the number of myeloid progenitor cells between 
genders. Values represent mean ± S.E.M. 
 
D Histogram illustrating the absolute number of thymocyte populations in the 
thymus of male and female C57BL/6 mice aged six weeks of age. There was no 
change in the number of DN2, DN3 or DN4 populations between male and 
female mice. Values represent mean ± S.E.M. 
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Figure 3.19 
Absolute cell numbers of haematopoietic progenitor populations compared between 
male and female mice, aged one year of age.  
 
A Histogram illustrating the absolute number of LT-HSC, ST-HSC and LMPP 
populations in the total BM of male and female C57BL/6 mice aged one year of 
age. There were a significantly higher number of all subsets in male mice than in 
female mice after aging. Values represent mean ± S.E.M. 
 
B Histogram illustrating the absolute number of LMPP, CLP and ETP populations 
in the BM and thymus of male and female C57BL/6 mice aged one year of age. 
There were a significantly higher number of LMPP, CLP and ETP cells in male 
mice compared to female mice. Values represent mean ± S.E.M. 
 
C Histogram illustrating the absolute number of myeloid progenitor populations in 
the BM of male and female C57BL/6 mice aged one year of age. There were a 
higher number of CMP and GMP cells in males than in females in aged mice. 
However the number of MEPs was similar between genders. Values represent 
mean ± S.E.M. 
 
D Histogram illustrating the absolute number of thymocyte populations in the 
thymus of male and female C57BL/6 mice aged one year of age. There a 
significantly higher number of ETP, DN2 and DN3 cells in aged male mice 
compared to aged female mice.  Values represent mean ± S.E.M. 
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We also wanted to investigate whether gender and age had any effect on the eYFP+ 
CLP, eYFP– CLP and ELP populations which were characterised using the Rag1wt/Cre x 
Rosa26wt/eYFP mice. As presented in Figure 3.20A, there was a higher frequency of 
eYFP+ CLP cells in males (38.8%) than in females (18.5%), and a lower frequency of 
eYFP– CLP cells. However, the absolute number of eYFP– CLP cells was not 
significantly different between male and female mice (Figure 3.20B). The number of 
eYFP+ CLP cells was significantly higher in males (4.3 x 103 ± 0.6 x 103) than in 
females (1.3 x 103 ± 0.7 x 103), possibly indicating a population which may be 
suppressed by oestrogen (Figure 3.20B). In addition, Figure 3.20C illustrates that the 
number of cells in the ELP population was also significantly higher in male mice (0.09 
x 103 ± 0.04 x 103) than female mice (0.008 x 103 ± 0.004 x 103). 
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Figure 3.20 
The relative frequency and number of ELP, CLP eYFP– and CLP eYFP+ populations in 
aged male and female mice. 
 
A Representative FACS plots of CLP cells in Rag1wt/Cre x Rosa26wt/eYFP male and 
female mice aged one year old. LIN– CLP cells were analysed for the frequency 
of eYFP expression. Three individual mice were analysed.  
 
B Bar chart illustrating the absolute number of CLP eYFP–, CLP eYFPint and CLP 
eYFP+ populations in Rag1wt/Cre x Rosa26wt/eYFP male and female mice, aged one 
year old. There were no significant differences in the number of CLP eYFP– or 
CLP eYFPint; however male mice exhibited a significantly higher number of 
CLP eYFP+ cells. Three individual mice were analysed. Values represent mean 
± S.E.M. 
 
C Bar chart illustrating the absolute number of cells in the ELP population utilising 
Rag1wt/Cre x Rosa26wt/eYFP male and female mice aged one year old. There were a 
significantly higher number of ELP cells in aged male mice compared to aged 
female mice. Three individual mice were analysed. Values represent mean ± 
S.E.M. 
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3.9 Expression of GATA-family transcription factors in 
haematopoietic progenitor populations 
Aside from exploring which factors affected the relative size and composition of 
haematopoietic progenitor subsets, we also aimed to determine the gene expression of 
these populations. To clarify which BM progenitor cells were definitive TSCs, we 
analysed the expression of Gata1 to 3 transcription factors in these populations, one set 
of transcription factors which have been implied in haematopoietic development. In 
order to assess the relative gene expression in lymphoid progenitor populations, all 
subsets were isolated and subject to qRT-PCR. As illustrated in Figure 3.21A, 
expression of Gata1 was predominantly expressed in the MEP population, with a lower 
amount of expression in the GMP and CMP populations. Gata1 expression was absent 
in HSC, LMPP and CLP subsets, demonstrating that Gata1 is a transcription factor 
expressed exclusively in the myelo-erythroid lineage. Similarly Gata2 was also 
expressed in all myelo-erythroid progenitor populations (Figure 3.21B), however the 
highest expression of Gata2 was observed in LMPPs and there was a substantial amount 
of expression in HSCs. Gata1 and Gata2 expression was not assessed in thymic 
populations as these transcription factors are thought to be mainly involved in 
specification of the myelo-erythroid lineage and most cells in the thymus are already 
specified to the T-cell lineage. In contrast to Gata1 and Gata2, the transcription factor 
Gata3 was expressed mainly in the lymphoid lineage. The highest expression of Gata3 
was observed in thymic CD4 SP T-cells, with lower amounts of expression in HSCs, 
ETPs, DN2, DN3 and DN4 subsets. Residual expression was found in LMPPs, CLPs 
and CD8 SP populations (Figure 3.21C). Due to the unexpected finding of relatively 
high levels of Gata3 mRNA in HSCs, but not in LMPPs and CLPs, this might suggest 
that the GATA-3 protein was not translated until HSCs developed into LMPPs, ELPs 
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and CLPs. Therefore, we next looked at the intracellular (IC) GATA-3 protein levels in 
lymphoid progenitor cells. 
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Figure 3.21 
Expression of GATA1-3 transcription factors in all haematopoietic progenitor 
populations of the BM. 
 
Sorted cell populations from six to eight week old C57BL/6 mice were subjected to 
RNA extraction, quality control and reverse transcription as described in materials and 
methods. 500 cell equivalent cDNA from each population was assessed in triplicates for 
each target gene, using the Qiagen primer/probe detection system. Arbp was used as a 
control to which all expression values were normalised. Values represent mean ± S.D. 
from at least three independent preparations of haematopoietic progenitors. 
 
A Graph illustrating the level of expression of the transcription factor Gata1 in all 
stem cell, lymphoid progenitor and myelo-erythroid progenitor populations. 
Expression was evident in CMP, GMP and MEP populations. 
 
B  Graph illustrating the level of expression of the transcription factor Gata2 in all 
stem cell, lymphoid progenitor and myelo-erythroid progenitor populations. 
Expression was evident in all populations except the CLP. 
 
C Graph illustrating the level of expression of the transcription factor Gata3 in all 
stem cell, lymphoid progenitor, myelo-erythroid progenitor and thymic 
populations. The highest expression of Gata3 was observed in CD4+ T-cells and 
HSCs. There was virtually no expression in myelo-erythroid progenitor 
populations, but there was evidence of residual expression in LMPP, CLP and 
CD8 populations. 
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Due to high Gata3 mRNA levels being present in BM HSCs and thymic lymphoid cells, 
we next set out to determine the GATA-3 protein levels in BM and thymic lymphoid 
progenitors. Seeing as though Gata3 is expressed in large amounts during CD4 lineage 
specification (Hernandez-Hoyos et al., 2003), we first analysed GATA-3 protein levels 
in the thymic CD4 population and used this result as a positive control. As shown in 
Figure 3.22A, the CD4+ TCRhi population expressed high levels of the GATA-3 protein 
as compared to the isotype control and the CD8+ TCRhi population. However, there was 
evidence for some GATA-3 protein expression in the DP compartment. This was 
expected, as cells develop from the DP pool into CD4 SP cells, therefore GATA-3 
would be expressed in CD4 committed DP cells. The residual presence of GATA-3 
protein in the CD8+ TCRhi population can be explained by the fact that these cells are 
originating from a population of cells which had previously expressed Gata3, therefore 
it is likely that some protein will still be present inside these cells. In the DN 
compartments of the thymus, similar to mRNA levels, the highest expression of 
GATA-3 was observed in the DN2 and DN3 compartments (Figure 3.22B). GATA-3 is 
thought to play an important role during β-selection at the DN3 stage of development 
(Hendriks et al., 1999), and these results are in agreement with this model. Slightly less 
protein levels were present in the ETP population and the lowest expression was 
illustrated in the DN4 population. However, none of the populations were completely 
negative for GATA-3 protein expression.  
We next analysed GATA-3 protein levels in BM lymphoid progenitor subsets (Figure 
3.22C). The majority of evidence in the literature supports a model whereby T-cell 
production is initiated from ELPs or CLPs, therefore we focused our studies on these 
populations. Taking into consideration that lineage mapping experiments had indicated 
heterogeneity in the CLP population, this subset was divided into eYFP+ and eYFP– 
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populations in order to address whether the expression of GATA-3 was different. As 
indicated by the mRNA levels, the protein levels of GATA-3 in these populations were 
minor. Using GATA-3 expression as a method of identifying T-cell progenitors of the 
BM, this data suggests that ELP and CLPs have equal opportunity to develop into 
T-cells. To further address which cell populations are able to give rise to T-cells in vivo, 
functional studies of these subsets would be required.  
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Figure 3.22 
GATA-3 intracellular protein levels in lymphoid cell populations of the BM and thymus. 
 
A Representative FACS plot illustrating GATA-3 IC protein levels in CD4 SP, 
CD8 SP and DP thymocytes of Rag1wt/Cre x Rosa26wt/eYFP mice. CD4 SP and 
CD8 SP cells were classified as TCRhi and assessed for GATA-3 protein levels. 
All GATA-3 levels were compared to an IgG2b isotype control. Thymi were 
pooled and processed together. Data are representative for one from six 
individual experiments.  
 
B Representative FACS plot illustrating GATA-3 IC protein levels in undepleted 
thymic DN1-4 populations of Rag1wt/Cre x Rosa26wt/eYFP mice. Cells were first 
analysed as LIN– and DN populations were identified based on CD44 and CD25 
expression. The DN1 population was further characterised by c-kit expression to 
identify the ETP population. All GATA-3 levels were compared to an IgG2b 
isotype control. Thymi were pooled and processed together. Data are 
representative for one from three experiments. 
 
C Representative FACS plots illustrating GATA-3 IC protein levels in lineage 
depleted ELP and CLP BM populations of Rag1wt/Cre x Rosa26wt/eYFP mice. BM 
was FACS-purified into ELP, CLP eYFP– and CLP eYFP+ populations (see 
Figure 3.11 A and B). GATA-3 protein levels were then analysed. All GATA-3 
levels were compared to an IgG2b isotype control. Data represent one 
experiment.  
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3.10 Discussion 
The specific path by which lymphoid progenitors develop into mature T- and B-cells 
still remains unclear. It has been argued that the CLP is the main cell type giving rise to 
T-cells, however there has been substantial evidence arguing against this theory. The 
CLP population, firstly isolated and characterised by Kondo and colleagues (Kondo et 
al., 1997), was used to competitively reconstitute lethally irradiated Ly5.1 mice with 
2 x 103 Ly5.2+ CLPs and 2 x 105 Ly5.1+ BM cells, resulting in only T- and B-cell 
reconstitution and without any myeloid reconstitution (Kondo et al., 1997). The CLP 
population was also reconstituted in sub-lethally irradiated Rag2-null mice, but still 
only T- and B-cells could be detected. To test for myeloid potential in vitro, CLPs were 
placed in methylcellulose culture which promotes myeloid colony formation, but 
myeloid colonies were not detectable from CLPs. Therefore, based on this report, it 
seemed in the first instance that this lymphoid-restricted progenitor was the main cell 
type giving rise to mature lymphocytes which was absent of any myeloid potential.  
However, numerous reports have questioned the concept that the CLP is the main 
pre-thymic progenitor. In one of these reports (Allman et al., 2003), it was revealed that 
in Ikaros mutant mice there was a complete lack of CLPs and subsequent B-lineage 
development, but ongoing thymopoiesis. This suggested that the CLP population could 
not be the only source of thymic progenitors and may be the main progenitor for 
B-cells. In another study (Bell and Bhandoola, 2008), ETPs were isolated, placed on 
OP9 stromal cells and gave rise to cells that expressed the myeloid marker CD11b. 
These cells also expressed the monocyte/macrophage markers MCSF-R, F4/80 and Gr1. 
Upon microscopic examination, these cells also resembled cells with monocytic 
morphology and were capable of phagocytosis. The authors deduced that ETPs 
possessed myeloid potential, as well as T, NK and DC potentials and could not arise 
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from lymphoid restricted CLPs alone. Instead the authors suggested derivation from 
earlier lymphoid subsets such as ELPs or LMPPs. These findings were supported by 
Wada et al., (Wada et al., 2008) who cultured DN1, DN2 and DN3 cells from adult 
thymus on PA6 or Tst-4/DLL1 cells which support the generation of myeloid cells. 
They found that CD11b+ cells were generated in these cultures, which also expressed 
F4/80 and which were capable of phagocytosis. On the other hand, Serwold and 
colleagues (Serwold et al., 2009) reported that because a lymphoid-restricted progenitor 
was not used as a control in these in vitro assays, the myeloid cells observed could have 
represented an artefact in the culture system. Therefore, in order to identify which cells 
had most thymic progenitor activity, Serwold et al. compared the kinetics of 
thymopoiesis between CLPs and MPPs. The results showed that seven days after 
transplantation, donor thymic T-lineage chimerism was evident in all mice transplanted 
with CLPs and peaked at day 21 when most cells were at the DP stage. In mice 
transplanted with MPPs however, T-lineage reconstitution was still evident at the DN 
stage at day 21 and continued to rise up until day 28, when DN thymocyte production 
was still ongoing. The authors deduced that CLPs gave rise to a single wave of 
thymopoiesis, whereas MPPs proliferated in the BM and generated CLPs before giving 
rise to thymocytes. Considering that DN production was ongoing after MPP 
transplantation, this data could have indicated that MPP cells proliferated more than 
CLPs before seeding the thymus and therefore a larger number of cells gave rise to 
ETPs, which could explain why this group observed DN1 production for longer. In 
addition, if MPP cells gave rise to CLP cells before entering the thymus, then it would 
be expected that the single wave of thymopoiesis, which was observed after CLP 
transplantation, would take place. However, this was not the case. Therefore it is 
possible that cells other than the CLP population can give rise to ETPs. Indeed Lai and 
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Kondo (Lai and Kondo, 2007) identified Flk-2hi VCAM-1– LMPPs which were positive 
for the chemokine receptor CCR9 and which exhibited similar characteristics in cell 
surface phenotype, gene expression patterns and differentiation potentials to ETPs.      
We attempted to further clarify the source of ETPs by utilising a lineage mapping 
system whereby Cre recombinase expression was driven by the Rag1 promoter. This 
identified an ‘ELP analogue’ which we hoped would mark the reported ELP population. 
Igarashi and colleagues (Igarashi et al., 2002) identified the ELP as approximately 3% 
to 5% of the LSK Flk-2+ CD27+ fraction and our ‘ELP analogue’ marked 5.94% of LSK 
Flk-2+ cells. In Rag1GFP mice, GFP expression was absent in all stem cells and 
myelo-erythroid progenitor populations, but increased significantly in the CLP 
population. In comparison to our results, we observed a virtual absence of eYFP 
expression in cells prior to the ELP stage and in all myelo-erythroid progenitor cells 
also. Therefore, the Rag1wt/Cre x Rosa26wt/eYFP strain was able to identify an accurate 
‘ELP analogue’ which phenotypically was identical to the ELP population. We used this 
reporter model to assess the relationship between lymphoid progenitor populations prior 
to their development into mature cells and to monitor the development of the ‘ELP 
analogue’. Expression of eYFP was analysed in all haematopoietic lineages from HSCs 
through to fully functional mature cell types in BM, spleen and thymus. 
In the spleen and BM, the frequency of eYFP expression in mature B- and T-cells was 
virtually 100%. This result was expected as B-cell receptor (BCR) and T-cell receptor 
(TCR) rearrangement, which are cell processes required for B- and T-cell maturation, 
utilise the Rag1 and Rag2 genes, so these cells would have passed via at least two stages 
of recombinase activity. In addition, NK T-cells also possess a functional TCR, 
explaining the complete expression of eYFP in this subset. 
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Splenic NK, DC and pDC cell populations exhibited similar frequencies of eYFP+ cells 
(20–30%). This data demonstrate heterogeneity within these pools and might indicate 
development from more than one origin. The fraction of cells which were positive for 
eYFP could have originated from the ELP population or a later progenitor pool such as 
the CLP which had partially acquired eYFP expression. In addition, splenic NK 
development may have occurred via the thymus whereby more than 75% of ETPs were 
positive for eYFP expression. Michie et al., (Michie et al., 2000) described a bipotent 
T/NK progenitor in the mouse foetal thymus which was defined by NK1.1 and c-kit 
expression and which could efficiently generate NK-cells in foetal thymic organ culture. 
It is possible that a cell population similar to this one described is present in the adult 
mouse thymus. In addition, there have been reports that GATA-3 is important in 
NK-cell development. Splenic NK-cells in Gata3-null mice show reduced production of 
IFNγ (Vosshenrich et al., 2006), therefore NK-cells could develop from progenitors 
expressing high levels of GATA-3, such as ETPs. Furthermore, a thymic developmental 
pathway for the production of NK-cells was identified (Vosshenrich et al., 2006) which 
was characterized by GATA-3 and IL-7Rα expression, indicating a lymphoid based 
pathway for the development of NK-cells which may have expressed Rag1. 
Alternatively, eYFP+ NK-cells may have developed from eYFP+ pre-pro B-cells which 
were CD19– but NK1.1+ and which have been shown to give rise to NK effector cells in 
the presence of IL-2 and IL-15 (Balciunaite et al., 2005).  
The development of eYFP– NK-cells may have occurred extrathymically. Indeed 
extrathymic NK development has been demonstrated during the absence of Notch1 
where the earliest thymic progenitors were absent, but NK-cells still remained (Radtke 
et al., 1999). Also, athymic mice display an adequate number of NK-cells. 
Alternatively, the cells which were negative for eYFP expression may be due to either 
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inadequate Cre protein levels in cells expressing low levels of Rag1, which in turn 
would not permit eYFP expression from the Rosa26 locus, or development from 
progenitor subsets which did not activate Rag1. Williams and co-workers (Williams et 
al., 1997) reported the differentiation of NK-cells in vitro from HSCs, a cell population 
which was negative for eYFP expression in our reporter model.   
Similarly to NK-cells, both lymphoid-derived and myeloid-derived DCs only partially 
expressed eYFP. Considering that pDCs and cDCs are thought to arise from the CDCP 
progenitor, which was virtually negative for eYFP expression, development of eYFP+ 
cells must have been due to further differentiation of the CDCP into eYFP+ precursors 
or from alternative progenitor pools. Similar to the development of NK-cells, 
development of the eYFP+ lymphoid-derived and myeloid-derived DCs may have 
occurred from eYFP+ progenitors in the BM or from eYFP+ intrathymic progenitors. 
The lymphoid-derived DCs have been considered to be related to the T-cell lineage due 
to their phenotype (Wu et al., 1996).  Indeed, DC potentials in early thymocyte subsets 
have been reported by Shen et al., (Shen et al., 2003). Moreover, eYFP+ pDC and cDC 
cells may have originated from eYFP+ pre-pro B-cells, as these cells have been reported 
to contain CD4+, Ly6C+ DC precursors capable of giving rise to cDCs and pDCs 
(Nakano et al., 2001; Miller et al., 2002). An alternative explanation for both eYFP+ and 
eYFP– cDC development is from the CLP or CMP progenitor pools. Manz et al., (Manz 
et al., 2001) compared the DC developmental potentials of BM progenitors and 
concluded that CLPs could give rise to CD8α+ and CD8α– thymic DCs, whereas the 
CMP developed into both types of splenic cDC populations. 
As expected due to lack of Rag1 expression in the myelo-erythroid lineage, all splenic 
and BM myelo-erythroid cells exhibited low frequencies of eYFP+ cells, except MHC 
class II expressing splenic myeloid cells. This subset of cells had a significantly higher 
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frequency of eYFP+ cells compared to MHC class II negative myelo-erythroid 
progenitors. Due to MHC class II expression, these cells have the functional ability to 
act as antigen presenting cells. It is not clear whether these cells are activated 
macrophages which develop via the myeloid lineage or whether they represent DC 
‘monocyte’ progenitors (Geissman et al., 2010). In any case, phagocytosed eYFP could 
be ingested by both DCs and macrophages causing quenching of the eYFP signal, 
which would explain the observed positive and intermediate levels of expression. 
During apoptosis of these eYFP+ cells, particle internalisation would have been initiated 
by the interaction of specific receptors on the surface of the phagocyte with ligands on 
the surface of eYFP+ cells. After internalisation of the particle, the phagosome would 
have matured by fusing with late endosomes and ultimately lysosomes to form a 
phagolysosome (Adrerem and Underhill, 1999).  
A similar reporter model has recently been published whereby Cre recombinase was 
knocked into the Rag1 locus in order to identify the ELP population, however this group 
used a tandem dimer red fluorescent protein (dtRFP) within the Rosa26 locus instead of 
eYFP (Welner et al., 2009). This reporter model also marked over 95% of mature B- 
and T-cells, but no more than 3% of granulocytes, identical to our results. 
In the BM, eYFP expression in all stem cells, myelo-erythroid progenitors and the 
CDCP population was virtually absent. However, in the LMPP compartment, 
expression of eYFP was significantly higher than in other progenitor populations, which 
suggested that the eYFP+ fraction of the LSK Flk-2+ LMPP pool represented ELPs. In 
addition, the frequency of eYFP+ LMPPs was almost identical to the corresponding 
fraction of ELPs identified by Igarishi et al., (2002). This clearly demonstrated that the 
Rag1wt/Cre x Rosa26wt/eYFP model could be used to identify a similar phenotype of ELP 
cells with good accuracy. Furthermore, as compared to other lymphoid-specific Cre 
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reporter mice, the Rag1wt/Cre x Rosa26wt/eYFP model proved to be expressed significantly 
earlier than in the corresponding cross with huCD2::iCre.  
One population in which there was a large frequency of eYFP+ cells was the CLP pool. 
This population exhibited an expression pattern allowing the isolation of eYFP–, eYFPint 
and eYFP+ cells, which could help in defining precursor-product relationships. Seeing 
as though the CLP is thought to be the cell population via which the ELP develops, this 
result was unexpected as only half of the cells expressed eYFP. This data therefore 
clearly demonstrated that the CLP pool is heterogeneous, with development occurring 
not only via the ELP, but also from an eYFP– population such as LMPPs. In order to 
determine that we had identified two separate CLP populations, we formally excluded 
the possibility that the Rosa26 locus was not accessible in the eYFP– CLP population by 
analysing a pan haematopoietic reporter model (vav1::iCre x Rosa26Rwt/eyfp mice), 
which exhibited complete eYFP expression in all BM progenitor populations. 
Furthermore, the expression of c-kit was also analysed in the eYFP+ and eYFP– 
fractions of the CLP. It was found that as cells upregulated eYFP, there was a small 
down-modulation of c-kit levels, resembling a similar observation in a recent report 
(Inlay et al., 2009). Inlay et al., reported that similar to eYFP expression, the CLP 
compartment could be separated into a Ly6D+ and a Ly6D– pool. The Ly6D– subset 
expressed higher levels of c-kit than the Ly6D+ subset, but lower levels of IL-7Rα. In 
addition, the Ly6D– subset retained full lymphoid potential and early thymic seeding 
activity whilst the Ly6D+ subset gave rise predominantly to B-cells. In order to compare 
these data to eYFP– and eYFP+ CLPs, in vivo transplantation studies were performed 
(see Chapter 4). 
Analysis in later developmental subsets illustrated that pre-pro B-cells were 87.87 ± 
1.76% eYFP+. This result was in agreement with Rag1GFP mice which marked 83% of 
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pre-pro B-cells (Esplin et al., 2009). In addition, Rumfelt and colleagues (Rumfelt et al., 
2006) reported DHJH rearrangement in 88% of pre-pro B-cells and in 48% of CLP cells, 
a process requiring the expression of Rag1. This result mirrored the expression of eYFP 
which we observed in these populations. Therefore, the eYFP expression observed in 
pre-pro B-cells should indicate a direct descendent from eYFP+ CLP progenitors. It has 
been suggested by some groups that CLPs are primarily the progenitors for B-cells 
(Schwarz and Bhandoola, 2004). Schwarz et al. examined the blood of adult mice to 
determine which progenitors in the BM could enter the circulation and give rise to 
T-cells. They found the presence of LSK cells, representing HSCs, LMPPs and ELPs, 
however no CLP cells were found in the blood. The authors concluded that CLP cells 
were restricted to the BM and therefore were more likely to be B-cell precursors. 
However, it is possible that CLPs could have changed their phenotype upon entering the 
circulation. In order to further investigate whether the eYFP+ and eYFP– CLP 
populations give rise to more B-cells than T-cells, functional analysis of these 
progenitor populations are necessary (see Chapter 4). Another interesting observation 
was that cells of the B-lineage first upregulated eYFP before acquiring CD19 
expression. This result indicates that cells progress from the CLP eYFP– pool into the 
CLP eYFP+ pool before irreversibly committing to the B-cell lineage.  
Investigation of the T-cell branch of the lymphoid pathway illustrated that the ETP 
subset was 75% positive for eYFP expression, a result similar to that of pre-pro B-cells. 
This result argues against the possibility that reporter negative CLPs are the main 
pre-thymic precursors, but is indicative of development primarily from eYFP+ 
progenitors such as ELP and eYFP+ CLPs.  One recent paper which identified the CLP 
as the main BM-derived T-cell precursor was that by Karsunky et al., (Karsunky et al., 
2008) who assessed the functional potential of Flk-2+ CLPs and concluded that this cell 
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population gave rise equally to B and T-lineages. Furthermore, despite ETP cells 
lacking IL-7Rα mRNA expression (Allman et al., 2003), new findings from Il7rαCre-
driven fate mapping experiments have showed that around 85% of ETP cells have a 
previous history of Il7rα expression (Schlenner et al., 2010), a result not dissimilar to 
the amount of eYFP expression observed in ETPs from our reporter model. Therefore, 
these new findings would argue that the earliest T-cell population is composed mainly 
from cells with a previous history of transcriptional activation of Il7rα, representing 
descendents of the CLP and to some extent the LMPP populations.  
The eYFP– fraction of the ETP population suggests derivation from progenitor pools 
such as LMPPs or eYFP– CLPs. Derivation from the LMPP pool can be favoured by the 
fact that alternate potentials have been reported in the ETP population. Previous results 
have shown that ETPs retain T, B, myeloid, DC and NK potentials (King et al., 2002; 
Gournari et al., 2002; Martin et al., 2003; Matsuzaki et al., 1993). Considering that the 
CLP was reported to have no myeloid potential (Kondo et al., 1997), alternative 
lymphoid progenitors such as LMPPs which retain myeloid potential must be 
contributing to thymic development. 
In order to determine the expression of transcription factors critically involved in 
haematopoietic development in BM progenitor populations, Gata1-3 gene expression 
was analysed in early haematopoietic subsets.  The results indicated that at least under 
homeostatic conditions, cells of the lymphoid lineage predominantly expressed Gata3, 
whereas progenitor cells derived from the myelo-erythroid lineages express only Gata1 
and Gata2. Since GATA-3 has important roles throughout T-cell development, it was 
expected that high levels of GATA-3 protein would be present in ETPs and CD4 SP 
T-cells. One study which clearly demonstrates the requirement for GATA-3 in CD4 SP 
T-cell development was that by Pai and colleagues (Pai et al., 2003). In this report, 
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conditional gene ablation of Gata3 using the Cre-lox system driven by the Lck or Cd4 
promoter to delete Gata3 at the DN3 stage or DP stages was carried out. This resulted in 
a severe reduction in the number of CD4 SP cells and suggested a vital role for 
GATA-3 in survival and progression of T-cell progenitors. Due to Gata3 expression 
being restricted to the lymphoid lineage and Gata1 and Gata2 expression in the 
myelo-erythroid lineages, these data indicated segregated lineage development with no 
alternate potentials in myelo-erythroid or lymphoid cells, at least in the manner of 
GATA transcription factor expression.  
We also considered other factors which may affect lymphoid progenitor development, 
such as gender and age. When comparing the number of progenitors in the BM and the 
thymus, it was clear that there were major differences between male and female mice. 
Male mice exhibited higher numbers of all BM progenitors than female mice regardless 
of their age. One obvious explanation is that oestrogen was exerting an inhibitory effect 
on the differentiation and proliferation of these populations. It has been previously 
reported that chronic administration of oestrogen can lead to a reduced mass of BM and 
thymic organs (Verthelyi et al., 1998) suggesting either that differentiation is being 
suppressed or that cell death is occurring in these organs. Indeed oestrogen has been 
shown to induce death of BM cells at the IL-7 sensitive stage (Smithson et al., 2005), 
which include the LMPP, ELP and CLP populations. In addition, Medina et al., 
(Medina et al., 2001) also reported that CLP and ELPs were depleted in oestrogen 
treated mice. The molecular mechanisms by which oestrogen exerts its effect are 
thought to be via an oestrogen receptor present on BM stromal cells (Smithson et al., 
2005) or by oestrogen receptors on haematopoietic cells. However, hormone responsive 
elements have also been identified upstream of several cytokine encoding genes such as 
IL-6 (Pottratz et al., 1994). This could influence the size of haematopoietic progenitor 
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compartments as IL-6 has been reported to induce the proliferation and differentiation 
of HSCs (Peters et al., 2000) and lymphoid progenitor cells (Ma et al., 2000) in vitro. 
We also considered the effect of aging in conjunction with gender on haematopoietic 
progenitor populations, a concept which has so far not been reported. We found that 
although there was a decrease in the absolute numbers of all BM lymphoid progenitors, 
there was an increase in the number of myeloid progenitors with age in both female and 
male mice and a rise in thymic progenitor numbers of male mice with age. Due to the 
fact that B-lymphopoiesis reduces with age (Min et al., 2006) it was expected that the 
number of lymphoid progenitors would also decrease. Our findings are consistent with 
evidence that the frequency and number of CLPs are reduced in aged mice (Miller et al., 
2003) as was the LMPP population. The underlying reason for this decline in lymphoid 
progenitor numbers could be due to decreased proliferation and differentiation of these 
subsets. During development, haematopoietic cells rely heavily on the BM 
microenvironment to regulate their growth, differentiation and survival and aging may 
change this environment such that levels of factors involved in this development are not 
adequate to maintain these cell populations. Changes in the endocrine system may also 
be playing a role. Decreases in the amount of anterior pituitary derived growth hormone 
occur with age (Lamberts et al., 1997) which may in turn be having an inhibitory effect 
on the production of hormone responsive HSCs.  
In terms of myeloid cells, there have been some reports which suggest there is an 
age-related decline in the function of macrophages and neutrophils, although the 
number of these cell types does not change with age (Chatta and Dale, 1996). Our 
results favour a model where BM-derived myeloid progenitors increase in number with 
age; however whether this is reflected in mature peripheral myeloid cells was not 
studied. An increase in apoptosis of myeloid progenitors later in development could be 
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occurring, therefore explaining the need for a higher number of cells at progenitor 
levels.  
The finding that the number of ETPs increased in male mice with age was rather 
intriguing. The thymus has been reported to involute with age due to a decrease in 
thymic epithelial volume and adipocytic degradation of stromal cells, therefore it would 
seem plausible that the number of thymic progenitors would decrease with age, as 
observed in female mice. However, current models of thymic involution have proposed 
that the frequency of ETPs actually increases with age and that their absolute number 
does not change (Aspinall et al., 2001). Due to the fact that reports have not 
discriminated between male and female mice, the overall number of ETPs remained 
unchanged in these studies, which would correspond with our results. We observed an 
increase in the number of ETPs in male mice and a decrease in female mice, which if 
analysed together would likely result in no overall change of numbers. The reported 
increase in the frequency of thymic progenitors is thought to be due to inhibited 
maturation of thymocytes, owing to defects in the thymic microenvironment, creating a 
compensatory increase in early compartments (as reviewed by Min et al., 2005). 
Therefore, this block in maturation would explain why fewer mature T-cells are 
produced and exported to the periphery in aged mice (as reviewed by Linton and 
Dorshkind, 2004). 
The results obtained so far indicated that the Rag1wt/Cre x Rosa26wt/eYFP reporter was 
phenotypically identical to the Rag1GFP model and therefore could be used to monitor 
lymphoid development from the ELP population. In addition, this reporter allowed 
critical dissection of lymphopoiesis due to Rag1 expression first occurring at the ELP 
stage as opposed to other models where reporter expression occurred at later stages of 
development. Lineage mapping studies revealed that ETPs and pre-pro B-cells were 
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derived from both eYFP– and eYFP+ progenitor populations such as the ELP, eYFP– 
CLP and eYFP+ CLP subsets, and the size of these progenitor pools were affected by 
both the age and gender of mice. In order to extend these observations, transplantation 
experiments assessing the functional potential of each population were undertaken. 
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ANALYSIS OF THE FUNCTIONAL POTENTIAL OF LYMPHOID 
PROGENITOR POPULATIONS IN VIVO AND IN VITRO 
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4.1 Introduction 
To further elucidate the developmental relationships between lymphoid progenitors and 
examine their developmental paths, we investigated the functional potential of these 
populations in vivo and in vitro. One unresolved issue is the exact nature of TSCs and 
the isolation of corresponding populations from BM and blood (Donskoy et al., 2003). 
Whilst some groups argue that the CLP is the main pre-thymic progenitor (Kondo et al., 
1997; Karsunky et al., 2008; Serwold et al., 2009, Schlenner et al., 2010), others have 
suggested a model by which LMPPs and ELPs can also contribute to thymic 
development (Igarashi et al., 2002; Allman et al., 2003; Balciunaite et al., 2005; Lai and 
Kondo, 2007; Wada et al., 2008; Bell and Bhandoola, 2008). An additional BM 
precursor population referred to as the “CLP-2” was also identified, however these cells 
appeared to be downstream progeny of CLPs, and retained limited thymic repopulating 
activity (Martin et al, 2003, Schwarz et al., 2007). Taking into consideration these 
previous reports, it remains possible that the thymus is seeded by more than one 
lymphoid progenitor population.  
In an attempt to characterise “thymic seeding cells” ETP subsets were divided into 
eGFPhi and eGFPlo cells, utilising reporter mice expressing enhanced green fluorescent 
protein (eGFP) from the endogenous Ccr9 locus (Benz and Bleul, 2005). Progenitors 
with both B- and T-cell potential were present in the eGFPhi fraction mirroring high 
levels of eGFP expression in BM LSK and CLP subsets. The authors suggested that 
both these BM populations were likely to be the source of “thymic seeding cells”. 
Another study by Schwarz et al., (Schwarz et al., 2007) reported that ELP, LMPP and 
CLP populations could efficiently generate T-lineage cells following intravenous or 
intrathymic injection, but with significant different kinetics. They also reported that 
HSCs did not generate T-cells after intravenous transfer until eight weeks post transfer, 
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whereas ELP, LMPP and CLP populations gave rise to T-cells after just four weeks. 
Therefore, the authors concluded that upon transplantation HSCs first homed to the BM 
and differentiated into LMPP or CLP cells before generating thymic input and therefore 
are unable to directly seed the thymus. This conclusion is in agreement with earlier 
observations by Mori and colleagues (Mori et al., 2001) who noted that after 
transplantation HSCs do not seed the thymus. In these experiments granulopoiesis, 
which is commonly used as a read-out for HSC development, was not recorded when 
thymocyte subsets from reconstituted radiation chimaeras were transferred into 
secondary recipients. Therefore, most evidence supports a model whereby ETPs are 
derived from ELP, LMPP or CLP progenitor populations of the BM.  
Our previous results showed that in the thymus, lineage mapping in Rag1wt/Cre x 
Rosa26wt/eYFP reporter mice labelled 75% of ETPs with eYFP. This indicates that the 
majority of ETPs are derived from eYFP+ BM progenitors such as ELP and CLP 
populations, whilst the eYFP– subset of ETPs may be attributed to CLP eYFP– or LMPP 
populations. To further explore this, we investigated the functional potential of ELPs 
and CLPs in wild type and reporter mice to determine their potential roles as committed 
progenitors for T- and B-cells. 
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4.2 Analysis of the functional potential of the ‘ELP analogue’ in vivo 
We first set out to analyse the functional potential of the ‘ELP analogue’ in Rag1wt/Cre x 
Rosa26wt/eYFP reporter mice to ensure that, as well as being phenotypically identical to 
the ELP, this population also had the same functional capacity. ELPs were defined as 
LSK Flk-2+ eYFP+ (Figure 4.1A). After FACS isolation (Figure 4.1B) ELPs were 
transferred i.v. into mice deficient for Rag2 and the common cytokine γ chain 
(Rag2/Il2rg-null). BM, spleen and thymus were analysed at three and five weeks post 
injection. Reconstitution of the transferred ‘ELP analogue’ was monitored by 
identifying donor-derived eYFP+ cells in the host mouse.  
At three weeks post ELP transfer, the frequency of donor-derived eYFP+ cells in the 
BM was 0.45% (Figure 4.2A) which consisted of either NK- or B-cells. The majority of 
ELP-derived cells at this time point were pre B-cells (57.20%, Figure 4.2A). There was 
also evidence for completed B-cell development in the BM as indicated by the presence 
of immature B-cells (16.10%). The remainder of graft-derived cells were NK1.1+ cells, 
demonstrating that at three weeks after transfer the ELP developed mainly into B- and 
NK-cells. There was no evidence for eYFP+ cells in the thymus (Figure 4.2B), 
indicating that intrathymic T-cell development did not occur yet. In addition, no eYFP+ 
myeloid cells were detected. T-cells were defined by TCRαβ expression and myeloid 
cells (neutrophils and monocyte/macrophages) were identified as Gr1+, CD11b+ 
(Lagasse and Weissman, 1996). 
 
 
 
 
CHAPTER 4 
 156 
Figure 4.1 
Analysis of the ELP population before and after FACS purification, isolated from the 
BM of Rag1wt/Cre x Rosa26wt/eYFP mice. 
 
A Pre-sort of the ELP population. BM from Rag1wt/Cre x Rosa26wt/eYFP mice were 
pooled and depleted for LIN– cells. The ELP population was isolated as LSK 
Flk-2+ eYFP+. Samples are representative of nine individual cell sorts. 
 
B Post-sort of the ELP population after isolation using the FACS Aria II. The ELP 
population was sorted to over 95% purity. 
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Figure 4.2 
Reconstitution potential of the ELP population in the BM and thymus of Rag2/Il2rg-null 
mice at three weeks post transfer. 
 
A Representative FACS plot illustrating reconstitution of the ELP population in 
the BM of Rag2/Il2rg-null mice. 103 eYFP+ ELPs from four to six week old 
Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. into sub-lethally irradiated 
(3 Gray) Rag2/Il2rg-null mice. Reconstitution was measured by the expression 
of eYFP. Staining is representative for one experiment. 
 
B Representative FACS plot illustrating reconstitution of the ELP population in 
the thymus of Rag2/Il2rg-null mice. 103 eYFP+ ELPs from four to six week old 
Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. into sub-lethally irradiated 
(3 Gray) Rag2/Il2rg-null mice. Compared to the control wildtype mouse (PBS 
injected), eYFP expression was virtually absent in the thymus. Staining is 
representative for one experiment. 
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Figure 4.3 
Reconstitution potential of the ELP population in the spleen of Rag2/Il2rg-null mice at 
three weeks post transfer. 
 
Representative FACS plot illustrating splenic reconstitution of the ELP three weeks post 
injection into Rag2/Il2rg-null mice. 103 eYFP+ ELPs from four to six week old 
Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. into sub-lethally irradiated (3 Gray) 
Rag2/Il2rg-null mice. Donor-derived cells were identified by eYFP expression. Staining 
is representative for one experiment. 
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Reconstitution restricted to NK and B-cells by ELPs was also evident in the spleen after 
three weeks post transfer (Figure 4.3). The frequency of ELP-derived splenic NK-cells 
was 22.80% (Figure 4.3). Splenic CD19+ IgM+ B-cells, encompassing immature and 
transitional B-cells, accounted for 51.50% of donor-derived cells and the remainder 
(26.00%) were mature B-cells. However, there was no evidence for significant eYFP+ 
splenic myeloid or T-cells. These data demonstrated that B- and NK-cell reconstitution 
from the ELP was evident after three weeks, in accordance with the observations of 
Igarashi and colleagues (Igarashi et al., 2002), which used ELPs derived from Rag1GFP 
mice in their experiments.  
We next extended our analysis and included later time points after transplantation to 
assess the lymphoid potential of ELPs after transfer into Rag2/Il2rg-null recipients. Five 
weeks post transplantation, B-, NK- and T-cell reconstitution was evident. In the BM, 
the vast majority of CD19+ cells were IgM+ immature B-cells (26.45 ± 12.82; Figure 
4.4A), with only 15.22 ± 6.25% of CD19+ cells in the pre B-cell compartment, 
suggesting a single wave of donor-derived B-cell development. NK-cells (21.01 ± 
10.22%) were still present in the BM, but no myeloid reconstitution was detectable 
(data not shown).  
At this time point, T-cell reconstitution was observed in the thymus (77.33 ± 8.74%; 
Figure 4.4B). A single wave of donor-derived T-cells had proceeded past the DN stages 
of development at five weeks post transfer and donor-derived cells gave rise to DP cells 
(27.94 ± 18.19%) CD4 SP (58.33 ± 16.66%) and CD8 SP (11.15 ± 1.4%) cells. The 
frequency of eYFP+ thymic cells expressing TCRαβ was also analysed. 5.31 ± 3.4% of 
eYFP+ cells expressed low levels of TCRαβ, identifying those cells as developing 
thymocytes, 26.03 ± 11.41% of eYFP+ cells were TCRαβint which were characterised as 
DP T-cells and 69.17 ± 15.02% of cells were TCRhi which represented CD4 SP and 
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CD8 SP cell populations. Therefore, reconstitution of the ELP via DN1-4 stages must 
have taken place between three and five weeks post transfer; a finding in agreement 
with previously reported results (Igarashi et al., 2002).  
In the spleen, ELP-derived cells were composed of T, B, NK and to a minor extent 
myeloid cells (Figure 4.5). T-cells were identified by TCRαβ and further characterised 
by CD4 and CD8 antigens, indicative of mature cells exported from the thymus. During 
maturation of BM-derived immature B-cells in the spleen, IgM is downregulated on the 
surface of cells and IgD is upregulated. Therefore, at five weeks post transfer, splenic 
B-cells which are characterised as CD19+ and IgMlo were likely to be mature cells 
which expressed IgD on their surface. Only a small frequency of eYFP+ cells were 
CD19+ IgMlo whilst the majority of reconstituted B-cells were CD19+ IgM+ representing 
either immature B-cells (CD19+ IgM+ IgD–) or immature B-cells in the transition to 
becoming mature cells (CD19+ IgM+ IgD+). There was a significant decrease in the 
frequency of eYFP+ splenic NK-cells at five weeks compared to at three weeks post 
transfer. Since only reconstituted NK and B-cells were observed in the spleen at three 
weeks, the high frequency of NK-cells at this time point was plausibly only caused by 
the low abundance of peripheral lymphoid cells. On the other hand, the high frequency 
of splenic NK-cells at three weeks post transfer could have indicated abundant 
reconstitution of NK-cells, which may have altered at five weeks post transfer. The 
decrease in the frequency of splenic NK-cells from three to five weeks may have been 
caused by cell death or migration of NK-cells from the spleen to alternate secondary 
organs such as lymph nodes. In addition, the frequency of reconstituted splenic myeloid 
cells was very low (0.44 ± 0.26%), suggesting that the injected ELP cells had minimal 
myeloid potential in vivo, an observation also reported by Igarashi and colleagues 
(Igarashi et al., 2002). 
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The transplantation of ELP cells into alymphoid mice proved that this population 
contained T-, NK- and B-cell potential, in agreement with Igarashi et al (Igarashi et al., 
2002). Donor-derived NK- and B-cell reconstitution was present in the BM and spleen 
at three and five weeks post transfer, however T-cell reconstitution was not evident in 
the thymus and spleen until five weeks post transfer. In addition, minimal myeloid 
potential was observed in the ELP population. These results show that the ‘ELP 
analogue’ was functionally as well as phenotypically identical to the originally 
described ELP population. 
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Figure 4.4 
Reconstitution potential of the ELP population in the BM and thymus at five weeks post 
transfer in Rag2/Il2rg-null mice. 
 
A Representative FACS plot illustrating ELP reconstitution of the BM five weeks 
post injection into Rag2/Il2rg-null mice. 103 eYFP+ ELPs from four to six week 
old Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. into sub-lethally irradiated 
recipients. Donor-derived cells were detected by expression of eYFP and further 
analysed for B-cell and NK-cell populations. Staining is representative for two 
experiments with two to three mice per group. 
 
B Representative FACS plot illustrating ELP reconstitution of the thymus five 
weeks post injection of the cells into Rag2/Il2rg-null mice. 103 eYFP+ ELPs 
from four to six week old Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. into 
sub-lethally irradiated recipients. Donor-derived cells were detected by 
expression of eYFP and further analysed for CD4 and CD8 antigens. Staining is 
representative for two experiments with two to three mice per group. 
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Figure 4.5 
 Reconstitution potential of the ELP population in the spleen at five weeks post transfer 
in Rag2/Il2rg-null mice. 
 
Representative FACS plot illustrating ELP reconstitution in the spleen five weeks post 
injection into Rag2/Il2rg-null mice. 103 eYFP+ ELPs from four to six week old 
Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. into sub-lethally irradiated recipients. 
Staining is representative for two experiments with two to three mice per group. 
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4.3 Analysis of the functional potential of the CLP population in vivo 
We next investigated the developmental potential of the CLP population in relation to 
the ‘ELP analogue’. In addition to previous reports indicating that the CLP population 
may be the main precursor for B-cells (Allman et al., 2003; Schwarz et al., 2004) but 
not T-cells (Wada et al., 2008; Bell and Bhandoola, 2008) there have also been studies 
suggesting myeloid potential in the CLP fraction (Balciunaite et al., 2005; Rumfelt et 
al., 2006; Mebius et al., 2001). Balciunaite and colleagues reported that one in ten CLP 
cells in vitro developed into macrophages (Balciunaite et al., 2005). Similarly, Rumfelt 
et al., (Rumfelt et al., 2006) found that CLP cells placed on a S17 stromal cell layer 
supplemented with SCF, Flk-2 ligand and IL-7 cytokines also produced a significant 
number of myeloid colonies. These CLP cells also expressed high mRNA levels of 
Csfr1, a gene expressed in the myeloid lineage. Furthermore, the phenotypical 
counterpart of the adult CLP in the foetal liver has been shown to give rise to 
macrophages in vitro (Mebius et al., 2001). Therefore, we aimed to compare the 
developmental potential of the CLP population to the ‘ELP analogue’ and assess any 
possible myeloid potential of the CLP in vivo. To do this, LIN– IL-7Rα+ Flk-2+ cells 
were isolated from B6 CD45.1-congenic mice (Figure 4.6) and injected into sub-lethally 
irradiated Rag2/Il2rg-null mice. Reconstitution by CLPs was monitored by identifying 
donor-derived CD45.1+ cells in the host mouse. 
At two weeks post transfer, the CLP population had reconstituted the BM, spleen and 
thymus and developed into B-, T- and NK-cells (Table 4). In the BM, donor-derived 
reconstitution was confined mainly to NK-cells, with some reconstitution into pre B and 
immature B-cells, but minimal reconstitution into myeloid cells. The low frequency of 
pre B-cells but the higher frequency of immature B-cells in the BM might indicate that 
an early wave of donor-derived B-cells had already developed. The very low frequency 
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of myeloid reconstitution in the BM after two weeks indicated that the CLP had 
minimal myeloid potential.  
In the spleen at two weeks post transfer, donor-derived immature and mature B-cell 
reconstitution was abundant in frequency and this was accompanied by some NK-cell 
reconstitution. The small frequency of donor-derived splenic NK-cells indicated that the 
majority of these cells were still confined to the BM. In addition, there was a virtual 
absence of reconstitution into splenic T- or myeloid cells.  
In the thymus at two weeks, reconstitution of donor-derived cells were predominantly at 
the DN stage, with a low frequency of CD4 SP and CD8 SP cells. This result differed 
from that of the ‘ELP analogue’, where T-cell reconstitution was not observed until 
after three weeks post transfer. There was also evidence for thymic NK-cells, which 
could have been due to re-circulation of NK-cells or NK-cell development in the 
thymus.   
 
 
 
CHAPTER 4 
 171 
Figure 4.6 
Analysis of BM CLP preparations before and after FACS purification, isolated from the 
BM of B6/J CD45.1 mice. 
 
A Analysis of the CLP population before FACS purification. The CLP population 
was isolated according to the definition LIN– IL-7Rα+ Flk-2+.  
 
B Analysis of the CLP population after FACS purification. The CLP population 
was sorted to over 95% purity. 
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Three weeks post transfer in the BM, the frequency of pre B-cells and immature B-cells 
was virtually negative, suggesting CLP-derived B-cells had completed development in 
this organ, had exited the BM and entered the periphery. Near completion of B-cell 
maturation was also observed in the spleen where the majority of reconstituted B-cells 
were mature. There was a minor increase in the frequency of reconstituted BM myeloid 
cells, although there was no evidence for abundant myeloid reconstitution in the spleen, 
indicating that the cells in the BM had not yet entered the spleen or that the small 
frequency of observed myeloid cells was an artefact. The frequency of CD45.1+ BM 
and splenic NK-cells showed no dramatic change compared to two weeks post transfer, 
however the relative contribution of transferred cells to the BM and spleen also did not 
change drastically.  
In the thymus, there was a minor fall in the frequency of reconstituted NK-cells from 
11.49 ± 4.23% at two weeks to 6.04 ± 3.18% at three weeks. T-cell reconstitution in the 
thymus was still restricted to the DN compartment, the same as at two weeks post 
transfer, which explained why there was a lack of reconstituted splenic T-cells. This 
result also mirrored what was observed in the thymus after reconstitution of the ‘ELP 
analogue’. 
At four weeks post transfer, the relative frequency of reconstituted B- and myeloid cells 
in the BM had increased, however this could have been due to the major decrease in the 
frequency of donor-derived NK-cells present in the BM at this time point. Alternatively, 
this could also have indicated that a second wave of B-cell development was occurring 
which was related to a developmental heterogeneity within the CLP pool and different 
rates of differentiation and proliferation. The relative frequency of reconstituted BM 
myeloid cells had increased substantially, from 2.08 ± 0.24% at three weeks to 17.38 ± 
7.90% at four weeks. Since the frequency of CLP-derived myeloid cells remained low 
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in the spleen, this suggested that the observed increase in the BM was due the lack of 
alternate cell types. The percentage of donor-derived NK-cells in the BM and thymus 
had decreased at this time point; however there was no evidence for a higher level of 
NK-cells in the spleen, suggesting that the cells may have died. In the thymus however, 
there was now evidence for reconstituted DP, CD4 SP and CD8 SP T-cells and low 
level T-cell reconstitution was also observed in the spleen (11.06 ± 16.3%).  
In comparison to the ‘ELP analogue’ at three weeks post transfer, the CLP population 
had virtually completed B-cell development in the BM. In addition, CLP-derived 
splenic immature and mature B-cells were also present; suggesting that BM-derived 
immature B-cells had seeded the spleen and continued maturation. However at this time 
point, the ‘ELP analogue’ was still progressing via B-cell development in the BM, as 
indicated by the abundance of pre B-cells. This indicated that both the ELP and CLP 
populations could give rise to B-cells as previously reported (Kondo et al., 1997; 
Igarashi et al., 2002) but that the CLP was at a developmentally later stage than the 
ELP.  Both cell types were also able to give rise to NK and T-cells. However, the CLP 
population was able to reconstitute thymic progenitor cells at the DN stage after two 
and three weeks, but this was not observed until five weeks post transfer with the ‘ELP 
analogue’, suggesting that longer time is required for ELP cells to generate T-cells than 
CLPs. This could be due to ELP cells remaining for longer in the circulation before 
entering the thymus than CLP cells, or ELP cells may first home to the BM and 
continue lymphoid development prior to migration to the thymus. With regards to 
myeloid development, the ELP population was virtually absent of any significant 
myeloid potential in vivo, but myeloid potential was detected in the BM of CLP-derived 
cell transfers. However, this increase in myeloid reconstitution may have been due to 
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the lack of alternate cell types in the BM at four weeks post transfer and therefore may 
not represent a significant myeloid reconstitution.  
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Table 4 
Reconstitution potential of the CLP population at two, three and four weeks after 
injection into Rag2/Il2rg-null mice. 
 
Table illustrating the reconstitution frequency of CD45.1+ CLP cells in Rag2/Il2rg-null 
mice at two, three and four weeks post injection. 2 x 103 CD45.1+ CLPs from four to six 
week old B6/J CD45.1 mice were injected i.v. into sub-lethally irradiated recipients. 
Donor-derived progeny was measured in the BM (orange), thymus (green) and spleen 
(blue) by gating on CD45.1+ cells. One experiment was performed. The number of 
recipients per time point is shown in the table.  
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4.4 Analysing the functional potential of the ELP, CLP eYFP– and 
CLP eYFP+ pools in vivo 
Analysis of eYFP expression in Rag1wt/Cre x Rosa26wt/eYFP mice, reported in chapter 3, 
demonstrated that the CLP could be subdivided into two pools, identified by the lack or 
presence of reporter expression. These data had also demonstrated that the majority of 
pre B-cells and ETPs were derived from eYFP+ progenitors. In addition, functional data 
of the CLP had indicated that there may have been two waves of B-cell development. 
Therefore, the next step was to isolate the ELP, CLP eYFP– and CLP eYFP+ 
populations and compare these cell types with respect to their B- and T-cell potential.  
Using Rag1wt/Cre x Rosa26wt/eYFP mice, the ELP population - isolated as previously 
described (Figure 4.1) - and CLP populations were isolated (Figure 4.7). All populations 
were transplanted into Rag2/Il2rg-null mice and the developmental potential of these 
cell populations were analysed at five weeks post transfer in the spleen.  
Splenic B-cell reconstitution was measured by CD19 expression and T-cell 
reconstitution was assessed by expression of TCRαβ. The mean frequency of splenic 
eYFP+ cells expressing CD19 was similar between the ELP, CLP eYFP– and CLP 
eYFP+ subsets (Figure 4.8A). The same could also be observed in the frequency of 
eYFP+ cells expressing TCRαβ in the spleen (Figure 4.8B). However, when absolute 
numbers of CD19+ donor-derived cells were compared between the three cell 
populations, there were significant differences.  
The ELP and CLP eYFP+ pools reconstituted significantly higher numbers of splenic 
CD19+ cells compared to the CLP eYFP– pool (Figure 4.9A). The number of 
ELP-derived cells which had reconstituted into splenic B-cells was 87.60 x 104 ± 49.05 
x 104 whilst CLP eYFP+ cells generated 49.12 x 104 ± 37.59 x 104 B-cells. However, the 
CLP eYFP– population only reconstituted 13.21 x 104 ± 10.53 x 104 splenic B-cells, 
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which was over five fold lower than the average number of reconstituted ELP splenic 
B-cells and over three fold lower than the number of CLP eYFP+-derived B-cells. The 
number of ELP-derived splenic B-cells was in the range of 53 x 104 to 79 x 104, 
however there appeared to be one outlier where the number of reconstituted splenic 
B-cells was 159.19 x 104 cells. Similarly, transfer of the CLP eYFP+ subset gave rise to 
numbers of splenic B-cells within the range of 43 x 104 to 93 x 104, however there was 
also one outlier which gave rise to only 2.80 x 104 B-cells. The range of splenic B-cells 
reconstituted by the CLP eYFP– population however were much lower and mostly in the 
range of 6 x 104 to 11 x 104 with one outlier reconstituting 31 x 104 cells, but this value 
was still lower than the range of B-cells reconstituted by the other cell types. Therefore, 
it appeared that the ELP and CLP eYFP+ populations were giving rise to significantly 
higher numbers of splenic B-cells than the CLP eYFP– population. This indicated that 
either the ELP and CLP eYFP+ subsets were more favourable candidates for pre B-cells 
than the CLP eYFP– population, or other factors such as migration and differentiation 
were influencing B-cell reconstitution from the CLP eYFP– subset. However, due to all 
three cell types being injected into the same host, which had been irradiated with 
3 Gray, all cell populations appeared to have equal opportunity to develop in the BM 
and migrate to the thymus and spleen. On the other hand, it was not clear whether all 
CLP eYFP– cells had undergone full development into eYFP+ progenitors or whether 
cells which had acquired eYFP were able to seed the spleen efficiently. Therefore, in 
order to address the issue of development, in vitro studies of CLP eYFP–-derived B-cell 
development were devised (see next study). The in vivo data indicated that all three cell 
populations could develop into B-cells but with distinct different efficiency: ELP and 
CLP eYFP+ populations generated more splenic B-cells than the CLP eYFP– population. 
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Therefore, there were clearly functional differences between the eYFP– and eYFP+ CLP 
populations, suggesting that these pools harbour different potential.  
Regarding T-cell development, there were no significant differences between all three 
cell populations (Figure 4.9B). The ELP population gave rise to 52.08 x 104 ± 26.47 x 
104 splenic T-cells on average whereas the CLP eYFP+ reconstituted 28.72 x 104 ± 
33.41 x 104 splenic T-cells and the CLP eYFP– pool on average gave rise to 29.62 x 104 
± 40.09 x 104 cells. The difference between the mean number of ELP-derived splenic 
T-cells compared to the other two populations was only 1.8 fold. However, the range of 
reconstituted T-cells was quite different. ELP-derived splenic T-cell numbers ranged 
from 62 x 104 to 66 x 104, with one outlier of a value of 12 x 104. In contrast the number 
of CLP eYFP+-derived splenic T-cells ranged from 0.12 to 19 x 104 cells with one 
outlier of 77.94 x 104 cells and the number of CLP eYFP–-derived cells ranged from 
0.02 to 47 x 104 cells with an outlier of 92 x 104 cells. These data indicated that all 
populations possessed T-cell potential however, outliers excluded, the ELP population 
appeared to have the highest and most consistent splenic T-cell reconstitution. 
Interestingly, splenic T-cell reconstitution was virtually absent in some mice. This 
suggests that, due to the altered thymic microenvironment in Rag2/Il2rg-null mice and 
the lack of progenitor cells constantly seeding the thymus; upon transplantation some 
cells were unable to efficiently enter the thymus and develop into T-cells. 
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Figure 4.7 
Analysis of CLP eYFP– and CLP eYFP+ preparations isolated from BM of Rag1wt/Cre x 
Rosa26wt/eYFP mice before and after FACS purification. 
 
A Analysis of CLP populations before FACS purification. The CLP populations 
were isolated as LIN– IL-7Rα+ Flk-2+ eYFP– or LIN– IL-7Rα+ Flk-2+ eYFP+. 
 
B Post-sort of the CLP eYFP– population. The CLP eYFP– population was sorted 
to over 95% purity. 
 
C Post-sort of the CLP eYFP+ population. The CLP eYFP+ population was sorted 
to over 95% purity. 
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Figure 4.8 
Frequency of splenic B- and T-cell reconstitution of ELP, CLP eYFP– and CLP eYFP+ 
populations five weeks post transfer in Rag2/Il2rg-null mice. 
 
A Graph illustrating splenic B-cell reconstitution frequencies of the ELP, CLP 
eYFP– and CLP eYFP+ populations, measured as the percentage of 
donor-derived CD19+ cells. 2 x 103 CLP eYFP–, 2 x 103 CLP eYFP+ or 103 
ELPs from four to six week old Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. 
into sub-lethally irradiated recipients. Mice were analysed for splenic B-cell 
reconstitution five weeks post transfer. Results are depicted individually and as 
an average. Results are representative of two experiments with two to three mice 
per group. 
 
B Graph illustrating splenic T-cell reconstitution frequencies of the ELP, CLP 
eYFP– and CLP eYFP+ populations, measured as the percentage of 
donor-derived TCRαβ+ cells. 2 x 103 CLP eYFP–, 2 x 103 CLP eYFP+ or 103 
ELPs from four to six week old Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. 
into sub-lethally recipients. Mice were analysed for splenic T-cell reconstitution 
five weeks post transfer. Results are depicted individually and as an average. 
Results are representative of two experiments with two to three mice per group. 
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Figure 4.9 
Absolute numbers of splenic B and T-cell reconstitution compared between ELP, CLP 
eYFP– and CLP eYFP+ populations five weeks post transfer into Rag2/Il2rg-null mice. 
 
A Graph illustrating splenic B-cell reconstitution numbers of the ELP, CLP eYFP– 
and CLP eYFP+ populations. 2 x 103 CLP eYFP– and 2 x 103 CLP eYFP+ or 103 
ELPs from four to six week old Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. 
into sub-lethally irradiated recipients. Mice were analysed for splenic B-cell 
reconstitution five weeks post transfer. Results are depicted individually and as 
an average. Results are representative of two experiments with two to three mice 
per group. 
 
B Graph illustrating splenic T-cell reconstitution numbers of the ELP, CLP eYFP–
and CLP eYFP+ populations. 2 x 103 CLP eYFP–, 2 x 103 CLP eYFP+ or 103 
ELPs from four to six week old Rag1wt/Cre x Rosa26wt/eYFP mice were injected i.v. 
into sub-lethally irradiated recipients. Mice were analysed for splenic T-cell 
reconstitution five weeks post transfer. Results are depicted individually and as 
an average. Results are representative of two experiments with two to three mice 
per group. 
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4.5 B-cell developmental potential of ELP, CLP eYFP– and CLP 
eYFP+ pools in vitro 
In order to investigate whether all CLP eYFP– cells could acquire eYFP during 
development into B-cells and to assess the rate of kinetics by which B-cells were 
generated, all three cell populations were sorted from Rag1wt/Cre x Rosa26wt/eYFP mice 
and placed on OP9 stromal cells in the presence of IL-7, Flk-2 ligand and SCF (see 
materials and methods) and analysed after three, five and ten days in culture. Cells 
expressing CD19 were considered as terminally-committed B-cell progenitors, since 
Cd19 is the target gene of the master regulator of B-lineage commitment Pax5 
(reviewed by Maier and Hagman, 2002).  
We first examined the generation of B-committed cells from the ELP population. CD19 
upregulation on ELP cells was not evident until day ten in culture (Figure 4.10A). Next, 
we investigated the ability of CLP eYFP– cells to give rise to B-cells (Figure 4.10B). In 
the CLP eYFP– cultures, both eYFP and CD19 expression were measured. These cells 
upregulated eYFP after just three days in culture and their frequency increased at five 
and ten days, where the majority of cells had acquired eYFP. CD19 upregulation 
however was not observed until day ten in this population and interestingly, the 
frequency of CD19 positive cells was lower than the frequency of cells which had 
upregulated eYFP+. This indicated that cells had to first upregulate eYFP before 
committing to the B-cell lineage, a result which was also observed during lineage 
mapping in the pre-pro B-cell compartment (chapter 3). A representative FACS plot of 
this developmental relationship, illustrating that only a minute frequency of cells which 
were CD19+ had not acquired eYFP expression is presented in Figure 4.11A. Both the 
ELP and the CLP eYFP– pools exhibited similar frequencies of CD19 expression by day 
ten, indicating that these two cell pools developed into B-cells in vitro with similar 
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kinetics.  In contrast, low level CD19 expression was evident in the CLP eYFP+ pool 
after just three days and by ten days virtually all cells expressed CD19, to a higher 
extent than what was observed in ELP or CLP eYFP– pools (Figure 4.10C). This 
indicated that the CLP eYFP+ pool was at a later stage of B-lineage development than 
the other subsets.  
We next assessed the number of cells generated throughout the time course from each 
subset. All three populations exhibited comparable numbers of cells in culture at three 
and five days, however at day ten significant differences were observed (Figure 4.11B). 
The number of CLP eYFP+ cells increased over a 100 fold from day five (2 x 104 cells) 
to day ten (4.2 x 106 cells), whereas the number of ELP cells increased from 3 x 104 
cells at day five to 4 x 105 cells at day ten, a difference of only 13 fold. In contrast to 
both the CLP eYFP– and ELP subsets, the number of CLP eYFP– cells exhibited only a 
marginal increase. 1.7 x 104 cells were present in culture at day five and this value 
increased only 3 fold to 5.6 x 104 cells at day ten. This observation suggests that the 
CLP eYFP+ pool proliferated more than the ELP or CLP eYFP– subsets between day 
five and day ten in culture, with the CLP eYFP– exhibiting only minimal proliferation. 
These results also indicate a 75 fold difference between the number of CLP eYFP+ and 
CLP eYFP– cells at day ten, providing evidence that the CLP population is 
heterogeneous in response to stimuli during in vitro culture. In addition, similar to the 
results obtained in vivo, the CLP eYFP+ pool was the first subset to give rise to B-cells; 
whereas the ELP and CLP eYFP– pools both exhibited similar kinetics of 
differentiation, suggestive for a closely related developmental stage. The CLP eYFP+ 
and ELP pools were proliferating more during B-cell development in vitro than the CLP 
eYFP– pool and this may have been the reason for the low number of reconstituted 
splenic B-cells observed in vivo. In addition, all CLP eYFP– cells expressed eYFP 
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during B-cell development in vitro, therefore the lower number of reconstituted B-cells 
derived from this population in vivo could not be attributed to an impaired 
differentiation into eYFP+ progenitors.  
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Figure 4.10 
Analysis of the B-cell potential of ELP, CLP eYFP– and CLP eYFP+ populations in 
vitro. 
 
A Representative FACS plot showing the upregulation of CD19 on ELP cells, 
isolated from the BM of Rag1wt/Cre x Rosa26wt/eYFP mice and placed on 
sub-confluent OP9 stromal cells. B-cell development was analysed after three, 
five and ten days in culture. Results are representative for three independent 
experiments.   
 
B Representative FACS plot showing the upregulation of eYFP and CD19 on CLP 
eYFP– cells, isolated from the BM of Rag1wt/Cre x Rosa26wt/eYFP mice and placed 
on sub-confluent OP9 stromal cells. B-cell development was analysed after 
three, five and ten days in culture. Results are representative for three 
independent experiments.  
 
C Representative FACS plot showing the upregulation of CD19 on CLP eYFP+ 
cells, isolated from the BM of Rag1wt/Cre x Rosa26wt/eYFP mice and placed on 
sub-confluent OP9 stromal cells. B-cell development was analysed after three, 
five and ten days in culture. Results are representative for three independent 
experiments.   
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Figure 4.11 
Sequence of B-cell development in lymphoid progenitors obtained from Rag1wt/Cre x 
Rosa26wt/eYFP reporter mice in vitro.  
 
A Representative FACS plot illustrating CD19 expression in the CLP eYFP– 
population after ten days in culture. Cells were co-incubated on GFP+ OP9 
stromal cells and kinetics of B-cell differentiation were assessed. Stroma cells 
were excluded from the analysis by gating on GFP– cells. Sample is 
representative for three independent experiments. 
 
B Graph illustrating the absolute number of ELP, CLP eYFP– and CLP eYFP+ 
cells in culture over time. Time in days is plotted against a logarithmic scale of 
the number of cells. Results are representative for three independent 
experiments.   
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4.6 Discussion 
Currently there are conflicting views in the literature regarding which BM-derived 
progenitors enter the circulation and seed the thymus, thereby giving rise to ETPs. 
Whilst some authors favour a model with the CLP representing the main lymphoid 
restricted progenitor pool which develops into ETPs, others have suggested that LMPPs 
and ELPs are more likely to be pre-thymic progenitors due to their similar phenotype 
and functional potential. We attempted to address this question by assessing the 
functional potential of the ELP and CLP populations. Utilising a novel lineage tracing 
reporter model whereby Rag1 expression would result in permanently marking all cells 
and their products by eYFP, we were able to identify an ‘ELP analogue’ population and 
dissect the CLP population into eYFP+ and eYFP– subsets. We compared the functional 
potential of these populations in vivo and in vitro in order to determine potential 
precursor-product relationships and further elucidate lymphoid progenitor pathways.  
We first compared the functional potential of the ‘ELP analogue’ with the published 
results for the original ELP by transfer into alymphoid recipients. We opted to use 
Rag2/Il2rg-null mice as hosts since this strain allows good engraftment of developing 
lymphoid progenitors and a superior read-out for non-lymphoid potential of transferred 
material (Colucci et al., 1999). The Rag2 gene is indispensable for the somatic 
rearrangement of B- and T-cell receptor gene segments during B- and T-cell 
development and the common cytokine receptor γ chain is a functional subunit of the 
receptors for IL-2, IL-4, IL-7, IL-9 and IL-15 and is required for the development of B-, 
T- and NK-cells (Di Santo et al., 1995). Therefore, mice deficient in both these genes 
lack mature B-, T- and NK-cells and have a reduced number of lymphoid progenitor 
cells, which limits competition for developmental niches following transfer of ELP or 
CLP populations.  
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Reconstitution analysis revealed that the ‘ELP analogue’ gave rise to NK-, B- and 
T-cells, corresponding to what was found by Igarashi and colleagues (Igarashi et al., 
2002). NK and B-cells were present in the BM and spleen at three and five weeks post 
transfer but T-cells were not evident in the thymus and spleen until five weeks post 
transfer. Furthermore, we did not observe any significant reconstitution of myeloid 
lineages in our experiments, in agreement with published results (Igarashi et al., 2002). 
Based on this, we concluded that the ‘ELP analogue’ was functionally and 
phenotypically largely identical to the ELP.  
We next compared the cellular reconstitution of the ‘ELP analogue’ to the CLP and also 
assessed the CLP population for putative myeloid potential. We found that the CLP 
population exhibited T-, B- and NK-cell reconstitution in agreement with its original 
description (Kondo et al., 1997) and similar to the observed reconstitution of the ‘ELP 
analogue’. However, both B- and T-cell reconstitution occurred earlier in recipients 
reconstituted with CLP cells compared to mice transplanted with the ‘ELP analogue’. 
This suggested that the CLP was at a developmentally later stage than the ELP 
analogue, which seems to be arguably in favour for a hierarchical model of progenitor 
development. In addition, we observed the presence of donor-derived myeloid cells at 
four weeks post CLP transfer, which is conflicting with the findings of Kondo et al 
(Kondo et al., 1997). This myeloid potential of the CLP may have been due to a lack of 
alternate cell types in the BM at later time points and a subsequent increase in the 
percentage of donor-derived myeloid cells. In this context it is of importance that 
myelopoiesis in general is relatively rapid compared to lymphopoiesis. In 
transplantation experiments, the CMP population develops into myeloid cells after just 
six days (Akashi et al., 2000) and the LMPP population after just one week (Adolfsson 
et al., 2001).  We injected CLP cells into Rag2/Il2rg-null mice, which lack all mature 
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lymphoid cells, but retain all myeloid cells. Therefore, graft-derived differentiation in 
this strain would be competing with endogenous myelopoiesis. Due to CLP-derived 
myelopoiesis not appearing until four weeks after transplantation in our experiments, it 
is unlikely that the CLP possessed significant myeloid reconstitution. Furthermore, 
because the ‘ELP analogue’ appeared to be at an earlier stage of development than the 
CLP, indicating that it may be a direct precursor of the CLP pool, and lacked any 
myeloid potential in vivo, it is unlikely that the CLP population retained myeloid 
potential. However, because there was some evidence for myeloid reconstitution, we 
cannot completely rule out the fact that the CLP contains minimal myeloid potential 
which is only observed after the production of all other cells.  
To investigate the lymphoid potential of the CLP population more rigorously, we 
dissected the CLP based on reporter expression in Rag1wt/Cre x Rosa26wt/eYFP mice and 
analysed their functional potential in vivo and in vitro. We found that in vivo, the CLP 
eYFP+ and the ELP generated similar numbers of splenic B-cells, which were 
significantly higher than the number of donor-derived splenic B-cells generated from 
the CLP eYFP– pool. This suggested that ELP and CLP eYFP+ subsets harbour a 
stronger constitutive potential to generate B-cells in vivo. This result is remarkably 
similar to more recent observations (Inlay et al., 2008), reporting that Ly6D+ CLPs 
predominantly gave rise to B-cells in vivo, as we observed with eYFP+ CLPs, indicating 
that both Ly6D and eYFP markers could be used to separate functional different subsets 
of CLPs. Alternatively, the low number of splenic B-cells generated from CLP eYFP– 
cells could indicate that only a small fraction of this population in vivo develops into 
B-cells. Furthermore, the CLP eYFP– population might not have proliferated as 
extensively during B-cell development than the CLP eYFP+ and ELP pools, or migrated 
and seeded the BM and spleen as efficiently.  
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To gain further information as to the kinetics of B-lineage differentiation between the 
three subsets, we also analysed their B-cell potential in vitro. The results indicated that 
the CLP eYFP+ pool gave rise to B-cells with faster kinetics than either the CLP eYFP– 
or ELP pools, indicating that the CLP eYFP+ subset was at a later developmental stage 
than the ELP and CLP eYFP– subsets and possibly already primed for B-lineage 
commitment. Månsson et al., (Månsson et al., 2010) also reported heterogeneity within 
the CLP using Rag1GFP mice which were crossed to mice expressing human CD25 
under the control of the mouse λ5 promoter. They divided the CLP into GFPlo and GFPhi 
cells and reported that GFPhi CLPs generated CD19+ cells already after 2.25 days in 
culture, whereas the GFPlo cells took 6.25 days to upregulate CD19. This group also 
reported a significant upregulation of Pax5 and Ebf1 in the GFPhi cells as compared to 
the GFPlo cells, both genes indicative of B-cell development. This report suggests that 
the CLP eYFP+ pool is already specified to the B-lineage due to the expression of 
B-lineage genes. In addition, in our hands, the ELP and CLP YFP– pools appeared to be 
at a similar stage of lymphoid development due to B-cell commitment occurring at day 
ten in both cell populations. 
The number of CLP eYFP+ cells in culture also rapidly increased throughout the time 
course, as did the ELP population, but not to the extent of the CLP eYFP+ population. In 
contrast there was no major increase in the number of CLP eYFP– cells. This suggested 
that the CLP eYFP+ and ELP fractions proliferated more during B-cell development 
than the CLP eYFP– pool and may have been the reason for the observed higher number 
of splenic B-cells reconstituted in vivo. The in vitro data also showed that eYFP– CLP 
cells first upregulated eYFP before committing to the B-cell lineage, indicative of a 
precursor-product relationship between the CLP eYFP– and CLP eYFP+ pools. Due to 
all cells of the ELP population already expressing eYFP, this pool might develop 
CHAPTER 4 
 198 
directly into the CLP eYFP+ pool (see proposed model of B-lineage development). In 
agreement with Schwarz and Bhandoola (Schwarz and Bhandoola, 2004) and Allman 
and colleagues (Allman et al., 2003), these results suggest that CLP eYFP+ cells 
represent the main B-cell precursors, which is also in accordance with our results 
showing that pre-pro B-cells ex vivo were derived predominantly from eYFP+ 
precursors. Similar to our data, a recent report (Welner et al., 2009) demonstrated that in 
Rag1wt/Cre x Rosa26 wt/tdRFP reporter mice, only 50% of the CLP compartment was 
marked. The same group found that the CLP RFP+ cohort in vitro proliferated to a 
higher extent and gave rise to CD19+ B-cells prior to the CLP RFP– population.  
The in vivo and in vitro data combined indicated that ELP and CLP eYFP+ populations 
were able to give rise to a higher number of B-cells both in vitro and in vivo than the 
CLP eYFP– pool. In addition they suggest the CLP eYFP+ subset was at a later stage of 
lymphoid development than both the ELP and CLP eYFP– pools. Taking into 
consideration that the CLP pool could also be divided based on the expression of Ly6D 
(Inlay et al., 2009), we proposed that both eYFP and Ly6D markers could be utilised to 
illustrate the development from lymphoid progenitors into pre-pro B-cells. Therefore, 
we analysed the expression of both eYFP and Ly6D on CLP cells, but found that 
expression of the two markers did not correlate (see proposed model of B-lineage 
development). Nevertheless, both markers could be used to signify development down 
the B-lineage pathway.   
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Proposed model of B-lineage development   
 
 
 
 
We also compared all three populations with respect to T-cell development. Unlike 
B-cell differentiation in vivo, the number of reconstituted splenic T-cells was similar 
between the three subsets. Therefore, this indicated that a similar number of T-cells had 
been produced in the thymus and exported to the spleen from each subset, showing that 
all three populations had T-cell potential. This result is in good agreement with our 
observation that Gata3 mRNA levels in all three populations were identical and 
therefore no genetic preference for T-cell development was obvious.  
However, we cannot completely rule out the fact that the three cell populations - ELP, 
CLP eYFP– and CLP eYFP+ - may not have migrated and seeded the organs with the 
same efficiency, despite functional potential being assessed under the same conditions. 
This might explain the low number of reconstituted splenic B-cells generated from the 
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CLP eYFP– fraction, compared to the CLP eYFP+ and ELP subsets. One possible 
explanation for these observations – apart from the aforementioned – could be the 
presence of non - T/B-cell potential such as NK and DC potential in the CLP eYFP– 
pool.  
Regarding the relevant contributions of all three entities to thymopoiesis, our lineage 
mapping data suggests that ETPs were derived predominantly from eYFP+ progenitor 
cells. Despite that, upon transfer into alymphoid recipients in vivo, all ELP, CLP eYFP– 
and CLP eYFP+ populations could give rise to ETPs (see proposed model of lymphoid 
development below). Similar to B-lineage development, we also based T-cell 
development on Ly6D expression. Based on the fact that ETPs expressed only low 
levels of Ly6D (Inlay et al., 2009), we proposed that only Ly6D– progenitors could 
produce ETPs. In addition, due to ELPs being a subpopulation of the LMPP, this 
population may also contain T-cell potential. 
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Proposed model of lymphoid development 
 
 
 
During the last three decades, several models of haematopoiesis have been proposed. 
The ‘classical model’ of haematopoiesis was proposed just after the finding that T-, B- 
and myeloid cells were all derived from HSCs (Abramson et al., 1977) and suggested a 
dichotomy between the myelo-erythroid and lymphoid lineages. However, this 
assumption was based on microscopic observations and a limited number of 
experimental findings.  
In 1983, the stochastic model of haematopoiesis was introduced in which lineage 
determination is completely random (Ogawa et al., 1983), a model which is evidently at 
odds with observations that multipotent progenitors become gradually more restricted 
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towards a particular lineage by expressing lineage specific transcription factors and by 
responding to lineage promoting cytokines.  
The sequential restriction model (Brown et al., 1985) suggested a defined sequence 
whereby if progenitor cells were exposed to various inducers of differentiation they 
would undergo development down a particular pathway. However, progenitor cells 
which did not encounter any signal for differentiation down that lineage would continue 
on to the next sequence of development. A cell could first make erythroid, then 
myeloid, B- and finally T-cells. This model does not sufficiently explain the existence 
of LMPP cells which can generate lymphoid and myeloid cells, but not erythroid cells.  
In 2001, the myeloid-based model of haematopoiesis (Katsura et al., 2001) was 
proposed. This model postulated that HSCs first diverged into a common 
myelo/lymphoid progenitor which then generated myelo/T- and myelo/B- progenitors 
capable of giving rise to B-, T- and myeloid cells. There is evidence that this sequence 
of events occurs in human haematopoiesis (Doulatov et al,, 2010) and in the foetal liver 
of mice (Lu et al., 2002). Unfortunately this model seems to be in conflict with the 
presence of the CLP population (Kondo et al., 1997) and later the ELP (Igarashi et al., 
2002) and LMPP (Adolfsson et al., 2005) populations since these cell types can produce 
both T- and B-cells with a gradual decrease in their myeloid potential. Although the 
LMPP population contains both lymphoid and myeloid potential and could be viewed as 
the common myelo/lymphoid progenitor proposed by Katsura et al., the ELP is a 
subpopulation of the LMPP and contains no detectable myeloid potential in vivo 
(Igarashi et al., 2002 and our data), suggesting that lymphoid progenitors lose myeloid 
potential and gradually become restricted to the lymphoid lineage. In addition, the 
detectable myeloid potential in the ETP (Wada et al., 2008; Bell and Bhandoola, 2008) 
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which also supports the model of Katsura et al. can be explained by the fact that the 
LMPP cells probably migrate to the thymus and form ETPs.  
A modified version of the classical model of haematopoiesis was proposed in 2005 by 
Adolfsson and colleagues (Adolfsson et al., 2005) which incorporated the LMPP 
population and in 2007 by Ye and Graf (Ye and Graf, 2007), incorporating both the 
ELP and LMPP populations. Our model supports a similar scheme of development, but 
with the refinement of a subdivision of the CLP. We propose that the eYFP+ CLP is 
likely to be the main pool for B-cell development. Both the ELP and CLP eYFP– 
populations must develop into the CLP eYFP+ pool before committing to the B-cell 
lineage. However, all ELP, CLP eYFP– and CLP eYFP+ populations can give rise to 
ETPs and further develop into T-cells. In addition, because the ELP is a subpopulation 
of the LMPP, this population is also potentially a pre-thymic progenitor. It has to be 
stressed that our proposed model represents a scheme of lymphoid development under 
homeostatic conditions. Under conditions resulting in significant alterations in the 
generation and/or turnover of specific subsets, as observed in acute or chronic infection, 
the pathways of cellular differentiation may exhibit a considerable degree of plasticity.  
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CHAPTER 5 
 
THE EFFECT OF AN ACUTE INFLAMMATORY RESPONSE ON 
THE COMPOSITION OF HAEMATOPOIETIC PROGENITOR 
COMPARTMENTS 
 
CHAPTER 5 
 205 
5.1 Introduction 
We next investigated the effects of inflammation on the composition of haematopoietic 
progenitor compartments and tried to define the molecular mechanism involved in the 
process. Previous models of bacterial-induced inflammation have reported decreased 
output of both BM myelopoiesis and lymphopoiesis and phenotypic changes in stem 
and progenitor compartments. A bacterial model of infection using Staphylococcus 
aureus (Scumpia et al., 2010) resulted in an expansion of the LSK compartment. To 
define the mechanism involved in this expansion, mice deficient for components of the 
TLR4 signalling pathway were analysed. Myd88-null, Trif-null or Myd88/Trif -null mice 
were infected, however there was no change in the increased frequency and number of 
LSK cells. This indicated that TLR signalling was not required in response to 
Staphylococcus aureus infection. This group additionally investigated the effect of 
polymicrobial sepsis induced by cecal ligation puncture on haematopoietic progenitor 
cells. They observed a tripling in the number of LSK cells and a subsequent increase in 
the frequency of ST-HSCs and LT-HSCs, which was also not altered in Myd88-null 
mice, or during blockade of TNFα, IL-1, IL-6 and IFNα inflammatory cytokines. A 
decrease in the number of BM B-cells and upstream CLP cells was also reported which 
was due in part to TLR4 signalling as Myd88-null mice displayed a delay in pre B-cell 
depletion. This indicated that the TLR4 pathway was partially responsible for the 
reduction in B-cells during infection, but did not alter the phenotype of earlier 
haematopoietic subsets. A decrease in the number of myeloid progenitor cells was also 
observed. However a previous report (Delano et al., 2007) suggests that this may be due 
to myeloid progenitor cells being exported to the periphery. 
In a bacterial infection model using E. coli (Zhang et al., 2008), the same expansion of 
the LSK compartment was observed and there was an increase in the number of LSK 
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cells incorporating 5-bromo-2’-deoxyuridine (BrdU) after infection, indicating that 
these cells had a higher proliferation rate than control cells. In contrast, there was a 
decrease in the LIN– c-kithi Sca-1– compartment. In vitro culture of LIN– c-kithi Sca-1– 
cells with plasma of E. coli infected mice resulted in a significant increase in the 
number of LSK cells, and the authors suggested that the reason for the expansion 
observed in the LSK compartment may have been due to LIN– c-kithi Sca-1– cells 
inverting their phenotype. The same could also be observed after culture with LPS, 
TNFα, IL-6 and IFNγ. After placing the ‘inverted’ cells in semi-solid medium, which 
supports the growth of CFU-granulocyte/erythrocyte/macrophage/megakaryocyte 
(CFU-GEMM), there was increased CFU-GM activity. Therefore there appeared to 
always be a decrease in the number of LIN– c-kithi Sca-1– cells during bacterial 
infection, representing myeloid progenitors during homeostatic conditions, and a 
subsequent increase in the frequency and number of LSK cells, which appeared to retain 
myeloid potential. However, bacterial-induced inflammatory changes in haematopoietic 
progenitor compartments could not be attributed to any specific mechanism. 
In order to determine this, we created a model of acute inflammation by injecting a 
sub-lethal dose of endotoxin from Salmonella minnesota into C57BL/6 mice. LPS is 
present in the outer membrane of all gram negative bacteria and is the component by 
which host cells recognise bacteria (reviewed by Freudenberg and Galanos, 1990), 
therefore we opted to use pure LPS to elicit an inflammatory response. One advantage 
of using LPS as opposed to the complete bacterium is that signalling mechanisms and 
their impact on innate immune responses have been extensively investigated.  
The interaction of LPS with cells of the innate immune system leads to the release of 
endogenous cytokines, which initiates inflammatory responses essential for antibacterial 
defence (Beutler et al., 2003). The release of high concentrations of these cytokines 
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however can cause toxic shock (Karima et al., 1999). Some of these symptoms include 
fever, nausea, leukopenia, thrombocytopenia and organ failure (Morrison et al., 1979). 
Due to the discovery that C3H/HeJ mice were non-responsive to LPS, owing to a 
mutation in the Tlr4 gene, TLR4 has been recognised as the signalling protein by which 
LPS activates cells (Poltorak et al., 1998). LPS consists of three parts; a lipid A, a core 
oligosaccharide and an O side chain. It is lipid A which binds to TLR4 and causes 
inflammatory effects.  TLR4, predominantly expressed on macrophages and DCs, 
recognises LPS (Hoshino et al., 1999) with the aid of CD14, MD-2 and LPS-binding 
protein (LBP; Shimazu et al., 1999), and signals via the MyD88 or TRIF pathways, 
subsequently activating NFκB and inducing the production of TNFα. The primary 
source of TNFα is macrophages (Rosenstreich et al., 1980) and this cytokine is the 
primary mediator of the lethal action of endotoxin (Beutler et al., 1985). During this 
inflammatory process, TNFα may be inducing changes in the proliferation and 
differentiation of haematopoietic progenitors. One report showed that TNFα could 
inhibit the proliferation of HSCs in vitro (Zhang et al., 1995). However, TNFα has also 
been suggested to cause proliferation of HSCs (Rezzoug et al., 2008). Rezzoug and 
colleagues found that TNFα increased the proliferation and differentiation of HSCs into 
multipotent progenitors in vitro and inhibited the apoptosis of HSCs in vivo. Therefore, 
the effect of TNFα on haematopoietic progenitor cells during inflammation remains 
unclear.  
The effects of LPS on haematopoietic progenitor cells have been studied by some 
groups (Scumpia et al., 2010; Welner et al., 2009). Scumpia and colleagues found that 
injection of 5µg LPS into mice caused a transient increase in the frequency of LSK 
populations which began at 18 hours post injection and lasted 72 hours. The authors 
deduced that this was due to an increase in LT-HSC and ST-HSC compartments. This 
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expansion was also observed in Ifnαr-null mice indicating that IFNα was not the only 
cytokine responsible, however the exact mechanism was not studied. Therefore, we 
aimed to investigate the effects of LPS on all haematopoietic progenitor populations, as 
well as mature cells in the circulation and determine the cause of inflammation-induced 
changes.  
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5.2 Analysis of the body temperature and circulating RBC and 
WBC number of C57BL/6 mice during LPS challenge 
Since high amounts of LPS causes endotoxic shock which results in death, we studied 
the effect of a sub-lethal dose of LPS. One symptom of septic shock is a change in body 
temperature, therefore to compare the lower concentration of LPS used in our studies, 
we monitored this parameter. As Figure 5.1A shows, there were no major differences in 
the temperature of LPS injected mice in comparison to control mice. We next looked at 
the number of circulating red and white blood cells during LPS challenge. There were 
also no major differences in the number of circulating RBCs in mice injected with LPS 
compared to control mice (Figure 5.1B). In contrast, there were clear differences in the 
number of circulating granulocytes and lymphocytes (Figure 5.2). These numbers were 
also different between male and female mice.  
As illustrated in Figure 5.2A, there was a mobilisation of granulocytes into the 
circulation in male mice 3.5 hours post LPS injection. The number of granulocytes in 
the peripheral blood increased significantly from 1.68 ± 0.16 x 109/l at control levels to 
7.98 ± 1.17 x 109/l after 3.5 hours. In female mice however, this was not evident until 
after seven hours, where an increase from 1.68 ± 0.16 x 109/l at control levels to 11.3 ± 
1.61 x 109/l could be observed. This indicated a delay in the increase of circulating 
granulocytes in response to LPS in females compared to male mice. In both genders, the 
number of granulocytes increased continually until 12 hours post injection, when both 
female number (11.45 ± 1.92 x 109/l) and male number (15.33 ± 2.45 x 109/l) reached 
their maximum. Granulocyte numbers had returned to steady state levels by 48 hours in 
female mice (1.83 ± 1.79 x 109/l), whereas it took until 72 hours for numbers in male 
mice (2.83 ± 1.8 x 109/l) to reach homeostatic levels. This observation indicated that 
neutrophils were being mobilised into the circulation in both male and female mice, but 
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male mice were more efficient in mobilising granulocytes and in reaching a higher 
number in peripheral blood.   
We next observed the effect of LPS on circulating lymphocytes. In male and female 
mice, there was a significant decrease in the number of lymphocytes immediately after 
LPS challenge (Figure 5.2B). The number of lymphocytes in male mice had decreased 
from 11.46 ± 0.39 x 109/l at control levels to 4.62 ± 0.34 x 109/l after just 3.5 hours, 
whilst female numbers declined from 10 ± 2.12 x 109/l at control levels to 1.9 ± 0.4 x 
109/l. The number of lymphocytes in female mice had returned to homeostatic levels by 
72 hours (11.43 ± 1.25 x 109/l), but more time was required in male mice.  
We also analysed the number of circulating monocytes (Figure 5.2C) and observed only 
minor changes between LPS injected and control mice. A significant decrease in the 
number of monocytes was observed in male and female mice at 3.5 hours post LPS 
injection and there was a significant increase in the number of monocytes at 48 hours 
post injection in male mice, however at all other time points there were no significant 
differences.   
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 Figure 5.1 
Body temperature and number of circulating RBCs in C57BL/6 mice injected with LPS 
as compared to control mice.  
 
A Graph illustrating the effect of a sub-lethal dose of LPS on the body temperature 
of C57BL/6 mice, aged eight weeks of age. Control mice were injected with 
double distilled water. Data are representative of three independent experiments, 
using 24 mice per group. Values represent mean ± S.E.M. 
 
B Graph illustrating the effect of a sub-lethal dose of LPS challenge on the 
circulating RBC number of C57BL/6 mice, aged eight weeks of age. Control 
mice were injected with double distilled water. The number of circulating RBCs 
did not enter outside of the physiological range during LPS challenge, therefore 
no anaemia was observed. Data are representative of four independent 
experiments, using one to six mice per group. Values represent mean ± S.E.M. 
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Figure 5.2 
Number of circulating granulocytes, lymphocytes and monocytes compared between 
LPS injected and control C57BL/6 mice. 
 
A Graph illustrating the number of circulating granulocytes in male (red line) and 
female (blue line) mice aged eight weeks of age, after LPS challenge. Control 
mice were injected with double distilled water (black line).  Data represents 
results from two independent male experiments and one independent female 
experiment, using three to five mice per time point. Significance was calculated 
using the Student’s T-test (p < 0.05). Values represent mean ± S.E.M. 
 
B Graph illustrating the number of circulating lymphocytes in male (red line) and 
female mice (blue line) aged eight weeks of age, after LPS challenge. Control 
mice were injected with double distilled water (black line). Data represents 
results from two independent male experiments and one independent female 
experiment, using three to five mice per time point. Significance was calculated 
using the Student’s T-test (p < 0.05). Values represent mean ± S.E.M. 
 
C Graph illustrating the number of circulating monocytes in male (red line) and 
female mice (blue line) aged eight weeks of age, after LPS challenge. Control 
mice were injected with double distilled water (black line). Data represents 
results from two independent male experiments and one independent female 
experiment, using three to five mice per time point. Significance was calculated 
using the Student’s T-test (p < 0.05). Values represent mean ± S.E.M. 
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5.3 The effects of LPS challenge on the frequency of mature myeloid 
and B-cells in the BM 
Based on the observations that there were an increased number of circulating 
granulocytes and a decrease in the number of circulating lymphocytes, we investigated 
whether the changes in these numbers could be due to alterations in the output of BM 
cells. In the following all numbers for BM cells are given per femur pair. We found that 
the total number of BM cells was reduced significantly throughout the time course 
(Figure 5.3). At 12 hours post LPS injection, there was a significant decrease in the 
number of cells from 3.4 x 107 ± 0.19 x 107 to 2.1 x 107 ± 0.2 x 107. This number 
remained low at 24 hours but had returned to homeostatic levels by 72 hours. Therefore, 
this indicated that cells from the BM may have been exported to the periphery between 
12 and 24 hours post LPS challenge.  
We next explored whether these cells may have been BM neutrophils and monocytes 
(Gr1+ CD11b+; Figure 5.4). At 12 hours post LPS there was a decline in the frequency 
of Gr1+ CD11b+ cells compared to control mice and this decreased even further at 24 
hours post LPS. At 72 hours however, the frequency returned to control levels. We also 
analysed BM Gr1+ CD11b+ cells at 120 hours post LPS to see if there was a 
compensatory increase in the frequency of myeloid cells after the total BM number had 
recovered. We found that this was indeed the case and the frequency of Gr1+ CD11b+ 
cells had increased almost three fold between 72 and 120 hours. Therefore, the reduced 
number of total BM cells at 12 and 24 hours post LPS reflected the export of BM 
neutrophils and monocytes into the circulation. In addition, in order to ‘refill’ the 
myeloid compartment, it seemed that there was a compensatory increase in the 
production of mature myeloid cells once the inflammation-induced effects of LPS 
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challenge had been cleared. This could have been due to increased production of mature 
cells from BM progenitors.  
Next, we observed the frequency of BM B-cells, which were identified by CD19 
expression (Figure 5.5). After 12 hours post LPS, there was no significant change in the 
frequency of cells compared to control mice, however at 24 hours an increase in the 
frequency of these cells was observed. This may have been due to B-cell progenitors 
developing into mature cells, or it could have been due to circulating B-cells homing to 
the BM during LPS challenge, which would be one explanation for the reduced number 
of these cells in the blood. In contrast, at 72 and 120 hours post LPS there was a virtual 
depletion of BM B-cells. This suggested that lymphopoiesis had stalled and might 
indicate the depletion of upstream progenitors.  
 
CHAPTER 5 
 217 
Figure 5.3 
Reduction in the total number of BM cells after LPS challenge in C57BL/6 mice. 
 
Graph illustrating the total number of BM cells per femur pair at 0, 12, 24 and 72 hours 
post LPS challenge in C57BL/6 mice, aged eight weeks of age. For the control, 
C57BL/6 mice were injected with double distilled water. Ten mice were analysed (five 
male and five female) per time point from three independent experiments. Significance 
was calculated using the Student’s T-test (p < 0.05). Values represent mean ± S.E.M. 
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Figure 5.4 
Frequency of BM neutrophils and monocytes during LPS challenge in C57BL/6 mice. 
 
Representative FACS plots illustrating the frequency of BM neutrophils and monocytes 
at 0, 12, 24, 72 and 120 hours post LPS challenge in C57BL/6 mice, aged eight weeks 
of age. Myeloid cells were identified by combined expression of Gr1 and CD11b. In all 
histograms, NK1.1+, CD3ε+ and 7AAD+ cells were electronically excluded from 
analysis. For the control, C57BL/6 mice were injected with double distilled water. 
Samples are representative of one experiment using five mice per time point.  
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Figure 5.5 
Frequency of BM B-cells during LPS challenge in C57BL/6 mice. 
 
Representative FACs plots illustrating the frequency of BM B-cells at 0, 12, 24, 72 and 
120 hours post LPS challenge in C57BL/6 mice, aged eight weeks of age. For the 
control, C57BL/6 mice were injected with double distilled water. In all histograms, 
NK1.1+, CD3ε+ and 7AAD+ cells were electronically excluded from analysis. Samples 
are representative of one experiment using five mice per time point.    
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5.4 Analysis of the number of haematopoietic progenitor cells during  
LPS challenge 
We had observed a virtual depletion of BM B-cells 72 hours after LPS challenge, 
therefore we investigated whether this was due to an absence of upstream lymphoid 
progenitor cells. All BM progenitor cells are identified as LIN–. We found that there 
was a decline in the total number of LIN– cells 12 and 24 hours post LPS injection 
(Figure 5.6A). A significant decrease in the number of LIN– cells occurred after 
12 hours (from 3.94 x 105 ± 0.49 x 105 to 2.58 x 105 ± 0.32 x 105) and more severely at 
24 hours post injection (1.24 x 105 ± 0.13 x 105), which had returned to steady state 
levels by 72 hours (2.97 x 105 ± 0.48 x 105). Therefore, during 12 and 24 hours post 
LPS, there was a decrease in the number of progenitor cells. Due to a reported 
expansion of the LSK compartment and a decrease in the number of LIN– c-kithi Sca-1– 
cells in other models of inflammation (Belyaev et al., 2010; Singh et al., 2008; Zhang et 
al., 2008), we analysed the number of cells in these populations throughout the time 
course. The number and frequency of LSK cells, representing during homeostatic levels 
stem cells and multipotent progenitors, increased significantly at 12, 24 and 72 hours 
post LPS injection (Figure 5.6B), in agreement with other published data. At 12 hours, 
the cell number increased 1.3 fold, from 2.13 x 104 ± 0.25 x 104 at control levels to 
2.94 x 104 ± 0.33 x 104. The number of cells further increased at 24 hours 
(3.05 x 104 ± 0.5 x 104) and 72 hours (4.99 x 104 ± 0.94 x 104). In contrast to an 
expansion in the LSK compartment, there was a major decrease in the number of LIN– 
c-kithi Sca-1– cells (Figure 5.6C), a compartment composed of myelo-erythroid 
progenitors during homeostatic levels. In control mice, the number of cells equated to 
10.48 x 104 ± 1.29 x 104 and this declined significantly to 1.96 x 104 ± 0.52 x 104 at 
12 hours. Similar numbers were observed at 24 hours (2.16 x 104 ± 0.46 x 104) and the 
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cell number began to return to steady state levels by 72 hours (9.91 x 104 ± 2.1 x 104). 
Therefore, as suggested by Zhang and colleagues (Zhang et al., 2008), the increase in 
the number of LSK cells could have been due to a conversion of LIN– c-kithi Sca-1– 
cells into LSK cells. On observation of the frequency of cells in these compartments, 
there was an increase in the frequency of LSK cells and a subsequent decrease in the 
frequency of LIN– c-kithi Sca-1– cells, which appeared to upregulate Sca-1 on their 
surface (Figure 5.7).  
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Figure 5.6 
Absolute number of LIN–, LSK and LIN–c-kithi Sca-1– cells during LPS challenge in 
C57BL/6 mice.  
 
A Graph illustrating the number of LIN– cells per femur pair in the BM at 0, 12, 24 
and 72 hours post LPS challenge of C57BL/6 mice, aged eight weeks of age. 
Control C57BL/6 mice were injected with double distilled water. Ten mice were 
analysed (five male and five female) per time point from three independent 
experiments. Significance was calculated using the Student’s T-test (p < 0.05). 
Values represent mean ± S.E.M.  
 
B Graph illustrating the number of LSK cells per femur pair in the BM at 0, 12, 24 
and 72 hours post LPS challenge of C57BL/6 mice, aged eight weeks of age. 
Control C57BL/6 mice were injected with double distilled water. Ten mice were 
analysed (five male and five female) per time point from three independent 
experiments. Significance was calculated using the Student’s T-test (p < 0.05). 
Values represent mean ± S.E.M.  
 
C Graph illustrating the number of LIN– c-kithi Sca-1– cells per femur pair in the 
BM at 0, 12, 24 and 72 hours post LPS challenge of C57BL/6 mice, aged eight 
weeks of age. Control C57BL/6 mice were injected with double distilled water. 
Ten mice were analysed (five male and five female) per time point from three 
independent experiments.  Significance was calculated using the Student’s T-test 
(p < 0.05). Values represent mean ± S.E.M. 
CHAPTER 5 
 226 
CHAPTER 5 
 227 
5.5 Composition of haematopoietic progenitor compartments during 
LPS challenge 
We next investigated the composition of LSK cells during LPS challenge and also 
analysed the CLP population. The frequency and number of LSK CD34+ Flk-2– cells, 
representing ST-HSCs during homeostatic conditions, were increased significantly at 
12, 24 and 72 hours post LPS challenge (Figure 5.7 and 5.8A). The number of cells in 
this compartment increased from 0.27 x 104 ± 0.03 x 104 in control mice to 1.17 x 104 ± 
0.16 x 104 at 12 hours post LPS injection. This number remained constant at 24 hours 
(1.18 x 104 ± 0.2 x 104) and starting declining at 72 hours (0.8 x 104 ± 0.15 x 104). The 
observed increase in frequency and number could have occurred for more than one 
reason; a higher number of ST-HSCs were needed during LPS challenge, CD34 was 
upregulated on LSK cells, or that CMP and GMP cells, which were CD34+ and usually 
resided in the LIN– c-kithi Sca-1– compartment, had upregulated Sca-1 on their surface 
and were also identified by these surface markers. In marked contrast, LSK CD34+ 
Flk-2+ progenitors, which would represent LMPPs during homeostatic conditions, 
decreased in frequency and number at 12 and 24 hours (Figure 5.7 and Figure 5.8B). 
The number of cells declined significantly from 0.94 x 104 ± 0.13 x 104 in control mice 
to 0.29 x 104 ± 0.06 x 104 at 12 hours post LPS. This number remained low at 24 hours 
(0.32 x 104 ± 0.09 x 104) and increased significantly at 72 hours (1.73 x 104 ± 0.34 x 
104). This number of LMPP cells at 72 hours was also significantly higher than the 
control, indicating a major production of LMPPs from ST-HSCs at this time point. By 
72 hours, cells in the LSK gate which were CD34+ and Flk-2– were likely representing 
true ST-HSCs because the frequency of LIN– c-kithi Sca-1– cells had returned to 
homeostatic levels (Figure 5.7), indicating that any cells which had upregulated Sca-1 
on their surface during LPS challenge, had lost the expression of this marker. Therefore, 
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it is conceivable that ST-HSCs could have differentiated into LMPP cells at 72 hours 
post LPS and induced an increase in the frequency and number of this population. 
Reasons for this increase may have been the need to compensate for the loss LMPPs 
during LPS challenge, which would subsequently lead to an increased production of 
both mature myeloid and lymphoid cells. This reactive mechanism would explain the 
observed increase in the frequency of mature myeloid cells at 120 hours post LPS 
challenge. Alternatively, because LMPPs contain cells primed to undergo development 
down the lymphoid lineage, their decrease in frequency and number could be the cause 
for the cessation of lymphopoiesis. 
To further investigate lymphopoiesis, the CLP population, which is thought to be 
downstream of the LMPP population and a precursor for B-cells (Allman et al., 2003, 
Schwarz and Bhandoola, 2004), was also analysed. 12 and 24 hours post LPS injection, 
there was a virtual depletion of the CLP population, both in terms of frequency and 
number (Figure 5.7 and Figure 5.8C). The number of CLP cells decreased significantly 
from 0.32 x 104 ± 0.06 x 104 in control mice to 0.03 x 104 ± 0.02 x 104 after 12 hours. 
This number also remained low at 24 hours (0.04 x 104 ± 0.01 x 104) but increased at 72 
hours (0.2 x 104 ± 0.06 x 104). Because there was a major increase in the number of 
LMPP cells at 72 hours post LPS, and an increase in the number of CLP cells also at 
this time point, this indicated that differentiation from the LMPP pool into the CLP had 
taken place. In addition, because CLP cells were virtually absent during LPS challenge, 
this could be one reason for the observed depletion of BM B-cells at 72 hours. On the 
other hand, the frequency of BM B-cells remained constant at 12 hours after LPS 
injection and increased at 24 hours post LPS, which could have been due to CLP cells 
rapidly differentiating into mature lymphocytes at the onset of LPS challenge. There 
was also a reduction in the level of Flk-2 expression on both LMPP and CLP cells at 12 
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and 24 hours compared to the control (Figure 5.7) and a decrease in the level of IL-7Rα 
expression on CLP cells. This indicated that there may have been a lack of production 
of cytokines promoting differentiation and proliferation of lymphoid progenitor cells, in 
order to inhibit lymphopoiesis.  
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Figure 5.7 
Frequency of haematopoietic progenitor compartments during LPS challenge in the BM 
of C57BL/6 mice.  
 
FACS plots illustrating the frequency of haematopoietic progenitor populations during 
LPS challenge in the BM of C57BL/6 mice, aged eight weeks of age. Control mice were 
injected with double distilled water. Mice were analysed at 0, 12, 24 and 72 hour time 
points and assessed for their expression of cell surface markers. Data is representative 
of one from three independent experiments using at least four mice per time point per 
group.    
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Figure 5.8 
Absolute number of progenitor cells in BM of LPS challenged C57BL/6 mice.  
 
A Graph illustrating the number of LSK CD34+ Flk-2– cells per femur pair at 0, 12, 
24 and 72 hours post LPS challenge in C57BL/6 mice, aged eight weeks of age. 
Control mice were injected with double distilled water. Ten mice were analysed 
(five male and five female) per time point from three independent experiments. 
Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M. 
 
B Graph illustrating the number of LSK CD34+ Flk-2+ cells per femur pair at 0, 12, 
24 and 72 hours post LPS challenge in C57BL/6 mice, aged eight weeks of age. 
Control mice were injected with double distilled water. Ten mice were analysed 
(five male and five female) per time point from three independent experiments. 
Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M. 
 
C Bar graph illustrating the number of LIN– IL-7Rα+ Flk-2+ cells per femur pair at 
0, 12, 24 and 72 hours post LPS challenge in C57BL/6 mice, aged eight weeks 
of age. Control mice were injected with double distilled water. Ten mice were 
analysed (five male and five female) per time point from three independent 
experiments. Significance was calculated using the Student’s T-test (p < 0.05).  
Values represent mean ± S.E.M.  
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5.6 The number of LT-HSCs remains constant throughout LPS 
challenge 
After observing a decrease in the frequency and number of LMPP and CLP populations 
and an increase in the number of LSK CD34+ Flk-2– cells during LPS challenge, we 
next attempted to further define the cause of expansion of LSK cells. To address 
whether the increase in LSK numbers was due to amplification of LT-HSCs during LPS 
challenge, we analysed the absolute cell number of LSK CD150+ CD48– cells (Figure 
5.9). Previous studies have reported that dormant LT-HSCs can be activated in vivo by 
inflammatory cytokines. Baldridge and colleagues (Baldridge et al., 2010) found that 
during chronic infection with Mycobacterium avium, LT-HSCs proliferated extensively 
as shown by the incorporation of BrdU. These LT-HSCs also lost some regenerative 
function and showed impaired engraftment after transplantation into irradiated 
recipients. These changes were due to IFNγ, as LT-HSCs removed from Ifng-deficient 
mice had a lower proliferative rate.  Other reports have shown that IFNα can also induce 
the proliferation of LT-HSCs (Sato et al., 2009; Essers et al., 2009). However, most 
importantly, Scumpia and co-workers found that there was a significant increase in the 
number of LT-HSCs after polymicrobial sepsis, induced by cecal ligation puncture and 
also LPS injection (Scumpia et al., 2010). In contrast to this data, we found no 
significant differences in the number of these cells throughout the study. Due to an 
observed increase in the LSK CD34+ Flk-2– compartment during LPS challenge, which 
represents ST-HSCs during steady state conditions and which are the immediate 
downstream progeny of LT-HSCs, the increase in the frequency and number of these 
cells was likely not due to a requirement for surplus ST-HSCs, as there was no evidence 
for an increased number of upstream LT-HSCs. The increase in the number of LSK 
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CD34+ Flk-2– cells therefore could have been due to upregulation of Sca-1 on myeloid 
progenitors and CD34+ CMP and GMP populations residing in the LSK compartment.  
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Figure 5.9 
Absolute number of LT-HSCs during LPS challenge in C57BL/6 mice. 
 
Graph illustrating the number of LSK CD150+ CD48– cells per femur pair at 0, 12, 24 
and 72 hours post LPS challenge in C57BL/6 mice, aged eight weeks of age. LT-HSC 
number showed no significant change throughout the study. Control mice were injected 
with distilled water. Ten mice were analysed (five male and five female) per time point 
from three independent experiments. Significance was calculated using the Student’s 
T-test (p < 0.05).  Values represent mean ± S.E.M.  
CHAPTER 5 
 237 
 
CHAPTER 5 
 238 
5.7 Phenotypic changes in myeloid progenitors during LPS 
challenge 
One explanation for the increase in the frequency and number of LSK cells was that 
myeloid progenitors from the LIN– c-kithi Sca-1– fraction may have upregulated Sca-1. 
Due to the lack of LIN– c-kithi Sca-1– cells during LPS challenge, we were not able to 
study conventional CMPs, GMPs and MEPs. Therefore, we used the FcγRII/III antigen 
as a marker of GM development (Akashi et al., 2000) in all cells which were LIN– 
c-kithi. As illustrated in Figure 5.10; 12, 24 and 72 hours post LPS challenge, there was 
still detectable FcγRII/III expression in LIN– c-kithi cells, indicating the presence of GM 
progenitors. Although the frequency (Figure 5.10) and number (see Figure 5.11) of 
FcγRII/III+ cells was reduced 12 and 24 hours post LPS challenge on LIN– c-kithi cells, 
the presence of FcγRII/III expressing progenitors remained throughout the study. This 
proved that CMP and GMP populations were present in the LSK compartment of the 
BM, indicating that Sca-1 must have been upregulated on these cells. In addition, the 
presence of CMP and GMP populations indicated that myelopoiesis was still ongoing. 
This may have been occurring in order to refill mature myeloid cell pools of the BM, 
which had been depleted due to export of these cells into the circulation.  
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Figure 5.10 
Frequency of LIN– c-kithi cells expressing FcγRII/III during LPS challenge in C57BL/6 
mice. 
 
FACS plots illustrating the presence of FcγRII/III expression on LIN– c-kithi cells. 
C57BL/6 mice aged eight weeks of age were analysed at 0, 12, 24 and 72 hours post 
LPS challenge. Control mice were injected with distilled water. Data is representative of 
one from three independent experiments using at least four mice per time point per 
group. 
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Figure 5.11 
Absolute number of LIN– c-kithi FcγRII/III+ cells during LPS challenge. 
 
Graph illustrating the number of LIN– c-kithi FcγRII/III+ cells per femur pair at 0, 12, 24 
and 72 hours post LPS challenge in C57BL/6 mice, aged eight weeks of age. Ten mice 
were analysed (five male and five female) per time point from three independent 
experiments. Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M.  
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5.8 Analysis of haematopoietic progenitor cells utilising the Rag1wt/Cre 
x Rosa26wt/eYFP reporter during LPS challenge 
We next investigated LPS challenge in Rag1wt/Cre x Rosa26wt/eYFP mice. This reporter 
model allows us to track the fate of cells by virtue of eYFP expression on cells which 
have passed via the ELP stage of development and expressed Rag1. We initially utilised 
this model in order to analyse the effect of LPS challenge on the ELP population. As 
expected due to a loss of LMPP and CLP cells, ELP cells were also absent at 12 hours 
post LPS (Figure 5.12). However there was some evidence for recovery at 24 hours and 
a substantial increase in the frequency of ELP cells at 72 hours, identical to what was 
observed in the LMPP population.  
Next we used the Rag1wt/Cre x Rosa26wt/eYFP to address whether eYFP+ lymphoid 
progenitor cells had been re-directed to the myeloid lineage during LPS challenge. This 
was based on results that there was a lack of lymphoid progenitor cells during LPS 
challenge and a cessation of lymphopoiesis, but the presence of FcγRII/III+ GMP and 
CMP populations. There have been previous reports suggesting that overexpression of 
cytokines and transcription factors in culture can re-direct lymphoid progenitors into the 
myeloid lineage. It has already been shown that CLPs from mice transgenic for human 
IL-2Rβ can be re-directed to the myeloid lineage after stimulation by human IL-2β in 
vitro (Kondo et al, 2000). The authors suggested that IL-2 receptor signalling was 
promoting the development of GM lineage cells from lymphoid committed cells and 
this revealed that lymphoid precursors retained a certain amount of developmental 
plasticity. However, under physiological conditions, CLPs do not express the IL-2Rβ 
chain and so this observed developmental plasticity may not occur in vivo.  
Furthermore, Iwasaki-Arai et al., (Iwasaki-Arai et al., 2003) reported that CLPs isolated 
from mice ubiquitously expressing the human GM-CSF receptor (hGM-CSFR) could be 
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instructed by hGM-CSF in vitro to develop into granulocytes, monocytes and DCs. The 
authors suggested that because CLP cells do not express GM-CSFR under physiological 
conditions and expression of this receptor is restricted to the myeloid lineage, lymphoid 
progenitor cells become restricted in their fate because of downregulation of receptors 
which respond to cytokines promoting myeloid differentiation. Indeed this may have 
been occurring after administration of LPS, but instead of downregulation of myeloid 
receptors on lymphoid cells, downregulation of receptors promoting lymphoid 
differentiation, such as Flk-2 and IL-7Rα, and upregulation of myeloid lineage 
promoting receptors may have occurred.  
In addition to cytokine receptor expression, it has also been reported that enforced 
expression of transcription factors required for GM and MegE development, in 
lymphoid progenitor cells, can also cause re-direction of cells from the lymphoid to the 
MegE and GM lineages. Iwasaki et al., showed that enforced expression of GATA-1 
could induce the differentiation of CLPs into the MegE lineage (Iwasaki et al., 2003). In 
addition, Xie et al (Xie et al., 2004) reported that BM and splenic B-cells could be 
reprogrammed into Mac-1+ cells after enforced expression of C/EBPα, a transcription 
factor required for myeloid development. These studies suggest that lineage 
specification of haematopoietic progenitors is governed by a variety of intrinsic and 
extrinsic factors, however reports of lineage re-direction induced by cytokines in vivo 
has not been well addressed.  
Access to Rag1wt/Cre x Rosa26wt/eYFP reporter mice enabled us to assess any potential 
developmental plasticity of the CLP population during LPS challenge directly. EYFP 
expression in Rag1wt/Cre x Rosa26wt/eYFP mice is confined to lymphoid progenitor cells 
only and is absent in all stem cells and myeloid progenitors. Therefore, any expression 
of eYFP in myeloid cells would indicate that ELPs or CLPs had been re-directed into 
CHAPTER 5 
 245 
myeloid progenitors and these cells had then matured into fully functional myeloid 
cells. We analysed mature neutrophils and monocytes in the BM (Figure 5.13) starting 
at 12 hours and up to five days after LPS challenge. There was no evidence for 
significant eYFP expression at any time point. To completely rule out eYFP expression 
in the myeloid compartment, we also analysed these cells in the spleen to ensure that 
cells had not already exited the BM by 12 hours post injection. As shown in Figure 
5.14, there was no significant increase in expression of eYFP on splenic myeloid cells at 
any time point, indicating that re-direction of lymphoid progenitor cells into the myeloid 
lineage had not occurred. Therefore, the decrease in the frequency and number of CLP 
cells during LPS challenge was due to either apoptosis of these cells or rapid 
development of these cells into mature lymphocytes immediately after LPS 
administration.  
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Figure 5.12 
Frequency of ELP cells in the BM during LPS challenge in Rag1wt/Cre x Rosa26wt/eYFP  
mice. 
 
FACS plots illustrating the loss of ELP cells during LPS challenge in Rag1wt/Cre x 
Rosa26wt/eYFP mice aged eight to ten weeks of age. Mice were analysed at 0, 12, 24, 72 
and 120 hours post LPS challenge. Control mice were injected with double distilled 
water. Ten mice were analysed (five male and five female) per time point from two 
independent experiments.  
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Figure 5.13 
Frequency of BM myeloid cells expressing eYFP in Rag1wt/Cre x Rosa26wt/eYFP mice 
during LPS challenge. 
 
FACS plots illustrating the lack of eYFP expression in mature myeloid cells of 
Rag1wt/Cre x Rosa26wt/eYFP mice aged eight to ten weeks of age. BM myeloid cells were 
analysed at 0, 12, 24, 72 and 120 hours post LPS challenge. Myeloid cells were 
identified by combined expression of Gr1 and CD11b. In all histograms NK1.1+, 
CD3ε+, 7AAD+ cells were excluded from the analysis. Ten mice were analysed (five 
male and five female) per time point from two independent experiments.  
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Figure 5.14 
Frequency of splenic myeloid cells expressing eYFP in Rag1wt/Cre x Rosa26wt/Cre mice 
during LPS challenge. 
 
FACS plots illustrating the lack of eYFP expression in splenic myeloid cells of 
Rag1wt/Cre x Rosa26wt/eYFP mice aged eight to ten weeks of age. Splenic myeloid cells 
were analysed at 0, 12, 24, 72 and 120 hours post LPS challenge. Cells were identified 
as NK1.1– CD3ε– 7AAD– and then analysed for Gr1 and CD11b expression. Ten mice 
were analysed (five male and five female) per time point from two independent 
experiments. 
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On initial observations LPS challenge resulted in a cessation of BM lymphopoiesis and 
a concomitant increase in myelopoiesis. This was reflected by an increase in the number 
of circulating granulocytes and a decrease in the number of circulating lymphocytes. 
Indeed, neutrophils have been shown to localize rapidly to the site of inflammation to 
elicit microbicidal activity (Burg et al., 2001). Consequently, the frequency of 
BM-derived neutrophils declined during LPS challenge, which was likely due to the 
export of these cells into the circulation. It is known that localisation of neutrophils to 
inflammatory sites in the circulation produces a brief neutropenia, which is resolved by 
migration of BM neutrophils into the circulation (Glasser et al., 1987). During LPS 
challenge, to compensate for the loss of BM neutrophils, there was increased production 
of these cells once LPS-induced inflammatory changes had cleared. However, 
production of these neutrophils from myeloid progenitor cells did not appear to be 
regulated. GMP cells which give rise to mature macrophages and granulocytes under 
steady state conditions (Akashi et al., 2000) could not be identified by their 
conventional phenotype. This appeared to be due to upregulation of Sca-1 on the 
surface of these cells and therefore FcγRII/III+ GMP cells resided in the LSK fraction of 
the BM. This observation was also reported by Belyaev et al (Belyaev et al., 2010) 
during infection of mice with malaria and they found that these cells could produce 
mature myeloid cells in vitro. Therefore, although these cells could be identified in the 
LSK compartment, along with stem cells and multipotent progenitors, these cells were 
likely still producing myeloid cells. In addition, the number of LIN– c-kithi FcγRII/III+ 
cells decreased during LPS challenge, suggesting that either development of myeloid 
progenitor cells into mature neutrophils had occurred rapidly, such that the number of 
cells present in the pool was minor, or that inflammatory cytokines were exerting an 
inhibitory effect on the number of these cells. Indeed a contraction in the number of 
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myeloid progenitor cells was also reported during malaria (Belyaev et al., 2010), 
Vaccinia virus (VV; Singh et al., 2008), human cytomegalovirus (HCMV; Gibbons et 
al., 1995) and E. coli infection (Zhang et al., 2010). 
In contrast to the production of mature myeloid cells, mature lymphocyte numbers 
appeared to decline. In the circulation there was an immediate decrease in the number of 
lymphocytes after LPS challenge. The same result was also reported by Chandra and 
colleagues (Chandra et al., 2008) who observed a marked decrease in the number of 
circulating B-cells, as well as T-cells, during endotoxemia. This suggested that 
lymphocytes could have been homing to organs in order to provide more space for 
infiltrating neutrophils; were reduced because of a lack of lymphoid progenitor cells; or 
the cells were dying. On analysis of the BM, the frequency of B-cells increased after 24 
hours, therefore this could have been indicative of circulating B-cells migrating into the 
BM.  However, at 72 hours post LPS challenge, there was a complete depletion of these 
cells. Ueda and co-workers (Ueda et al., 2004) showed that TNFα and IL-1β could 
substantially reduce the number of lymphocytes in the BM, therefore TNFα release 
from macrophages during LPS challenge could be one reason for the absence of BM 
B-cells. Analysis of progenitor populations also revealed that LMPP and CLP cells were 
depleted 12 hours post LPS challenge, which would subsequently cause a cessation of 
B-cell production. However, this depletion was not due to re-direction of cells from the 
lymphoid lineage into the myeloid lineage. Contraction of the CLP population was also 
evident in malaria infection (Belyaev et al., 2010), but increased during VV infection 
(Singh et al., 2008). This was probably due to clearance of VV predominantly by the 
adaptive immune system, as opposed to the innate immune response during LPS 
challenge. Therefore, during LPS challenge, it appeared that lymphopoiesis was halted 
in favour of myelopoiesis.  
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Analysis of the stem cell compartment revealed that the number of LT-HSC cells did 
not change during LPS challenge. This suggested that there was no requirement for the 
enhanced production of ST-HSCs and even though there was an expansion in the 
number of LSK CD34+ Flk-2+ cells, this was most likely due to the presence of CD34+ 
myeloid progenitors within the LSK compartment. Therefore, the changes in 
haematopoietic progenitor cells seemed to be transient.   
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5.9 IFNγ and TNFα cytokines are responsible for the upregulation of 
Sca-1 on haematopoietic progenitor cells during LPS challenge 
Next we attempted to define the potential mechanisms involved in the alteration of BM 
progenitor phenotype and number during LPS challenge. We focused on the cause of 
Sca-1 upregulation on LIN– c-kithi Sca-1– cells and hypothesised that this upregulation 
was due to an increase in pro-inflammatory cytokines after LPS administration. Due to 
TNFα being the primary mediator of the effects of LPS (Beutler et al., 1985), we 
investigated whether this cytokine was responsible for the modulation of Sca-1 
expression. In order to address this, we analysed LPS challenge in mice which were 
unable to respond to TNFα (Tnfr1-null mice).  Due to the increase in Sca-1 expression 
being most prominent at 12 hours post LPS, mice were analysed at this time point. As 
shown in Figure 5.15C, compared to LPS challenge in C57BL/6 mice at 12 hours post 
LPS (Figure 5.15B) there appeared to be only a subtle downregulation of Sca-1 on LSK 
cells. However, when we analysed Sca-1 expression more closely on LIN– c-kithi cells, 
there was a reduction in both the frequency (Figure 5.16C) and number (Figure 5.17C) 
of Sca-1+ cells in Tnfr1-null mice compared to LPS challenge in C57BL/6 mice and a 
significant increase in the frequency (Figure 5.16B) and number (Figure 5.17B) of 
Sca-1int cells. There was also a significant increase in the frequency (Figure 5.16A) and 
number (Figure 5.17A) of Sca-1– cells. This data indicated that TNFα was partly 
responsible for the upregulation of Sca-1 on LIN– c-kithi Sca-1– cells, however it was 
not the sole cause. 
Due to previous studies reporting that IFNγ is able to induce an expansion of the LSK 
compartment both in vitro (Zhao et al., 2010) and in vivo (Belyaev et al., 2010) during 
inflammatory conditions, we next assessed the effect of IFNγ on Sca-1 expression 
during LPS challenge. In order to do this, we analysed the phenotype, frequency and 
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number of haematopoietic progenitor cells in mice lacking the IFNγ receptor 1 
(Ifngr1-null). Our results illustrated that LSK cells in Ifngr1-null mice exhibited much 
reduced levels of Sca-1 expression such that the frequency of cells in the LSK 
compartment (Figure 5.15D) were now comparable to control mice (Figure 5.15A). 
However, the frequency of LIN– c-kithi Sca1– cells was not fully restored to wildtype 
levels (Figure 5.15D). On observation of Sca-1 levels in all LIN– c-kithi cells, there was 
a significant increase in the frequency (Figure 5.16A) and number (Figure 5.17A) of 
Sca-1– cells. This was mirrored by a decrease in the frequency and number of Sca-1+ 
cells (Figure 5.16C and 5.17C). In contrast to LPS challenge in Tnfr1-null mice, there 
was no evidence for an increase in the number of Sca-1int cells and instead there was a 
significant decrease in the number of LIN– c-kithi cells expressing intermediate levels of 
Sca-1 compared to the control (Figure 5.17B). In comparison to Sca-1 modulation in  
Tnfr1-null mice, Ifngr1-null mice appeared to exert a larger downregulation of Sca-1 on 
LSK cells both in terms of frequency (Figure 5.16) and number (Figure 5.17). 
Therefore, IFNγ seemed to be largely responsible for the expression of Sca-1 on LIN– 
c-kithi Sca1– cells.  However, the frequency and number of Sca-1– cells in the LIN– 
c-kithi fraction were not fully restored to wildtype levels in Tnfr1-null or Ifngr1-null 
mice. 
In order to fully restore the frequency and number of LIN– c-kithi Sca-1– cells during 
LPS challenge to wildtype levels, we next investigated whether TNFα and IFNγ could 
be acting in synergy to upregulate Sca-1 on LIN– c-kithi Sca-1– cells. This assumption 
was based on reports which have previously shown that TNFα and IFNγ can act in 
synergy in other immunological processes. One study proved that TNFα and IFNγ 
acting together could enhance tumour cytotoxicity and activate macrophages (Esparza et 
al., 1987). In addition, another study investigating Sca-1 expression in vitro showed that 
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TNFα cultured alone with BM cells could not induce Sca-1, however in conjunction 
with IFNγ, TNFα could act synergistically to further increase the percentage of Sca-1, 
higher than that of IFNγ alone (Malek et al., 1989). We therefore wanted to measure the 
induction of Sca-1 on LIN– c-kithi Sca-1– cells in the absence of both IFNγ and TNFα 
signalling. To achieve this we injected neutralising anti-TNFα mAb into Ifngr1-null 
mice. 
Our results demonstrated that the frequency of both the LSK and LIN– c-kithi Sca-1– 
compartments in these mice (Figure 5.15E) were almost identical to the control mice 
(Figure 5.15A).  The frequency of Sca-1– cells on all LIN– c-kithi progenitors had been 
restored to the same level as control mice (Figure 5.16A), and this was also reflected by 
a subsequent decrease in the frequency of Sca-1+ cells back to steady-state levels 
(Figure 5.16C). This result is also illustrated in Figure 5.18 which clearly shows that a 
major increase in Sca-1 expression was evident after injection of LPS into C57BL/6 
mice. There was a minor reduction in Sca-1 upregulation in Tnfr1-null mice, however 
LPS injection in Ifngr1-null mice showed a major decline in Sca-1 expression. Finally 
we showed that ablating the effects of both IFNγ and TNFα signalling fully restored the 
frequency of Sca-1 to homeostatic levels. In addition, the absolute numbers of all Sca-1 
levels in LIN– c-kithi cells, after ablation of TNFα and IFNγ signalling, exhibited no 
significant change compared to control mice (Figure 5.17). Therefore this data proved 
that the upregulation of Sca-1 on LIN– c-kithi Sca-1– cells was caused by IFNγ and 
TNFα.  
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Figure 5.15 
Analysing the cytokines responsible for the upregulation of Sca-1 on haematopoietic 
progenitor cells during LPS challenge using various receptor knock out models. 
 
FACS plots illustrating the analysis of cytokine receptor ‘knock out’ models in order to 
restore Sca-1 levels on LSK cells during LPS challenge after 12 hours. All mice 
analysed were aged eight to ten weeks of age. One representative experiment is shown 
for each mouse strain. Ten mice were analysed for each strain (five males and five 
females) from 15 independent experiments (three individual experiments per knock out 
mouse).  
 
A Frequency of LIN– c-kithi Sca-1– and LSK cells in control mice injected with 
endotoxin-free water.  
 
B Frequency of LIN– c-kithi Sca-1– and LSK cells during LPS injection into 
C57BL/6 mice. 
 
C Frequency of LIN– c-kithi Sca-1– and LSK cells during LPS injection into 
Tnfr1-null (TNFR1-/-) mice. 
 
D Frequency of LIN– c-kithi Sca-1– and LSK cells during LPS injection into 
Ifngr1-null (IFNγR1-/-) mice. 
 
E Frequency of LIN– c-kithi Sca-1– and LSK cells during LPS injection into 
Ifngr1-null (IFNγR1-/-) mice neutralised with TNFα antibody. 
CHAPTER 5 
 259 
 
CHAPTER 5 
 260 
Figure 5.16 
Frequency of Sca-1 negative, intermediate and positive levels on LIN– c-kithi cells at 12 
hours post LPS challenge in C57BL/6, Tnfr1-null, Ifngr1-null and TNFα-neutralised  
Ifngr1-null mice. 
 
A Bar chart illustrating the frequency of Sca-1– cells in LIN– c-kithi cells of 
C57BL/6, Tnfr1-null (TNFR1-/-), Ifngr1-null (IFNγR1-/-) and TNFα-neutralised 
Ifngr1-null (IFNγR1-/-) mice 12 hours post LPS injection. Control mice were 
injected with distilled water. Ten mice were analysed for each mouse strain from 
15 independent experiments. Significance was calculated using the Student’s 
T-test (p < 0.05). Values represent mean ± S.E.M. 
 
B Bar chart illustrating the frequency of Sca-1int cells in LIN– c-kithi cells of 
C57BL/6, Tnfr1-null (TNFR1-/-), Ifngr1-null (IFNγR1-/-) and TNFα-neutralised 
Ifngr1-null (IFNγR1-/-) mice 12 hours post LPS injection. Control mice were 
injected with distilled water. Ten mice were analysed for each mouse strain from 
15 independent experiments. Significance was calculated using the Student’s 
T-test (p < 0.05). Values represent mean ± S.E.M. 
 
C Bar chart illustrating the frequency of Sca-1+ cells in LIN– c-kithi cells of 
C57BL/6, Tnfr1-null (TNFR1-/-), Ifngr1-null (IFNγR1-/-) and TNFα-neutralised 
Ifngr1-null (IFNγR1-/-) mice 12 hours post LPS injection. Control mice were 
injected with distilled water. Ten mice were analysed for each mouse strain from 
15 independent experiments. Significance was calculated using the Student’s 
T-test (p < 0.05). Values represent mean ± S.E.M. 
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Figure 5.17 
Absolute numbers of Sca-1 negative, intermediate and positive levels on LIN– c-kithi 
cells at 12 hours post LPS challenge in C57BL/6, Tnfr1-null, Ifngr1-null and TNFα-
neutralised  Ifngr1-null mice. 
 
A Bar chart illustrating the number of Sca-1– cells in LIN– c-kithi cells of C57BL/6, 
Tnfr1-null (TNFR1-/-), Ifngr1-null (IFNγR1-/-) and TNFα-neutralised Ifngr1-null 
(IFNγR1-/-) mice 12 hours post LPS injection. Control mice were injected with 
distilled water. Ten mice were analysed for each mouse strain from 15 
independent experiments. Significance was calculated using the Student’s T-test 
(p < 0.05). Values represent mean ± S.E.M. 
 
B Bar chart illustrating the number of Sca-1int cells in LIN– c-kithi cells of 
C57BL/6, Tnfr1-null (TNFR1-/-), Ifngr1-null (IFNγR1-/-) and TNFα-neutralised 
Ifngr1-null (IFNγR1-/-) mice 12 hours post LPS injection. Control mice were 
injected with distilled water. Ten mice were analysed for each mouse strain from 
15 independent experiments. Significance was calculated using the Student’s 
T-test (p < 0.05). Values represent mean ± S.E.M. 
 
C Bar chart illustrating the number of Sca-1+ cells in LIN– c-kithi cells of C57BL/6, 
Tnfr1-null (TNFR1-/-), Ifngr1-null (IFNγR1-/-) and TNFα-neutralised Ifngr1-null 
(IFNγR1-/-) mice 12 hours post LPS injection. Control mice were injected with 
distilled water. Ten mice were analysed for each mouse strain from 15 
independent experiments. Significance was calculated using the Student’s T-test 
(p < 0.05). Values represent mean ± S.E.M. 
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Figure 5.18 
Frequency of Sca-1 levels in LIN– c-kithi cells directly compared between different 
mouse strains at 12 hours post LPS challenge. 
 
Representative histogram illustrating the Sca-1 levels of LIN– c-kithi cells after LPS 
challenge in different mouse strains. Sca-1 levels in control mice (dark blue line) were 
analysed in mice injected with distilled water. Sca-1 upregulation was observed after 
LPS injection in C57BL/6 mice (green line). There was only a minor reduction in Sca-1 
levels after analysis of Tnfr1-null mice (orange line), but a major reduction of Sca-1 
expression in Ifngr1-null mice (light blue line). However, Sca-1 levels were only fully 
restored once TNFα-neutralisation in Ifngr1-null mice was carried out (red line). 
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5.10 Analysis of the absolute number of haematopoietic progenitor 
cells in mice deficient in IFNγ and TNFα signalling 
In order to assess whether the changes in ST-HSC, LMPP and CLP numbers were also 
due to the combined effect of TNFα and IFNγ during LPS challenge, we analysed the 
absolute number of these progenitor cells in Tnfr1-null, Ifngr1-null and Ifngr1-null mice 
injected with blocking anti-TNFα mAb. Due to the effects of LPS being reverted by 72 
hours, we analysed progenitor cell numbers at 12 and 24 hours post LPS. As shown in 
Figure 5.19A, Tnfr1-null mice exhibited a significant increase in the number of cells 
with the LSK CD34+ Flk-2– phenotype representing ST-HSC, CMP and GMP cell types 
when compared to controls. This result was indicative of only a minor decrease of Sca-1 
expression on myeloid cells in Tnfr1-null mice. In addition, the number of LSK CD34+ 
Flk-2+ cells, representing LMPPs, and LIN– IL-7Rα+ Flk-2+ cells, representing CLPs, 
still decreased significantly after 12 and 24 hours post LPS challenge, similar to 
C57BL/6 LPS injected mice. Therefore, no major changes were observed in the number 
of ST-HSC, LMPP or CLP populations in Tnfr1-null mice in comparison to LPS 
injected C57BL/6 mice. This data suggested that TNFα signalling via TNFR1 was not 
responsible for the observed decline in lymphopoiesis during LPS challenge. 
In LPS injected Ifngr1-null mice however, there was a major decrease in the absolute 
number of LSK CD34+ Flk-2– cells (Figure 5.19B) at 12 and 24 hours compared to 
C57BL/6 (Figure 5.6) and Tnfr1-null LPS injected mice (Figure 5.19A). The number of 
LSK CD34+ Flk-2– cells did not significantly increase at 12 hours post LPS in 
Ifngr1-null mice compared to control mice and although the increase in the number of 
cells at 24 hours was significant, it was minor compared to the increase observed in 
C57BL/6 and Tnfr1-null LPS injected mice. Due to the frequency of LSK cells in 
Ifngr1-null mice during LPS challenge being similar to control mice (Figure 5.15D), 
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this suggested that Sca-1 expression on LIN– c-kithi Sca-1– cells had been significantly 
downregulated. Therefore, the increase in the number of LSK CD34+ Flk-2– cells 
observed in C57BL/6 mice may have been due in part to upregulation of Sca-1 on 
CD34+ CMP and GMP cells caused mainly by IFNγ. In contrast, the number of LSK 
CD34+ Flk-2+ numbers did reduce, but this decrease was only significant after 24 hours 
post LPS (Figure 5.19B). This suggested that the reduction in the number of LMPP cells 
during LPS challenge was due in part to IFNγ. In addition, although LIN– IL-7Rα+ 
Flk-2+ numbers still decreased after 12 and 24 hours (Figure 5.19B), the recovery of 
these cells was already beginning at 24 hours. This was not observed in C57BL/6 or 
Tnfr1-null mice where the number of CLP cells at 24 hours remained low. These results 
indicated that IFNγ was playing a major role both in the upregulation of Sca-1 on LIN– 
c-kithi Sca-1– cells and in the reduction of lymphopoiesis, but that a high degree of 
redundancy was present in the system. We next investigated whether the cessation of 
lymphoid development following LPS challenge is dependent on the combined action of 
IFNγ and TNFα. 
During previous analysis of the frequency and number of Sca-1 levels on LIN– c-kithi 
cells after LPS injection, both IFNγ and TNFα were responsible for restoring Sca-1 
expression to wildtype levels. Therefore, we next investigated whether these two 
cytokines combined were also responsible for the sequestration of lymphopoiesis during 
LPS challenge. The number of progenitor cells in Ifngr1-null mice injected with 
antibodies specific to TNFα was calculated (Figure 5.19C). Interestingly, the number of 
haematopoietic progenitors was not restored to control levels. Instead, what we 
observed was a significant increase in the LSK CD34+ Flk-2– (ST-HSC) numbers after 
12 and 24 hours, a significant decrease in the LSK CD34+ Flk-2+ (LMPP) numbers after 
12 hours and a significant decrease in the LIN– IL-7Rα+ Flk-2+ (CLP) numbers at 12 
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and 24 hours. Since the frequency and number of Sca-1 levels were fully restored to 
steady state levels in these mice, we assumed that ST-HSC, LMPP and CLP cells could 
all be identified according to their conventional phenotype. Therefore, in these mice it 
appeared that ablating the effects of both TNFα and IFNγ did not restore the number of 
lymphoid progenitors or stem cells back to control levels. This indicated that the 
mechanisms responsible or the level of cytokines required for the upregulation of Sca-1 
on LIN– c-kithi Sca-1– cells must be different to those leading to the transient cessation 
of lymphopoiesis. One obvious explanation for this observation might be the only 
partial neutralisation of TNFα bioactivity, resulting in ongoing TNFα signalling. A 
complete absence of TNFα would be required to restore lymphoid differentiation, but 
only partial absence of TNFα was needed to inhibit the expression of Sca-1 on LIN– 
c-kithi Sca-1– cells. However, even if TNFα was not completely neutralised it would be 
expected that the number of progenitor cells would still mirror those observed in 
Ifngr1-null mice, where TNFα signalling was not disrupted, however this was not the 
case. Therefore, another explanation is that LPS may have been exerting a direct effect 
on TLR4 receptors present on LMPP and CLP cells (Nagai et al., 2006) which caused 
these cells to apoptose.  
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Figure 5.19 
Absolute numbers of haematopoietic progenitor subsets in Tnfr1-null, Ifngr1-null and 
TNFα-neutralised Ifngr1-null mice during LPS challenge. 
 
A Graph illustrating the number of LSK CD34+ Flk-2–, LSK CD34+ Flk-2+ and 
LIN– IL-7Rα+ Flk-2+ cells per femur pair in Tnfr1-null (TNFR1-/-) mice 12 and 
24 hours post LPS challenge. Significance was calculated using the Student’s 
T-test (p < 0.05). Ten mice were analysed per time point from three independent 
experiments. Values represent mean ± S.E.M. 
 
B Graph illustrating the number of LSK CD34+ Flk-2–, LSK CD34+ Flk-2+ and 
LIN– IL-7Rα+ Flk-2+ cells per femur pair in Ifngr1-null (IFNγR1-/-) mice 12 and 
24 hours post LPS challenge. Significance was calculated using the Student’s 
T-test (p < 0.05). Ten mice were analysed per time point from three independent 
experiments. Values represent mean ± S.E.M. 
 
C Graph illustrating the number of LSK CD34+ Flk-2–, LSK CD34+ Flk-2+ and 
LIN– IL-7Rα+ Flk-2+ cells per femur pair in TNFα-neutralised Ifngr1-null 
(IFNγR1-/-) mice 12 and 24 hours post LPS challenge. Significance was 
calculated using the Student’s T-test (p < 0.05). Ten mice were analysed per 
time point from three independent experiments. Values represent mean ± S.E.M. 
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5.11 Analysis of the number of circulating white blood cells in mice 
deficient in IFNγ and TNFα signalling  
Since the number of stem cells and progenitors was only partially rescued during LPS 
challenge in the absence of TNFα and IFNγ signalling, we next investigated whether the 
number of circulating granulocytes, lymphocytes and monocytes was changed. 
Coinciding with results obtained after LPS challenge in C57BL/6 mice, the number of 
granulocytes in both male and female mice increased significantly after LPS injection in 
Tnfr1-null mice (Figure 5.20A). Both male and female mice exhibited the highest 
number of granulocytes at 12 hours post LPS challenge (9.28 ± 3.69 x 109/l and 6.30 ± 
0.57 x 109/l). However, the number of granulocytes in male and female mice of 
Tnfr1-null mice did not reach the maximum number which was observed in C57BL/6 
male (15.33 ± 2.45 x 109/l) and female mice (11.3 ± 1.61 x 109/l). The number of 
granulocytes in male and female mice had reduced at 24 hours (2.62 ± 0.39 x 109/l and 
2.94 ± 0.99 x 109/l) and this was in contrast to LPS injected C57BL/6 mice where the 
number of granulocytes returned to homeostatic levels at 48 hours in female and 72 
hours in male mice. Therefore, this suggested that TNFα signalling was important in the 
recruitment of granulocytes to the site of infection and could play a role in the export of 
granulocytes from the BM and into the periphery. 
The number of circulating lymphocytes in LPS injected Tnfr1-null mice (Figure 5.20B) 
was very similar to the number observed during LPS challenge in C57BL/6 mice. 
Immediately after LPS challenge, at 3.5 hours there was a steep decrease in the number 
of circulating lymphocytes in male mice (4.4 ± 0.61 x 109/l from 16.20 ± 1.09 x 109/l) 
and female mice (4.2 ± 0.82 x 109/l from 15.47 ± 0.89 x 109/l). Both male and female 
lymphocyte number remained low until 48 hours but at 72 hours there was an increase 
in the number of cells compared to the control. The number of cells in male mice 
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increased to 19.42 ± 1.38 x 109/l and the number of lymphocytes in female mice 
increased to 15.47 ± 0.89 x 109/l. Therefore, due to the same change in the number of 
lymphocytes occurring in Tnfr1-null mice compared to C57BL/6 mice during LPS 
challenge, this indicated that TNFα signalling was not playing a major role in the 
reduction of lymphocytes in the circulation. 
The monocyte number in Tnfr1-null mice (Figure 5.20C) also resembled that of 
C57BL/6 LPS injected mice. There were only minor changes observed throughout the 
study, which were observed as a significant decrease in the number of monocytes in 
male and female mice at 3.5 hours post LPS and an increase in the number of 
monocytes in male and female mice at 72 hours post LPS challenge compared to control 
values. Therefore, in the absence of TNFα signalling, no major changes were observed 
in the number of circulating monocytes or lymphocytes compared to C57BL/6 LPS 
injected mice, but TNFα could be involved in regulating the number of circulating 
granulocytes.  
We also looked at the number of circulating white blood cells in Ifngr1-null mice 
(Figure 5.21). Unlike in the absence of TNFα signalling, the number of granulocytes in 
male and female mice did not increase until 7 hours post LPS challenge (Figure 5.21A). 
In male mice the number of granulocytes increased further at 12 hours post LPS and the 
maximum amount of cells was reached (21.20 ± 5.00 x 109/l). This number was higher 
than LPS challenge in C57BL/6 and Tnfr1-null mice, suggesting that IFNγ may have 
been inhibiting the production and export of granulocytes from the BM to the periphery 
in male mice during LPS challenge. However in contrast, the number of granulocytes in 
female mice remained at a relatively constant level at 7, 12 and 24 hours post LPS 
(between 5.68 and 7.30 x 109/l cells). Therefore, this suggested that in female mice, the 
number of circulating granulocytes during LPS challenge was dependent on IFNγ 
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signalling. Therefore, these results suggested that IFNγ as well as TNFα, may also play 
a role in the mobilisation of granulocytes from the BM into the periphery. In addition, it 
appeared that the response to IFNγ and TNFα cytokines was different in male and 
female mice. A reduction in the number of granulocytes was observed at 72 hours in 
male and female mice.  
The number of lymphocytes in Ifngr1-null mice (Figure 5.21B) during LPS challenge 
was similar to that observed in C57BL/6 and Tnfr1-null mice in that there was a 
significant decline in the number of cells at 3.5 hours post LPS challenge in male (2.57 
± 0.62 x 109/l from 7.76 ± 0.68 x 109/l) and female mice (2.2 ± 0.27 from 11.92 ± 0.8 x 
109/l). Interestingly, the number of circulating lymphocytes increased in male mice at 7 
hours (8.55 ± 2.78 x 109/l) and 12 hours (9.27 ± 1.84 x 109) and these values were not 
significantly different to those of the control. However, the number of lymphocytes 
declined again at 24 hours post LPS and had recovered at 72 hours. These changes were 
not observed in female mice where the number of lymphocytes remained low and 
increased only at 72 hours.  
Similar to C57BL/6 and Tnfr1-null mice, there were no major changes observed in the 
number of monocytes in Ifngr1-null mice throughout the study (Figure 5.21C). 
We next analysed the number of circulating white blood cells in TNFα-neutralised 
Ifngr1-null mice (Figure 5.22). In contrast to C57BL/6, Tnfr1-null mice and Ifngr1-null 
mice, the number of granulocytes peaked in male (18.8 x 109/l) and female mice (7.3 x 
109/l) at 7 hours post LPS challenge (Figure 5.22A). In addition, similar to Ifngr1-null 
mice, the number of granulocytes in female mice remained lower than male mice 
throughout the study and ranged from 4.5 to 8.2 x 109/l between 7 and 72 hour time 
points. The number of granulocytes in male mice started to decline at 12 hours (12.25 ± 
9.85 x 109/l) and decreased further at 24 hours (6.35 ± 1.91 x 109/l). However, at 12 
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hours post LPS in all other mouse strains, the maximum number of cells was reached. 
Therefore, the increase in the number of circulating granulocytes during LPS challenge 
seemed to be taking place over a shorter time period in the absence of TNFα and IFNγ 
signalling, indicating key roles for both of these cytokines in LPS-induced 
inflammation.  
The number of lymphocytes in TNFα-neutralised Ifngr1-null mice (Figure 5.22B) was 
similar to that observed in the other mouse strains, in that the number of cells declined 
after LPS injection. In contrast to other mouse strains, the number of lymphocytes had 
not recovered by 72 hours post LPS. The number of monocytes also mirrored what was 
observed in the other mouse strains in that there were no major changes (Figure 5.23C). 
Therefore, this data indicate that TNFα and IFNγ were the key regulating elements for 
the mobilisation of granulocytes during LPS challenge. Although the number of white 
blood cells was not restored to wild type levels in any of the knock out strains during 
LPS challenge, mice deficient in IFNγ signalling and TNFα did recover at earlier time 
points in comparison to C57BL/6 injected mice.  
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Figure 5.20 
Number of circulating granulocytes, lymphocytes and monocytes in LPS injected 
Tnfr1-null mice at 0, 12, 24 and 72 hour time points. 
 
A Graph illustrating the number of circulating granulocytes in male (red line) and 
female mice (blue line), compared to control mice (black line). Data represents 
results from three independent experiments, using four mice (two male and two 
female) per time point. Significance was calculated using the Student’s T-test (p 
< 0.05). Values represent mean ± S.E.M. 
 
B Graph illustrating the number of circulating lymphocytes in male (red line) and 
female mice (blue line), compared to control mice (black line). Data represents 
results from three independent experiments, using four mice (two male and two 
female) per time point. Significance was calculated using the Student’s T-test (p 
< 0.05). Values represent mean ± S.E.M. 
 
C Graph illustrating the number of circulating monocytes in male (red line) and 
female mice (blue line), compared to control mice (black line). Data represents 
results from three independent experiments, using four mice (two male and two 
female) per time point. Significance was calculated using the Student’s T-test (p 
< 0.05). Values represent mean ± S.E.M. 
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Figure 5.21 
Number of circulating granulocytes, lymphocytes and monocytes in LPS injected 
Ifngr1-null mice at 0, 12, 24 and 72 hour time points. 
 
A Graph illustrating the number of circulating granulocytes in male (red line) and 
female mice (blue line), compared to control mice (black line).  Data represents 
results from three independent experiments, using four mice (two male and two 
female) per time point. Significance was calculated using the Student’s T-test (p 
< 0.05). Values represent mean ± S.E.M. 
 
B Graph illustrating the number of circulating lymphocytes in male (red line) and 
female mice (blue line), compared to control mice (black line). Data represents 
results from three independent experiments, using four mice (two male and two 
female) per time point. Significance was calculated using the Student’s T-test (p 
< 0.05). Values represent mean ± S.E.M. 
 
C Graph illustrating the number of circulating monocytes in male (red line) and 
female mice (blue line), compared to control mice (black line). Data represents 
results from three independent experiments, using four mice (two male and two 
female) per time point. Significance was calculated using the Student’s T-test (p 
< 0.05). Values represent mean ± S.E.M. 
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Figure 5.22 
Number of circulating granulocytes, lymphocytes and monocytes in LPS injected 
TNFα-neutralised Ifngr1-null mice at 0, 12, 24 hour time points. 
 
A Graph illustrating the number of circulating granulocytes in male (red line) and 
female (blue line) mice aged eight weeks of age, during steady state levels 
(black line) and after LPS challenge. Data represents results from three 
independent experiments, using one to two mice per time point. Significance 
was calculated using the Student’s T-test (p < 0.05). Values represent mean ± 
S.E.M. 
 
B Graph illustrating the number of circulating lymphocytes in male (red line) and 
female (blue line) mice aged eight weeks of age, during steady state levels 
(black line) and after LPS challenge. Data represents results from three 
independent experiments, using one to two mice per time point. Significance 
was calculated using the Student’s T-test (p < 0.05). Values represent mean ± 
S.E.M. 
 
C Graph illustrating the number of circulating monocytes in male (red line) and 
female (blue line) mice aged eight weeks of age, during steady state levels 
(black line) and after LPS challenge. Data represents results from three 
independent experiments, using one to two mice per time point. Significance 
was calculated using the Student’s T-test (p < 0.05). Values represent mean ± 
S.E.M. 
CHAPTER 5 
 280 
 
CHAPTER 5 
 281 
5.12 Serum levels of IFNγ and TNFα during LPS challenge 
To further investigate why stem and progenitor cell numbers in the BM and circulating 
granulocyte and lymphocyte numbers were not fully restored in anti-TNFα injected 
Ifngr1-null mice and to determine when the highest amounts of IFNγ and TNFα were 
released during LPS challenge, we measured the serum levels of TNFα and IFNγ in the 
different mouse strains. The levels of IFNγ and TNFα were assessed in LPS injected 
C57BL/6, Ifngr1-null and TNFα-neutralised Ifngr1-null mice (Figure 5.23).  
The levels of IFNγ (Figure 5.23A) in C57BL/6 control mice (26.8 ± 11.64 pg/ml) and 
control Ifngr1-null mice (12.13 ± 4.04 pg/ml) were relatively low, but levels of IFNγ 
were higher in control TNFα-neutralised Ifngr1-null mice (100.08 ± 56.33 pg/ml). This 
result indicated that neutralisation of TNFα caused an increase in IFNγ levels. 
At 12 hours post injection, the level of IFNγ remained constant in C57BL/6 mice (22.04 
± 6.48 pg/ml) but in Ifngr1-null mice and TNFα-neutralised Ifngr1-null mice, the levels 
of IFNγ increased significantly to 1001.20 ± 470.14 pg/ml and 1421.06 ± 163.06 pg/ml 
in comparison to levels at 0 hours.  
At 24 hours post LPS, the levels of IFNγ increased in C57BL/6 mice (68.69 ± 56.14 
pg/ml) compared to levels at 0 and 12 hours. This coincided with a decline in total BM 
cellularity, export of mature myeloid cells to the periphery, and a decrease in the 
number of LIN– cells, indicating that at 24 hours, IFNγ could be exerting the most 
severe effects. However, the levels of IFNγ decreased significantly in Ifngr1-null mice 
(74.89 ± 24.82 pg/ml). In TNFα-neutralised Ifngr1-null mice there was also a decrease 
in the level of IFNγ in the blood (991.76 ± 169.21), but not to the extent of Ifngr1-null 
mice. 
The level of TNFα in all mouse strains was low in unchallenged naïve controls (Figure 
5.23B). At 12 hours post injection however, the levels of TNFα increased significantly 
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in C57BL/6 mice (89.58 ± 12.29 pg/ml), Ifngr1-null mice (284.61 ± 92.27 pg/ml) and 
TNFα-neutralised Ifngr1-null mice (97.85 ± 12.37 pg/ml). The presence of TNFα in 
mice injected with anti-TNFα mAb might indicate that TNFα had not been completely 
blocked, although serum levels were reduced by 66% in comparison to Ifngr1-null 
mice. However, because only partial neutralisation occurred, this may have been one 
reason why lymphopoiesis was not completely restored in these mice. The level of 
TNFα in all strains at 24 hours were much reduced and at similar levels, but the largest 
decrease was observed in Ifngr1-null mice.  
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Figure 5.23 
Levels of IFNγ and TNFα in C57BL/6, Ifngr1-null and TNFα-neutralised Ifngr1-null 
mice at 0, 12 and 24 hours post LPS injection. 
 
A Graph illustrating the levels of IFNγ in C57BL/6, Ifngr1-null and 
TNFα-neutralised Ifngr1-null mice at 0, 12 and 24 hours post LPS injection. Six 
mice were analysed (three males and three females) per mouse strain at each 
time point.  
 
B Graph illustrating the levels of TNFα in C57BL/6, Ifngr1-null and 
TNFα-neutralised Ifngr1-null mice at 0, 12 and 24 hours post LPS injection. Six 
mice were analysed (three males and three females) per mouse strain at each 
time point. 
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5.13 Analysis of E. coli infection on haematopoietic progenitor 
compartments 
We next compared the effects of LPS challenge on the phenotype of haematopoietic 
progenitors to bacteria-induced septicaemia, by injecting heat-inactivated E. coli into 
C57BL/6 mice. Based on the study by Freudenberg et al (2001), we calculated that the 
number of E. coli cells which was equivalent to 40µg LPS was 1.5 x 109 cells. 
However, after i.p. injection of this amount of E. coli, mice died after just 12 hours. 
Therefore, we reduced the amount of E. coli cells injected into C57BL/6 mice by five 
fold to 3 x 108 cells. The parameters first measured were body temperature and the 
circulating RBC number (Figure 5.24A and B). In marked contrast to LPS injected 
C57BL/6 mice, we observed a severe hypothermia after E. coli injection. The onset of 
hypothermia started after just five hours (34.79 ± 0.47oC) and continued throughout the 
time course, reaching a minimum at 12 hours post infection (30.97 ± 1.61oC). Mice 
started to recover from this hypothermia after 15 hours (33.27 ± 0.62oC) and returned to 
normal body temperature by 72 hours (37.63 ± 0.15oC). We next looked into the blood 
at the number of circulating RBCs. As shown in Figure 5.24B, there was no effect of 
E. coli on the number of circulating RBCs compared to the water injected control mice. 
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Figure 5.24 
Body temperature and number of circulating RBCs in mice injected with E. coli, 
compared to LPS injected and water injected mice.  
 
A Graph illustrating the effect of E. coli on the body temperature of C57BL/6 male 
mice, aged eight weeks of age. Mice injected with E. coli (green line) were 
compared to LPS challenged (red line) and water injected mice (black line). 
Data are representative of one experiment, using three male mice per group. 
Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M. 
 
B Graph illustrating the effect of E. coli on the circulating RBC number of 
C57BL/6 male mice, aged eight weeks of age. Mice injected with E. coli (green 
line) were compared to LPS challenged (red line) and water injected mice (black 
line). The number of circulating RBCs did not enter outside of the physiological 
range during LPS challenge or E. coli infection, therefore no anaemia was 
observed. Data are representative of one experiment, using three male mice per 
group. Values represent mean ± S.E.M. 
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We next analysed the effect of E. coli infection on the composition of stem cells and 
progenitor cells (Figure 5.25). Similar to LPS challenge, there was an increase in the 
frequency of LSK cells 12 hours post E. coli infection, which remained after 24 hours 
and started returning to steady state levels by 72 hours. Subsequently, this lead to an 
increase in the number of LSK CD34+ Flk-2– cells (Figure 5.26A), a decrease in the 
frequency of LSK CD34+ Flk-2+ cells (Figure 5.26B) and a virtual absence of LIN– 
IL-7Rα+ Flk-2+ cells (Figure 5.26C). These results were identical to what was observed 
during injection of LPS. However, one obvious difference between E. coli infection and 
LPS challenge on haematopoietic progenitor cells was that, although the frequency of 
LSK cells increased after E. coli injection, there was little evidence for a contraction of 
LIN– c-kithi Sca-1– cells (Figure 5.25). Therefore, this indicated that expansion of the 
LSK compartment might have been due to an increase in the number of both LT-HSCs 
and ST-HSC cells. To further investigate this, we calculated the number of LT-HSCs, 
which are upstream of ST-HSCs and would proliferate and differentiate in response to a 
surplus requirement for ST-HSCs. In contrast to LPS challenge, there was a significant 
increase in the number of LT-HSCs (Figure 5.27), 12 and 24 hours post E. coli infection 
in comparison to the control, which had returned to steady state levels by 72 hours. This 
indicated that LT-HSCs and ST-HSCs populations were proliferating and differentiating 
rapidly during E. coli infection and indicated that the inflammatory response must have 
been more severe than with LPS challenge.  
In order to further investigate this, we measured the levels of IFNγ and TNFα in the 
serum after E. coli injection and compared these values to LPS injected C57BL/6 mice, 
LPS injected Ifngr1-null mice and LPS injected TNFα-neutralised Ifngr1-null mice 
(Figure 5.28). We found that after 12 hours, the levels of IFNγ in the serum after E. coli 
infection (Figure 5.28A) in C57BL/6 mice (1967.9 ± 416.63 pg/ml) were 90 fold higher 
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than in LPS injected C57BL/6 mice (22.04 ± 6.48 pg/ml). The amount of IFNγ in E. coli 
infected mice at 12 hours was also higher than in LPS injected Ifngr1-null mice and 
TNFα-neutralised Ifngr1-null mice. The level of TNFα in the serum was also much 
higher during E. coli infection (Figure 5.28B). After 12 hours, TNFα levels in E. coli 
infected C57BL/6 mice (400.78 ± 91.86 pg/ml) were almost five fold higher than in 
LPS injected C57BL/6 mice (89.58 ± 12.29). The amount of TNFα in E. coli infected 
mice at 12 hours was also higher than in LPS injected Ifngr1-null mice and 
TNFα-neutralised Ifngr1-null mice. Therefore, these data indicate that during E. coli 
infection there was a stronger inflammatory response which was characterised by 
increased levels of both IFNγ and TNFα cytokines in the serum compared to LPS 
injected mice. Consequently, this may have been the reason that a significant increase in 
LT-HSC and ST-HSC cell number was observed, indicative of induced proliferation 
and differentiation of these subsets in order to clear the infection.  
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Figure 5.25 
Frequency of haematopoietic progenitor compartments during E. coli infection in the 
BM of C57BL/6 mice.  
 
FACS plots illustrating the frequency of haematopoietic progenitor populations during 
E. coli infection in the BM of C57BL/6 mice, aged eight weeks of age. Mice were 
analysed at 0, 12, 24 and 72 hour time points and assessed for their expression of cell 
surface markers. Data is representative of one experiment using three male mice per 
time point.    
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Figure 5.26 
Number of haematopoietic progenitor cells during E. coli infection in C57BL/6 mice. 
 
A Graph illustrating the number of LSK CD34+ Flk-2– cells at 0, 12, 24 and 72 
hours post E. coli infection in C57BL/6 mice, aged eight weeks of age. Data is 
representative of one experiment using three male mice per time point. 
Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M. 
 
B Graph illustrating the number of LSK CD34+ Flk-2+ cells at 0, 12, 24 and 72 
hours post E. coli infection in C57BL/6 mice, aged eight weeks of age. Data is 
representative of one experiment using three male mice per time point. 
Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M. 
 
C Bar graph illustrating the number of LIN– IL-7Rα+ Flk-2+ cells at 0, 12, 24 and 
72 hours post E. coli infection in C57BL/6 mice, aged eight weeks of age. Data 
is representative of one experiment using three male mice per time point. 
Significance was calculated using the Student’s T-test (p < 0.05). Values 
represent mean ± S.E.M.  
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Figure 5.27 
Number of LT-HSCs during E. coli infection in C57BL/6 mice. 
 
Graph illustrating the number of LSK CD150+ CD48– cells at 0, 12, 24 and 72 hours 
post E. coli infection in C57BL/6 mice, aged eight weeks of age. Data is representative 
of one experiment using three male mice per time point. Significance was calculated 
using the Student’s T-test (p < 0.05). Values represent mean ± S.E.M.  
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Figure 5.28 
Serum levels of IFNγ and TNFα during E. coli infection in C57BL/6 mice. 
 
A Graph illustrating the levels of IFNγ in C57BL/6, Ifngr1-null, TNFα-neutralised 
Ifngr1-null mice and E. coli infected mice (red bars) at 0, 12 and 24 hours post 
LPS injection. Six mice were analysed (three males and three females) in LPS 
injected mice and three male mice were analysed in E. coli infected mice at each 
time point.  
 
B Graph illustrating the levels of TNFα in C57BL/6, Ifngr1-null, TNFα-neutralised 
Ifngr1-null mice and E. coli infected mice (red bars) at 0, 12 and 24 hours post 
LPS injection. Six mice were analysed (three males and three females) in LPS 
injected mice and three male mice were analysed in E. coli infected mice at each 
time point. 
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5.14 Discussion 
During homeostatic conditions, development of HSCs into fully functional mature cells 
occurs by differentiation of cells into the myelo-erythroid or lymphoid lineages. The 
myeloid lineage produces cells which form the innate immune response and which act 
at the front line of defence upon encounter of a pathogen, whilst the lymphoid lineage 
encompasses cells of the adaptive immune system, which are activated by innate 
immune cells in order to provide a stronger defence. In order for haematopoiesis to 
occur, HSCs must respond to extracellular cues, such as cytokines present in the BM 
stroma, which enables differentiation down a particular lineage. Some well studied 
examples of cytokines which promote lymphoid development are Flk-2 ligand and IL-7 
whilst GM-CSF favours myeloid differentiation. However, during infection, 
pro-inflammatory cytokines such as IFNγ and TNFα are produced by innate immune 
cells that can also influence HSC differentiation. IFNγ is produced by NK (Kasahara et 
al., 1983), CD4 Th1 and CD8 cytotoxic lymphocytes (Shtrichman and Samuel, 2001). 
Some publications have reported that IFNγ inhibits haematopoiesis (Raefsky et al., 
1985; Zoumbos et al., 1984; Neumann et al., 1982; Selleri et al., 1996). In contrast, 
Brugger et al. (Brugger et al., 1993) stated that IFNγ was able to promote the expansion 
of peripheral blood CD34+ progenitor cells by two fold in combination with SCF, IL-1, 
IL-3, IL-6 and erythropoietin. In addition, Caux and colleagues (Caux et al., 1992) and 
Yang et al., (Yang et al., 2005) reported that IFNγ was capable of stimulating early 
stage myelopoiesis in vitro. Therefore, IFNγ appears to exert both proliferative and 
inhibitory effects on haematopoiesis. The role of IFNγ during an acute infection was 
addressed in our laboratory using mouse malaria as a model (Belyaev et al., 2010). It 
was observed that during peak parasitaemia, there was a contraction in the frequency 
and number of LIN– c-kithi Sca-1– cells, but an expansion in the LSK compartment. 
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Interestingly, these LSK cells also expressed the FcγRII/III antigen and cells positive 
for this marker were able to give rise to myeloid progeny in vitro. Therefore, it appeared 
that myeloid progenitors had upregulated Sca-1 on their surface and were now residing 
in the LSK compartment. Interestingly, the number of LT-HSCs remained unchanged. 
In addition, there was also a contraction in CLPs accompanied by a subsequent loss of 
pro and pre B-cells. However, a new population of LIN– c-kithi IL-7Rα+ ‘atypical’ cells 
emerged during infection which was able to give rise to both lymphoid and myeloid 
progeny in vitro, but mainly myeloid cells in vivo. In addition, these ‘atypical’ 
progenitors expressed Mpo, a gene expressed in myelocytes and neutrophilic 
granulocytes and Cebpα, a master regulator for myelopoiesis. Therefore, although these 
cells expressed a functional IL-7 receptor they predominantly generated myeloid cells. 
These observed changes were dependent on IFNγ as during infection in Ifngr1-null 
mice, there was no observed upregulation of Sca-1 on myeloid progenitor cells, the CLP 
pool remained stable and there was no emergence of ‘atypical progenitors’. These 
results indicate that myelopoiesis was favoured during malaria infection at the expense 
of lymphoid development.  
Similar results were also reported by Zhang and co-workers who investigated the effect 
of E. coli on haematopoiesis in vitro (Zhang et al., 2008). This group observed an 
expansion of the LSK compartment after E. coli infection and a subsequent reduction in 
the LIN– c-kithi Sca-1– fraction. The authors concluded that LIN– c-kithi Sca-1– cells 
were inverting their phenotype and forming part of the LSK pool of cells. Although 
LPS, TNFα, IL-6 and IFNγ were all reported to be able to induce the conversion of 
LIN– c-kithi Sca-1– cells into LSK cells, the precise mechanism was not addressed. In 
summary, these results suggested that during infection, whereby the innate immune 
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response was required for clearance of the pathogen, lymphopoiesis was temporarily 
halted and myelopoiesis augmented.  
Singh and colleagues (Singh et al., 2005), in addition to Belyaev and colleagues 
(Belyaev et al., 2010) and Zhang et al., (Zhang et al., 2008) also reported an increase in 
the number of LSK cells after VV infection and a decrease in the number of LIN– c-kithi 
Sca-1– cells. Furthermore, CD34+ cells in the LSK compartment, representing ST-HSC 
cells during homeostatic conditions, were primarily expanded during infection. In 
contrast to malaria and E. coli infection however, the authors observed an increase in 
the frequency and number of the CLP population. Whereas the increase in the CLP 
compartment was attributable to TLR4 signalling, as Myd88-null mice did not show 
increased CLP numbers, the observed decline in the frequency of myeloid progenitors 
was not changed during infection in Myd88-null mice. Therefore, the authors suggested 
that these results illustrated independent regulation of CMP and CLP compartments 
during VV infection. Therefore, although these studies have suggested that 
haematopoiesis can be ‘remodelled’ during infection, our understanding of the 
mechanisms involved are by no means complete. We aimed to further elucidate the 
process of haematopoiesis during inflammatory conditions by administration of LPS. 
The first evidence for an innate immune response elicited by LPS was observed during 
analysis of circulating white blood cells. There was an observed increase in the number 
of circulating granulocytes and a decrease in the number of circulating lymphocytes. 
These circulating granulocytes would be predominantly neutrophils, which are recruited 
to the site of infection by chemokines and cytokines (Gomez et al., 2008). LPS is bound 
by a TLR4-containing complex which is present on macrophages and DCs and also on 
haematopoietic progenitor cells (Nagai et al, 2006). During the binding of LPS to TLR4 
on macrophages, TNFα is released, which recruits neutrophils, elevates their 
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bactericidal capacity (Chilvers et al., 2000) and increases their life span. Furthermore, 
the release of TNFα is thought to act as a trigger for the upregulation of IL-8 expression. 
IL-8 is a central mediator of inflammation which induces the transmigration of 
neutrophils across endothelial barriers and to the site of infection (Baggiolini et al., 
1989). Our results indicated that TNFα played a pivotal role in recruitment of 
granulocytes, as Tnfr1-null mice had a reduced number of circulating cells compared to 
LPS-injected C57BL/6 mice. We also found that there was a decrease in the frequency 
of BM-derived myeloid cells during LPS challenge, which also indicated that these cells 
had been exported to the periphery.  
In contrast to increasing granulocyte number, there was a severe decrease in the number 
of circulating lymphocytes. This is in agreement with studies showing that B-cells are 
markedly depleted following endotoxin (Chandra et al., 2008) and sepsis challenges 
(Remick et al., 2000). Although it is thought that IFNγ can cause inhibition of B-cell 
development, as over expression of IFNγ leads to severe B-cell lineage reduction 
(Young et al., 1997; Grawunder et al., 1993) as well as NK–cell development 
deficiencies (Shimozato et al., 2002), we observed only minor increases in the number 
of circulating lymphocytes after LPS administration in Ifngr1-null mice. On the other 
hand, there have been some studies suggesting TNFα can have an indirect inhibitory 
effect on B-lineage development (Ueda et al., 2004; Sedger et al., 2002). Ueda and 
colleagues demonstrated that TNFα reduced the level of the chemokine CXCL12 in the 
BM and this coincided with lymphocyte depletion and mobilisation of B-cell 
progenitors into the blood; and that Tnfα-deficient mice showed much reduced BM 
lymphopenia. Our results demonstrated that TNFα alone was not the cause of 
lymphopenia in the circulation as LPS challenge in Tnfr1-null mice did not alter the 
circulating lymphocyte number compared to LPS-injected C67Bl/6 mice. Our data 
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suggests that the observed decrease in number could have been due to either homing of 
lymphocytes into peripheral organs, a loss of lymphoid progenitor cells or cell death. 
We did observe an increase in the frequency of BM B-cells at 24 hours post LPS 
challenge, which could have indicated some homing of circulating lymphocytes to the 
BM. However, these cells were completely depleted at 72 hours after injection. Similar 
declines in BM B-cell numbers have also been observed upon cecal ligation (Scumpia et 
al., 2010) and during in vitro LPS stimulation where LSK cells developed only into 
mature Gr1+ CD11b+ cells and not B-cells (Nagai et al., 2006). Taking into 
consideration that there was a vast increase in the number of granulocytes, at the 
expense of lymphocytes in the blood, we next looked at BM progenitor cells. 
We found that there was a significant decrease in the total number of LIN– cells, 12 and 
24 hours post LPS challenge. This was attributable to the virtual depletion of LMPP, 
ELP and CLP cells. At 12 and 24 hours post LPS, the frequency and number of LMPP, 
ELP and CLP populations were markedly reduced. This in turn could have been one 
reason for the loss of mature lymphocyte numbers observed in the circulation. There 
were several possible reasons for the loss of these cells; lymphoid progenitor cells may 
have re-directed into an alternative lineage; pro-inflammatory cytokines may have 
caused inhibition of lymphopoiesis; the downregulation of cell surface markers by 
which lymphoid progenitors are identified; or cells may have apoptosed. This data was 
in contrast to the effects observed during Mycobacterium avium infection (Baldridge et 
al., 2010) and herpes virus infection (Welner et al, 2008) where the number of CLP 
cells increased or remained constant. These reports indicated that clearance of 
Mycobacterium avium or Herpes Virus relied on the responses of both the innate and 
adaptive immune systems. 
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We addressed whether ELP and CLP progenitor cells had been re-directed into the 
myeloid lineage utilising Rag1wt/Cre x R26Rwt/eYFP mice which label lymphoid 
progenitors with eYFP fluorescence after activation of Rag1 at the ELP stage of 
development. There have been some reports whereby re-direction of lymphoid 
progenitor cells into the myeloid lineage has occurred (Kondo et al., 2000; Iwasaki et 
al., 2000; Xie et al., 2004). However, we found that eYFP+ lymphoid progenitors did 
not re-direct into the myeloid lineage as there was no evidence for a significant increase 
in the expression of eYFP in BM or splenic mature myeloid cells throughout LPS 
challenge. However, Nagai and colleagues (Nagai et al., 2006) reported that CLPs 
placed in serum free culture produced CD11b+ Gr1– CD11c+ DCs after administration 
of LPS. Therefore, it is possible that CLPs could have differentiated into DCs and 
exited the BM.   
We also observed the effect of TNFα and IFNγ cytokines on the inhibition of lymphoid 
progenitor development. We found that although the frequency and number of LMPP 
and CLP populations were not completely restored during analysis of TNFα-neutralised 
Ifngr1-null mice, the frequency and number of cells did return to homeostatic levels in a 
shorter time period. However, because antibody treatment did not completely remove 
the cytokine from the circulation, TNFα could still have been inducing an inhibitory 
effect. In addition to TNFα and IFNγ, other cytokines may also have been involved in 
the block of lymphopoiesis. It has previously been reported that IFNα and IFNβ, which 
can be released from BM macrophages, have been shown to inhibit IL-7 dependent 
proliferation of BM cells in vitro (Wang et al., 1995). 
During analysis of haematopoietic progenitor populations, it was clear that Flk-2 and 
IL-7Rα cell surface markers were downregulated during LPS challenge. This may have 
been due to a reduced secretion of IL-7 cytokine and Flk-2 ligand which promote 
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lymphoid development and an increase in cytokines promoting myeloid development, 
such as GM-CSF. Therefore there may not have been any physiological requirement for 
these markers to be present on progenitor cells.  
Cell death of lymphoid progenitors could have been another reason for the virtual 
absence of LMPP and CLP populations. It was reported in 1995 (Maciejewski et al., 
1995) that activation of Fas antigen on stem and progenitor cells could occur by both 
IFNγ and TNFα cytokines, which subsequently leads to transduction of a cell death 
signal. Therefore, because both TNFα and IFNγ cytokines levels were increased in the 
serum during LPS challenge, activation of Fas antigen on LMPP and CLP populations 
may have occurred. This may also have occurred on B-cells and myeloid progenitors, 
other cell populations which reduced in number after LPS challenge. 
We also analysed more thoroughly the composition of the LSK compartment where 
LMPPs and HSCs were defined. We found that there was a significant increase in both 
the frequency and number of LSK cells after LPS injection, which seemed to be at the 
expense of LIN– c-kithi Sca-1– cells. This same result was also reported in 2010 by 
Scumpia et al., who injected either LPS, induced cecal ligation and puncture to induce 
bacterial sepsis, or administered Staphylococcus aureus infection and observed a 
transient expansion of LSK cells. In addition, other models of inflammation including 
malaria (Belyaev et al., 2010), VV (Singh et al., 2005), HCMV (Gibbons et al., 1995), 
Pseudonomas aeruginosa (Rodriguez et al., 2009) and E. coli infection (Zhang et al., 
2008) also induced LSK expansion, whilst other pathogens such as Anaplasma 
phagocytophilum (Johns et al., 2009) diminished LSK numbers. Our results indicated 
that myelo-erythroid progenitor cells residing in the LIN– c-kithi Sca-1– fraction had 
upregulated Sca-1 on their surface. This was evident due to observed FcγRII/III 
expression in LIN– c-kithi cells which included LSK cells. Consequently, there was a 
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significant increase in the frequency and number of LSK CD34+ Flk-2– cells; which 
could encompass ST-HSC, CMP and GMP populations during LPS challenge. However 
there was also a reduction in the number of LIN– c-kithi FcγRII/II+ GMP cells, similar to  
results obtained during malaria (Belyaev et al., 2010) and murine cytomegalovirus 
(MCMV; Broxmeyer et al., 2007) infection. This decrease in myeloid progenitor 
number may have been attributable to the direct effects of IFNγ (Murphy et al., 1986; 
Broxmeyer et al., 1983) and TNFα (Broxmeyer et al., 1986) seeing as though previous 
reports have illustrated an inhibitory effect of both these cytokines on myeloid 
progenitor growth. In addition, overexpression of Sca-1 has also been shown to 
decrease myeloid colony forming units in vitro (Bradfute et al., 2005).  
In order to verify whether the increase in LSK CD34+ Flk-2– populations was due to a 
surplus requirement of ST-HSCs during LPS challenge, we calculated the number of 
LT-HSC, as these cells feed directly into the ST-HSC pool. We deduced that there was 
no change in the number of LT-HSCs throughout LPS challenge. Therefore, it appeared 
that Sca-1 expression on LIN– c-kithi Sca-1– myeloid progenitor cells was the main 
reason for the increase in the LSK CD34+ Flk-2– population. Due to the lack of 
lymphoid cells during LPS challenge, but a requirement for myelopoiesis, Sca-1 may 
have somehow been advantageous to the host in amplifying this process. 
Sca-1 is a glycosyl phosphatidylinositol-anchored cell surface protein which is also 
found on mesenchymal stem cells (Baddoo et al., 2003) and has been shown to be 
necessary for normal HSC activity. This has been illustrated in Sca-1 knock out mice 
which presented defects in the short term serial transplantation of HSCs (Ito et al., 
2003) and has lead to the idea that Sca-1 is important for stem cell proliferation and 
self-renewal. Members of the interferon family have been reported to modify the 
expression of Sca-1; on T-cells (Dumont et al., 1987) and B-cells (Chen et al., 2003) by 
CHAPTER 5 
 306 
IFNγ and on LT-HSCs by IFNα (Essers et al., 2009). We determined that, although the 
TNFα cytokine was not completely blocked in TNFα-neutralised Ifngr1-null mice, the 
number and frequency of Sca-1 levels in LIN– c-kithi cells were completely restored 
back to wildtype levels. This indicated that both IFNγ and TNFα cytokines were 
involved in the modulation of Sca-1 expression, but we found that the phenotype was 
mostly reduced in the absence of IFNγ signalling, indicating that IFNγ was exerting the 
most pronounced effect. Belyaev and colleagues (Belyaev et al., 2010) did report that 
receptors for this cytokine were present on all haematopoietic progenitor cell types and 
Nagai and co-workers (Nagai et al., 2006) found that LSK cells in vitro acquired the 
IFNγR in response to LPS within 24 hours, allowing these cells to respond to the 
cytokine. Similar results were also reported by Zhao et al, (2010). This group studied 
the effect of IFNγ on haematopoietic progenitor cells in vitro and demonstrated that 
addition of IFNγ to a culture containing LIN– c-kithi Sca-1– cells, resulted in a 
conversion of their phenotype to resemble LSK cells.   
Because Sca-1 expression on myeloid cells was reduced completely in 
TNFα-neutralised Ifngr1-null mice, we presumed that all lymphoid progenitor cells 
could be identified by their classical phenotypes. Interestingly, we found that the 
number of ST-HSCs increased significantly 12 and 24 hours post LPS injection, the 
number of LMPP cells decreased at 12 hours but had recovered by 24 hours, and the 
number of CLP cells also reduced at 12 hours. Due to both IFNγ and to a certain extent 
TNFα signalling pathways been inhibited, the effects which we observed may have been 
due to either partial neutralisation of TNFα, an involvement from other cytokines, or 
LPS acting directly on haematopoietic progenitor cells. Due to the absence of IFNγ 
signalling during LPS challenge, it could be possible that there is redundancy between 
the IFNγ, IFNα and IFNβ genes and these cytokines are inhibiting lymphopoiesis. 
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Indeed, both IFNγ and IFNα have been shown to elicit similar function in stimulating 
HSCs in vivo during Mycobacterium avium infection (Baldridge et al., 2010), so they 
may both exert inhibitory effects on downstream progenitors.  
LPS has also been reported to act directly on haematopoietic cells. Nagai and colleagues 
reported that TLR4 receptors were present on the surface of HSCs, all LIN– c-kithi 
progenitors and to a lesser extent CLPs, which enables progenitor cells to detect 
infection and respond immediately. Therefore, activation of this pathway may have lead 
to a change in progenitor cell number. Indeed Scumpia et al, (Scumpia et al., 2010) 
reported that LPS-induced expansion of the LSK compartment in vivo was absent in 
TLR4 mutant C3H/HeJ mice and this may also be the case for LMPP and CLP 
reduction. In order to fully analyse whether TLR4 signalling was causing this effect, 
TNFα-neutralised Ifngr1-null mice crossed to the C3H/HeJ background or 
TLR4-deficient mice would need to be analysed.  
We next compared LPS challenge to true septicaemia by infecting C57BL/6 mice with 
the whole E. coli bacterium. We initially injected mice with the amount of E. coli cells 
equivalent to the concentration of LPS used, however these mice died after just 12 
hours, therefore illustrating that the full bacterium was exerting more severe 
inflammatory effects. Incidentally, we reduced the number of E. coli cells injected and 
found that there was a severe hypothermia throughout the time course. One possibility 
is that E. coli infection was causing vasodilation of arterial walls, which subsequently 
lead to a loss of heat and a decrease in body temperature. However, identical to LPS 
challenge, no anaemia was observed. The frequency and number of LSK CD34+ Flk-2– 
cells had also increased after infection which was coupled with a decrease in the 
frequency and number of LSK CD34+ Flk-2+ and LIN– IL-7Rα+ Flk-2+ cells. The 
increase in the LSK CD34+ Flk-2– fraction of cells, which encompassed ST-HSC, CMP 
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and GMP during LPS challenge, did not appear to contain myeloid progenitors, as there 
was no obvious upregulation of Sca-1 on these cells. Therefore, the increase in the LSK 
compartment during E. coli may have been due to an increased requirement of 
ST-HSCs. To verify this, we analysed the number of LT-HSCs. In contrast to LPS 
challenge, we found that the number of LT-HSCs increased significantly throughout the 
time course. This result was identical to what was reported during polymicrobial sepsis 
(Scumpia et al., 2010) and during Mycobacterium avium infection (Baldridge et al., 
2010), suggesting that the immune defence against bacteria requires an increase in 
LT-HSC number. This indicated that a higher proliferation and differentiation of 
LT-HSCs and ST-HSCs was necessary during E. coli infection than during LPS 
challenge. In order to test whether this was due to a higher level of pro-inflammatory 
cytokines being released from innate cells, we measured the level of IFNγ and TNFα in 
the serum of E. coli infected mice. We found that the levels of both IFNγ and TNFα in 
the serum of mice were significantly higher than during LPS challenge in C57BL/6 
mice. Therefore, these results suggest that LPS challenge could reflect in part how the 
immune system responds to gram negative bacteria, however injection of the full 
bacterium elicited a stronger inflammatory response. 
We have shown that during host recognition of LPS or E. coli, an innate immune 
response is activated, which in turn leads to the production of pro-inflammatory 
cytokines, namely IFNγ and TNFα. Release of these cytokines induces ‘haematopoietic 
remodelling’ whereby lymphopoiesis is transiently switched off and conversely myeloid 
cells are augmented. This illustrates that there is a certain degree of plasticity within the 
haematopoietic system such that development of cells alters in order to benefit the host, 
already at the level of progenitors. During this transition, IFNγ and to a lesser extent 
TNFα exert inhibitory effects on the size and composition of progenitor pools, limiting 
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the amount of mature cells which can be produced. This subsequently leads to an 
increased production of cells once the pathogen has been cleared. Most importantly 
however, is the finding that almost immediately after infection with either LPS or        
E. coli, haematopoietic progenitor cells are able to directly respond to bacteria, inducing 
phenotypic changes which ultimately lead to restoration of homeostasis.  
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Determining the pathways of lymphoid development and factors which influence them, 
is of crucial importance in order to fully understand haematopoiesis and use this 
knowledge to increase the effectiveness of peoples’ immune systems. In this study, we 
aimed to investigate lymphoid development from BM progenitors to mature 
lymphocytes in conjunction with age, gender and infection. An important issue which 
remains unclear during lymphoid development, at steady state levels, is the identity of 
BM-derived progenitors which give rise to T- and B-cells. Determining the source of 
“thymic seeding cells” is essential, as transplanting these cells into patients with HIV, 
who have a deficiency in CD4+ T-cells, would enable a more efficient development of 
T-cells. In addition, the identification of transcription factors specifying lymphoid 
commitment is of importance as aberrant differentiation of these factors may be the 
cause of some leukaemias. Many groups have aimed to elucidate the identity of “thymic 
seeding cells”. Results from Ikaros ‘knock-out’ mice favoured ELP and LMPP 
populations as pre-thymic candidates (Allman et al., 2003), whilst transplantation and in 
vitro experiments comparing the developmental potential of lymphoid progenitors in 
comparison to ETPs, have suggested roles for LMPP, ELP and CLP populations (Lai 
and Kondo, 2007; Wada et al., 2008; Bell and Bhandoola, 2008; Serwold et al., 2009). 
However, there has been a lack of studies whereby reporter mice have been used to map 
lymphoid development from early progenitors to ETPs. We attempted to address this by 
monitoring lineage development in Rag1-driven Cre reporter mice, a gene whose 
expression is indispensable for lymphoid development.  
On analysis of Rag1wt/Cre x Rosa26wt/eYFP mice we found that the CLP population was 
heterogeneous with respect to eYFP expression, in agreement with other published data 
(Welner et al., 2009; Månsson et al., 2010). This indicated that the CLP population must 
have descended from two phenotypically different progenitor pools, an eYFP+ subset 
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such as the ELP, and an eYFP– subset, such as the LMPP. In order to identify 
progenitors which give rise to ETPs and pre-pro B-cells, we analysed eYFP expression 
in these compartments and correlated them with expression in BM progenitor cells. 
Although previous expression in Rag1wt/Cre x Rosa26wt/tdRFP mice has been reported in 
early lymphoid compartments (Welner et al., 2009), tdRFP expression in ETP and 
pre-pro B-cell subsets to determine the source of T- and B-cells was not studied. 
Therefore, we provide new data showing that approximately 75% of ETPs express 
eYFP, indicating that this population is derived predominantly from ELP or eYFP+ CLP 
subsets, with some contribution from eYFP– CLPs. These results can be correlated with 
those of Schlenner and colleagues (Schlenner et al., 2010) who found that the majority 
of ETPs had previously expressed il7rα transcripts throughout their development, 
indicative of ELP and CLP populations. In addition, although the B-lineage potential of 
marked and unmarked CLP populations from Rag1Cre-reporter mice have been analysed 
in vitro (Welner et al., 2009; Månsson et al., 2010), a direct comparison of B- and T-cell 
potential between ELP, CLP eYFP– and CLP eYFP+ populations has not been reported 
in vivo or in vitro. In our hands, comparative in vivo analysis of ELP, CLP eYFP– and 
CLP eYFP+ populations revealed that all subsets had the potential to give rise to splenic 
T-cells with similar kinetics and numbers, suggesting that all three populations were 
potential ‘thymic seeding cells’. In addition, all three populations expressed similar 
mRNA and protein levels of the transcription factor GATA-3, which is important for 
T-cell fate specification (Ting et al., 1996; Hattori et al., 1996; Hendriks et al., 1999). 
With regards to putative B-cell potential, similar to results obtained utilising Rag1GFP 
mice (Esplin et al., 2009), we found that approximately 88% of pre-pro B-cells 
expressed eYFP. In vivo transplantation experiments revealed that CLP eYFP+ and ELP 
populations gave rise to a higher number of splenic B-cells than the CLP eYFP– pool, 
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data which is so far unpublished. In addition, the CLP eYFP+ pool seemed to proliferate 
more extensively than either the CLP eYFP– or the ELP pool in vitro, whereas the CLP 
eYFP– and ELP pools exhibited similar kinetics of B-lineage development, suggesting 
that these populations were upstream precursors of the CLP eYFP+ pool and at similar 
stages of development. Interestingly, the CLP eYFP– pool first had to express eYFP 
before upregulation of CD19, indicative of a precursor-product relationship between the 
CLP eYFP– and CLP eYFP+ pools. In order to fully assess the proliferative rate of the 
ELP, CLP eYFP– and CLP eYFP+ populations, isolation of these subsets and labelling 
of the cells with CFSE would provide valuable information as to whether these 
populations are truly distinct. 
Based on lineage mapping data, transplantation experiments and in vitro culture of 
lymphoid progenitor subsets, we propose an alternative model of lymphoid 
development, whereby cells develop from HSCs into LMPPs and ELPs which is 
immediately followed by a bifurcation into two developmental pathways. Based on 
eYFP expression, we presumed that eYFP– LMPP cells were able to give rise to eYFP– 
CLP cells, whilst ELP cells produced eYFP+ CLPs. In addition, we also determined that 
that the upregulation of eYFP on CLP cells was coupled with a down regulation of c-kit 
expression, in agreement with Esplin and colleagues (Esplin et al., 2009). This result 
was also similar to what was observed by Inlay and co-workers (Inlay et al., 2009) who 
utilised Ly6D expression to separate the CLP population into two distinct subsets. They 
also found that as CLPs upregulated Ly6D, they downregulated c-kit. Therefore, we 
assumed that throughout B-cell development, both eYFP and Ly6D markers could be 
used to define heterogeneity within the CLP pool. We proposed that eYFP– and eYFP+ 
CLP populations acquired the expression of both eYFP and Ly6D during B-cell 
development so that B-lineage committed CLP cells were eYFP+, Ly6D+.  
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In relation to T-cell development, because ETP cells express low levels of Ly6D (Inlay 
et al., 2009) we proposed that only Ly6D– ELP and CLP populations could give rise to 
ETPs. In order to verify these statements, isolation and functional analysis of the CLP 
subsets, utilising both eYFP and Ly6D markers, for T- and B-cell potential may provide 
further insight into which cells are the main progenitors for T- as well as B-cells. 
In order to further deduce the sequence of lymphoid development and to assess any 
potential developmental plasticity between lymphoid and myeloid lineages, we analysed 
haematopoiesis during acute inflammation. The phenotype and function of 
haematopoietic progenitor cells has been shown to be altered during malaria (Belyaev et 
al., 2010), VV (Singh et al., 2006), Mycobacterium avium (Baldridge et al., 2010) and 
Staphylococcus aureus infection (Scumpia et al., 2010). However, the effects of LPS 
and E. coli on haematopoietic progenitor cells have not been well studied. Nagai and 
colleagues (Nagai et al., 2006) found that CLP cells could be directed towards a DC fate 
during LPS challenge in vitro and Scumpia and colleagues (Scumpia et al., 2010) 
reported an increase in the frequency and number of LSK cells during LPS challenge in 
vivo, however additional phenotypic alterations and the mechanisms responsible were 
not elucidated. In addition, E. coli-induced changes on haematopoiesis have been 
vaguely reported by only one group (Zhang et al., 2008). We provide new data which 
critically addresses the effect of both LPS and E. coli infection on progenitor and 
mature cell composition in vivo, thereby enhancing our understanding of the 
haematopoietic response to these infections in every day life. 
During administration of LPS and E. coli, we found there was a cessation of 
lymphopoiesis, but an augmentation of myelopoiesis. A loss of BM-derived B-cells was 
coupled with a virtual absence of ELP and CLP cells, further clarifying these progenitor 
populations as sources of pre-pro B-cells. This loss was also reflected by a reduction in 
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the number of circulating lymphocytes. During LPS challenge, we utilised the Rag1wt/Cre 
x Rosa26wt/eYFP reporter to assess any potential re-direction of lymphoid cells into the 
myeloid lineage. However, we found no evidence of re-direction, suggesting the loss of 
lymphoid cells was due to the downregulation of cell surface markers or apoptosis. 
In contrast, during LPS challenge, there was an increase in myelopoiesis, as evident by 
the increased number of circulating granulocytes and the mobilisation of BM myeloid 
cells into the blood. We also observed phenotypic alterations within the myeloid 
progenitor compartment. LPS injected LIN– c-kit+ Sca-1– CD34+ myeloid cells 
upregulated Sca-1 on their surface, thus residing within the LSK compartment. 
Subsequently, this resulted in a decrease in the number of LIN– c-kit+ Sca-1– cells and 
an increase in the number of LSK CD34+ cells. Interestingly, there was no change in the 
number of LT-HSCs during LPS challenge. In the absence of IFNγ signalling and the 
neutralisation of TNFα, Sca-1 levels were restored to control levels on myeloid 
progenitor cells, subsequently resolving the frequency and number of LIN– c-kithi 
Sca-1– and LSK cells. This was evident even though TNFα was only partially 
neutralised. However, the frequency and number of lymphoid progenitors did not fully 
revert back to steady state levels, indicating that TNFα and IFNγ are not the only 
cytokines responsible for the loss of lymphoid progenitor cells during LPS challenge. 
These results are indicative for a high degree of plasticity within haematopoietic 
progenitor compartments during inflammation. To identify whether lymphopoiesis was 
not resolved due to only partial neutralisation of TNFα, it would be useful to analyse 
lymphoid progenitor populations during LPS challenge in Ifngr1/Tnfr1-null mice. This 
would definitively identify whether TNFα was responsible for the observed reduction in 
lymphoid progenitor numbers during LPS challenge. 
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We also compared the effects of E. coli infection to LPS challenge and found that 
although there was still a rise in the frequency and number of LSK cells, this was 
attributable to an increased production of LT-HSCs, as opposed to the upregulation of 
Sca-1 on myeloid progenitors during LPS challenge. This indicated that during an acute 
inflammatory response induced by LPS, homeostasis was regulated at the level of 
haematopoietic progenitors, whereas during a more chronic infection with E. coli, there 
was also a modulation in the stem cell compartment. We elucidated that the cytokines 
responsible for the observed phenotypic changes during LPS challenge and E. coli 
infection were both IFNγ and TNFα. This was reflected by an increase in the 
concentration of these cytokines in the serum. In addition, we found that there was a 
higher concentration of TNFα and IFNγ cytokines produced during E. coli infection 
than during LPS challenge, suggesting that different immunological responses were 
induced. Our results directly compare the haematopoietic response to LPS and E. coli 
infection, showing that a stronger immunological response was exhibited with E. coli. 
Although we did not verify the exact molecular mechanism responsible for the observed 
phenotypic changes in E. coli infection, we did determine that TNFα and IFNγ were 
playing vital roles in the immune response to both E. coli and LPS; in the modulation of 
haematopoietic progenitor phenotypes; in the cessation of lymphopoiesis and in the 
recruitment and export of granulocytes from the BM into the circulation. Our 
observations link the immune response directly with a transient reorganisation of 
developmental pathways in the progenitor compartment of the haematopoietic system 
and define a novel role for both TNFα and IFN-γ as key mediators for a stress-induced 
response of BM haematopoiesis. To assess which specific inflammatory changes were 
induced by LPS and which additional responses occurred after E. coli infection, 
analysing E. coli infection in tlr4-null mice would be necessary. In addition, because 
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LT-HSCs were increased in number during E. coli infection, but not during LPS 
challenge, isolation and cell cycle analysis of LT-HSCs during both inflammatory 
responses would indicate whether LT-HSCs were ‘driven into cycle’ during E. coli 
infection. Furthermore, the isolation and functional analysis of LSK cells for myeloid 
and lymphoid potential during LPS challenge and E. coli may provide information as to 
the degree of plasticity which haematopoietic progenitor cells retain during both 
inflammatory conditions. This could also be further elucidated by analysing the 
transcriptional signature of LSK cells by qRT-PCR during homeostatic conditions and 
after either LPS challenge or E. coli infection. 
We also investigated the effects of age and gender on the composition of lymphoid 
progenitor populations and hoped to provide new insight into the causes of 
immunological deterioration with age, and differences between males and females. 
Although aging is known to reduce the number and function and mature haematopoietic 
cells and of HSCs, there is a lack of evidence for aging significantly inhibiting 
lymphoid progenitor number. In addition, aging analysed simultaneously with gender 
has not been reported. Our data revealed that male mice had a higher frequency and 
number of lymphoid progenitor populations than female mice, regardless of age. This 
indicated that oestrogen could have been exerting an inhibitory effect on lymphoid 
progenitor composition throughout the lifetime of female mice. However, our data also 
indicated that the number of lymphoid progenitors declined in both genders with age. 
Therefore, a reduction in the number of mature T- and B-cells in aged females in 
particular, could be attributable to an extent to a loss of lymphoid progenitor cells via 
oestrogen inhibition and also aging. In contrast, there were no differences in the 
frequency or number of myeloid progenitor cells in female mice compared to male mice 
at six weeks of age, suggesting that myeloid development was not affected by sex 
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hormones. However, the number of myeloid progenitor cells increased in both genders 
with age, which may have been a compensatory mechanism due to the lack of 
lymphopoiesis. It would be informative to measure the levels of oestrogen in young and 
old, male and female mice in order to identify whether the reduced lymphoid cell 
number in females was attributable to high levels of this hormone.  
We also analysed the immune response to LPS in young male and female mice in order 
to assess whether the cytokines produced and the function of mature cells was different 
between genders. After LPS-induced inflammation, male mice produced an overall 
higher number of circulating granulocytes and lymphocytes compared to female mice 
and there was also a delay in the mobilisation of granulocytes into the circulation in 
female mice. Therefore, we expected that male mice would clear the infection quicker 
than females. However, the number of circulating granulocytes and lymphocytes 
returned to steady state levels at an earlier time in female mice. We determined that 
TNFα was partly responsible for the export of granulocytes from the BM in both male 
and female mice, but IFNγ also played a role in females. Therefore one reason for the 
female mice being able to respond to LPS challenge in a shorter time frame was likely 
due to the involvement of additional inflammatory cytokines. This data clearly 
illustrates that the immune response to LPS challenge in males and females is under 
alternate regulation, which may in turn be influenced by hormones. In order to 
determine whether alternate immunological responses in aged mice were also observed, 
LPS challenge in aged male and female mice could be undertaken and directly 
compared to the results from young mice.  
Collectively our results demonstrate that precursor-product relationships between 
haematopoietic progenitor cells may be more complex than what has been previously 
proposed. The findings of markers, such as Rag1, which can separate lymphoid 
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progenitors into functionally and phenotypically distinct subsets suggests that many 
routes of development exist. In addition, the size of these subsets can be influenced by 
many extracellular factors, such as inflammation, aging and gender. In conditions 
whereby the lymphoid lineage is depressed, such as in aged mice or during infection, 
proliferation of the myeloid lineage occurs, suggesting that there is a high degree of 
cellular communication between the innate and adaptive immune system, even at the 
level of early progenitors. This communication undoubtedly leads to the production of 
mature cells which form an adequate immune response in order to maintain protection 
of the host during stressful conditions.  
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